Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NC_000016.9:g.(?_8829577)_(10274288_?)dup	ABAT|GRIN2A|PMM2|USP7|CARHSP1|TMEM186|C16orf72		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV001003189	16	8829577 - 10274288			1003189	986587		
Single allele	ABCA3|CCNF|ECI1|DNASE1L2|E4F1|NTN3|PKD1|TSC2|RNPS1|RAB26|TBC1D24|CASKIN1|MLST8|TEDC2|TRAF7|BRICD5|PGP|MIR1225		not provided	Uncertain significance(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000560100	16	2134202 - 2527088			560100	550816		
NM_001101.5(ACTB):c.474_475dup (p.Val159fs)	ACTB	V159fs	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319337	7	5568238 - 5568239	7	5528607 - 5528608	1319337	1309590		NC_000007.14:5528607:CCCC:CCCCCC
NM_001101.5(ACTB):c.874dup (p.Asp292fs)	ACTB	D292fs	Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Feb 25, 2021)	no assertion criteria provided	VCV001174495	7	5567744 - 5567745	7	5528113 - 5528114	1174495	1163739		NC_000007.14:5528113:C:CC
NM_001101.5(ACTB):c.7_8delinsTT (p.Asp3Phe)	ACTB	D3F	Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000968546	7	5569281 - 5569282	7	5529650 - 5529651	968546	955181		NC_000007.14:5529649:TC:AA
NM_001101.5(ACTB):c.616dup (p.Arg206fs)	ACTB	R206fs	Baraitser-Winter syndrome 1	Uncertain significance(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000944265	7	5568097 - 5568098	7	5528466 - 5528467	944265	924877		NC_000007.14:5528466:G:GG
NM_001101.5(ACTB):c.1097dup (p.Ser368fs)	ACTB	S368fs	Baraitser-Winter syndrome 1|Inborn genetic diseases	Likely pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000495294	7	5567409 - 5567410	7	5527778 - 5527779	495294	486791	rs1554329078	NC_000007.14:5527778:CC:CCC
NM_201525.4(ADGRG1):c.843_844delinsGC (p.Ser281_Gly282delinsArgArg)	ADGRG1		Polymicrogyria, bilateral perisylvian, autosomal recessive|Polymicrogyria, bilateral frontoparietal|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000372698	16	57689385 - 57689386	16	57655473 - 57655474	372698	360182	rs1057517931	NC_000016.10:57655472:CG:GC
NM_201525.4(ADGRG1):c.944_945dup (p.Val316fs)	ADGRG1	V141fs, V264fs, V146fs, V321fs, V316fs	Polymicrogyria, bilateral frontoparietal|not provided	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000211096	16	57689830 - 57689831	16	57655918 - 57655919	211096	208292	rs797045602	NC_000016.10:57655918:TT:TTTT
Single allele	ADORA2A|DDT|GGT1|GGT5|GSTT1|GSTT2|IGLL1|MIF|MMP11|SMARCB1|SNRPD3|ZNF70|SPECC1L|CABIN1|VPREB3|DRICH1|UPB1|SUSD2|SLC2A11|GUCD1|DERL3|C22orf15|RGL4|LRRC75B|CHCHD10|GSTT2B|DDTL		Epilepsy|Intellectual disability	Pathogenic(Last reviewed: Feb 25, 2021)	no assertion criteria provided	VCV000997818	22	23699269 - 24992266			997818	985536		
NM_000682.7(ADRA2B):c.636dup (p.Pro213fs)	ADRA2B	P213fs	not specified	Uncertain significance(Last reviewed: Feb 10, 2019)	criteria provided, single submitter	VCV000929047	2	96781252 - 96781253	2	96115513 - 96115514	929047	916885		NC_000002.12:96115513:CCCCCCC:CCCCCCCC
NM_000682.7(ADRA2B):c.675_686delinsGTTTGGCAG (p.His225_Leu229delinsGlnPheGlyArg)	ADRA2B		Epilepsy, familial adult myoclonic 2	Uncertain significance(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000192366	2	96781203 - 96781214	2	96115464 - 96115475	192366	190153	rs879255577	NC_000002.12:96115463:AAAGCCCCACCA:CTGCCAAAC
NM_006796.3(AFG3L2):c.634dup (p.Val212fs)	AFG3L2	V212fs	Spastic ataxia 5, autosomal recessive	Pathogenic(Last reviewed: Jan 4, 2021)	criteria provided, single submitter	VCV001027438	18	12360043 - 12360044	18	12360044 - 12360045	1027438	1015257		NC_000018.10:12360044:C:CC
NM_001371928.1(AHDC1):c.2424_2425dup (p.Gly809fs)	AHDC1	G809fs	Xia-Gibbs syndrome	Pathogenic(Last reviewed: Apr 7, 2021)	no assertion criteria provided	VCV001064444	1	27876201 - 27876202	1	27549690 - 27549691	1064444	1052634		NC_000001.11:27549690:CAC:CACAC
NM_001080.3(ALDH5A1):c.34dup (p.Ala12fs)	ALDH5A1|GPLD1	A12fs	Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001075244	6	24495254 - 24495255	6	24495026 - 24495027	1075244	1060644		NC_000006.12:24495026:GGGG:GGGGG
NM_001080.3(ALDH5A1):c.967_968dup (p.Gln323fs)	ALDH5A1	Q275fs, Q323fs, Q336fs	Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001073790	6	24520724 - 24520725	6	24520496 - 24520497	1073790	1060649		NC_000006.12:24520496:CA:CACA
NC_000006.11:g.(?_24495225)_(24523163_?)dup	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Uncertain significance(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV001064059	6	24495225 - 24523163			1064059	1039088		
NM_001080.3(ALDH5A1):c.307_308insA (p.Arg103fs)	ALDH5A1	R103fs	Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000948582	6	24495531 - 24495532	6	24495303 - 24495304	948582	924310		NC_000006.12:24495303::A
NM_001080.3(ALDH5A1):c.1506_1521dup (p.Lys508fs)	ALDH5A1	K460fs, K508fs, K521fs	Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000835064	6	24533829 - 24533830	6	24533601 - 24533602	835064	831786		NC_000006.12:24533601:GTGGAGTGCCCTTTTGGTGGAGTG:GTGGAGTGCCCTTTTGGTGGAGTGCCCTTTTGGTGGAGTG
NM_001080.3(ALDH5A1):c.566_567insTTGCCCT (p.Val190fs)	ALDH5A1	V190fs	Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Jul 29, 2018)	criteria provided, single submitter	VCV000663114	6	24503613 - 24503614	6	24503385 - 24503386	663114	634794	rs755029414	NC_000006.12:24503385:GCCCT:GCCCTTTGCCCT
NM_001080.3(ALDH5A1):c.*1267dup	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000356164	6	24535206 - 24535207	6	24534978 - 24534979	356164	299698	rs886061275	NC_000006.12:24534978:A:AA
NM_001080.3(ALDH5A1):c.1343+1_1343+3delinsTT	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 28, 2016)	no assertion criteria provided	VCV000225890	6	24528395 - 24528397	6	24528167 - 24528169	225890	227703	rs875989801	NC_000006.12:24528166:GTA:TT
NM_001182.5(ALDH7A1):c.538dup (p.Glu180fs)	ALDH7A1	E152fs, E180fs	Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001075197	5	125912882 - 125912883	5	126577190 - 126577191	1075197	1060198		NC_000005.10:126577190:C:CC
NM_001182.5(ALDH7A1):c.1412_1415+9delinsGTTGGG	ALDH7A1		Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV001033773	5	125885879 - 125885891	5	126550187 - 126550199	1033773	1020033		NC_000005.10:126550186:AAGTTGTACCCAA:CCCAAC
NM_001182.5(ALDH7A1):c.19_32delinsCACATACTGAGCC (p.Ala7fs)	ALDH7A1	A7fs	Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000857207	5	125930859 - 125930872	5	126595167 - 126595180	857207	829886		NC_000005.10:126595166:TGCACACACAGCGC:GGCTCAGTATGTG
NC_000005.10:g.(?_126575400)_(126575484_?)dup	ALDH7A1		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000832610	5	125911092 - 125911176			832610	819530		
NM_001182.5(ALDH7A1):c.914-118dup	ALDH7A1		Pyridoxine-dependent epilepsy|not provided	Benign(Last reviewed: Aug 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000802152	5	125895126 - 125895127	5	126559434 - 126559435	802152	790511	rs759132307	NC_000005.10:126559434:TTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTT
NM_001182.5(ALDH7A1):c.1566-14dup	ALDH7A1		not provided|Pyridoxine-dependent epilepsy	Likely benign(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000794427	5	125880719 - 125880720	5	126545027 - 126545028	794427	787402	rs1396199299	NC_000005.10:126545027:AAAAAA:AAAAAAA
NM_001182.5(ALDH7A1):c.866_871+2dup	ALDH7A1		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000661262	5	125903948 - 125903949	5	126568256 - 126568257	661262	651338	rs1581378971	NC_000005.10:126568256:ACCAAACC:ACCAAACCACCAAACC
NM_001182.5(ALDH7A1):c.141_142insA (p.Arg48fs)	ALDH7A1	R20fs, R48fs	Pyridoxine-dependent epilepsy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 13, 2020)	criteria provided, conflicting interpretations	VCV000631954	5	125930749 - 125930750	5	126595057 - 126595058	631954	620179	rs1296037862	NC_000005.10:126595057::T
NM_001182.5(ALDH7A1):c.50dup (p.Leu18fs)	ALDH7A1	L18fs	Pyridoxine-dependent epilepsy|Seizures	Conflicting interpretations of pathogenicity(Last reviewed: Sep 9, 2019)	criteria provided, conflicting interpretations	VCV000588446	5	125930840 - 125930841	5	126595148 - 126595149	588446	579107	rs1444879414	NC_000005.10:126595148:TT:TTT
NM_001182.5(ALDH7A1):c.43_46dup (p.Ser16fs)	ALDH7A1	S16fs	Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 19, 2020)	criteria provided, single submitter	VCV000574950	5	125930844 - 125930845	5	126595152 - 126595153	574950	559979	rs767805540	NC_000005.10:126595152:TGGT:TGGTTGGT
NM_001182.5(ALDH7A1):c.*998_*1000dup	ALDH7A1|LOC112997555		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350567	5	125879656 - 125879657	5	126543964 - 126543965	350567	300629	rs60217601	NC_000005.10:126543964:TTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTTT
NM_001182.5(ALDH7A1):c.*999_*1000dup	ALDH7A1|LOC112997555		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350566	5	125879656 - 125879657	5	126543964 - 126543965	350566	300627	rs60217601	NC_000005.10:126543964:TTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTT
NM_001182.5(ALDH7A1):c.*1000dup	ALDH7A1|LOC112997555		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350565	5	125879656 - 125879657	5	126543964 - 126543965	350565	296877	rs60217601	NC_000005.10:126543964:TTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTT
NM_001182.5(ALDH7A1):c.*1002_*1003insA	ALDH7A1|LOC112997555		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350563	5	125879654 - 125879655	5	126543962 - 126543963	350563	300608	rs886059844	NC_000005.10:126543962::T
NM_001182.5(ALDH7A1):c.*1004dup	ALDH7A1|LOC112997555		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350562	5	125879652 - 125879653	5	126543960 - 126543961	350562	296868	rs886059843	NC_000005.10:126543960:G:GG
NM_001182.5(ALDH7A1):c.*1748_*1749delinsAT	ALDH7A1		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350545	5	125878908 - 125878909	5	126543216 - 126543217	350545	296855	rs386692155	NC_000005.10:126543215:CA:AT
NM_001182.5(ALDH7A1):c.*2464dup	ALDH7A1		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350533	5	125878192 - 125878193	5	126542500 - 126542501	350533	295023	rs200155555	NC_000005.10:126542500:AAAAAAAAA:AAAAAAAAAA
NM_001182.5(ALDH7A1):c.*2568_*2569dup	ALDH7A1		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350528	5	125878087 - 125878088	5	126542395 - 126542396	350528	296790	rs771970643	NC_000005.10:126542395:GC:GCGC
NM_001182.5(ALDH7A1):c.*2820dup	ALDH7A1		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350523	5	125877836 - 125877837	5	126542144 - 126542145	350523	300526	rs886059832	NC_000005.10:126542144:A:AA
NM_001182.5(ALDH7A1):c.*2996_*2997dup	ALDH7A1		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350522	5	125877659 - 125877660	5	126541967 - 126541968	350522	300576	rs5871217	NC_000005.10:126541967:AAAAAAAAAAA:AAAAAAAAAAAAA
NM_001182.5(ALDH7A1):c.*2997dup	ALDH7A1		Pyridoxine-dependent epilepsy	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350521	5	125877659 - 125877660	5	126541967 - 126541968	350521	300521	rs5871217	NC_000005.10:126541967:AAAAAAAAAAA:AAAAAAAAAAAA
NM_001182.5(ALDH7A1):c.31_33delinsGAG (p.His11Glu)	ALDH7A1	H11E	not specified|Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000204861	5	125930858 - 125930860	5	126595166 - 126595168	204861	201843	rs796052269	NC_000005.10:126595165:GTG:CTC
NM_021926.4(ALX4):c.976_985delinsCTAAGATCTCAACAGAGATGGCAACT (p.Asp326fs)	ALX4	D326fs	Parietal foramina 2	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000155904	11	44286655 - 44286664	11	44265105 - 44265114	155904	165649	rs587777702	NC_000011.10:44265104:GCACCGGGTC:AGTTGCCATCTCTGTTGAGATCTTAG
NM_000481.4(AMT):c.259-8dup	AMT		Non-ketotic hyperglycinemia	Likely benign(Last reviewed: Nov 9, 2019)	criteria provided, single submitter	VCV001151472	3	49459011 - 49459012	3	49421578 - 49421579	1151472	1135104		NC_000003.12:49421578:AA:AAA
NM_000481.4(AMT):c.878-6dup	AMT		Non-ketotic hyperglycinemia	Likely benign(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001126468	3	49455411 - 49455412	3	49417978 - 49417979	1126468	1114201		NC_000003.12:49417978:G:GG
NM_000481.4(AMT):c.257dup (p.Thr87fs)	AMT	T87fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001075196	3	49459537 - 49459538	3	49422104 - 49422105	1075196	1059852		NC_000003.12:49422104:T:TT
NM_000481.4(AMT):c.609dup (p.Phe204fs)	AMT	F148fs, F160fs, F204fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV001071928	3	49456779 - 49456780	3	49419346 - 49419347	1071928	1059848		NC_000003.12:49419346:GGG:GGGG
NM_000481.4(AMT):c.996dup (p.His333fs)	AMT	H277fs, H289fs, H333fs	not provided|Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000969545	3	49455287 - 49455288	3	49417854 - 49417855	969545	953530		NC_000003.12:49417854:T:TT
NC_000003.12:g.(?_49419700)_(49419798_?)dup	AMT		Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000830943	3	49457133 - 49457231			830943	819408		
NM_000481.4(AMT):c.849dup (p.Val284fs)	AMT	V240fs, V228fs, V284fs	Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000557993	3	49456431 - 49456432	3	49418998 - 49418999	557993	543129	rs1553638408	NC_000003.12:49418998:A:AA
NM_000481.4(AMT):c.57_59dup (p.Pro20dup)	AMT|NICN1		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000556727	3	49459824 - 49459825	3	49422391 - 49422392	556727	543261	rs386833686	NC_000003.12:49422391:GGGGGG:GGGGGGGGG
NM_000481.4(AMT):c.1033+2dup	AMT		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000554551	3	49455248 - 49455249	3	49417815 - 49417816	554551	542984	rs976598152	NC_000003.12:49417815:A:AA
NM_000481.4(AMT):c.982dup (p.Ala328fs)	AMT	A328fs, A284fs, A272fs	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000554261	3	49455301 - 49455302	3	49417868 - 49417869	554261	543236	rs1553638266	NC_000003.12:49417868:CCCCC:CCCCCC
NM_000481.4(AMT):c.705_710dup (p.Pro236_Val237dup)	AMT		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000553314	3	49456570 - 49456571	3	49419137 - 49419138	553314	542986	rs1553638433	NC_000003.12:49419137:ACCGGCACCG:ACCGGCACCGGCACCG
NM_000481.4(AMT):c.1199_1202delinsTAT (p.Tyr400fs)	AMT	Y344fs, Y356fs, Y400fs	Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000553002	3	49454983 - 49454986	3	49417550 - 49417553	553002	542982	rs1553638191	NC_000003.12:49417549:GTAT:ATA
NM_000481.4(AMT):c.1034-1dup	AMT		Non-ketotic hyperglycinemia|not provided	Likely pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552170	3	49455150 - 49455151	3	49417717 - 49417718	552170	543125	rs1238918084	NC_000003.12:49417717:CC:CCC
NM_032316.3(NICN1):c.*2266dup	AMT|NICN1		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346040	3	49459999 - 49460000	3	49422566 - 49422567	346040	295436	rs886058684	NC_000003.12:49422566:GGGGG:GGGGGG
NM_000481.4(AMT):c.982_983delinsT (p.Ala328fs)	AMT	A272fs, A328fs, A284fs	Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056241	3	49455301 - 49455302	3	49417868 - 49417869	56241	70880	rs386833692	NC_000003.12:49417867:GC:A
NC_000012.11:g.(?_4479509)_(6235003_?)dup	ANO2|RAD51AP1|KCNA6|GALNT8|KCNA5|C12orf4|NDUFA9|VWF|FGF6|DYRK4|FGF23|AKAP3|NTF3|KCNA1		Episodic ataxia type 1	Uncertain significance(Last reviewed: Jun 9, 2020)	criteria provided, single submitter	VCV000998926	12	4479509 - 6235003			998926	986501		
NC_000023.10:g.(?_46696536)_(47436910_?)dup	ARAF|CDK16|RP2|SYN1|UBA1|ZNF41|ZNF157|USP11|RBM10|INE1|RGN|JADE3|NDUFB11|LINC01560		Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV001011944	X	46696536 - 47436910			1011944	986717		
NM_020361.5(CPA6):c.1127-25_1127-24dup	ARFGEF1-DT|CPA6		Familial temporal lobe epilepsy 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363601	8	68334940 - 68334941	8	67422705 - 67422706	363601	315167	rs60236534	NC_000008.11:67422705:AAAAAAAAAAA:AAAAAAAAAAAAA
NM_020361.5(CPA6):c.1127-25dup	ARFGEF1-DT|CPA6		Familial temporal lobe epilepsy 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363600	8	68334940 - 68334941	8	67422705 - 67422706	363600	305780	rs60236534	NC_000008.11:67422705:AAAAAAAAAAA:AAAAAAAAAAAA
NM_006420.3(ARFGEF2):c.656dup (p.Val220fs)	ARFGEF2	V220fs	not provided|Hydrocephalus|Seizures|Global developmental delay	Pathogenic(Last reviewed: Mar 10, 2015)	criteria provided, single submitter	VCV000183282	20	47570141 - 47570142	20	48953604 - 48953605	183282	181464	rs730882200	NC_000020.11:48953604:CCCC:CCCCC
NM_001353921.2(ARHGEF9):c.1126_1128dup (p.Asp376dup)	ARHGEF9		Early infantile epileptic encephalopathy 8	Uncertain significance(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000971668	X	62875566 - 62875567	X	63655686 - 63655687	971668	959329		NC_000023.11:63655686:ATC:ATCATC
NM_001353921.2(ARHGEF9):c.583-11dup	ARHGEF9		Early infantile epileptic encephalopathy 8|not provided	Likely benign(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000533664	X	62898459 - 62898460	X	63678579 - 63678580	533664	534888	rs782366734	NC_000023.11:63678579:AAAA:AAAAA
Single allele	ARR3|DLG3|P2RY4|KIF4A|PDZD11|GDPD2|RAB41		Seizures	Likely pathogenic(Last reviewed: May 1, 2018)	no assertion criteria provided	VCV000559404	X	69478269 - 69722349			559404	550134		
NM_139058.3(ARX):c.428_451dup (p.Gly143_Ala150dup)	ARX|LOC109610631		not provided|Epileptic encephalopathy, early infantile, 1|Epileptic encephalopathy, early infantile, 1|Mental retardation, with or without seizures, ARX-related, X-linked|Mental retardation, with or without seizures, ARX-related, X-linked|Partington syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 28, 2018)	criteria provided, conflicting interpretations	VCV000011187	X	25031660 - 25031661	X	25013543 - 25013544	11187	26226	rs387906493	NC_000023.11:25013543:CGGCCGCGGCTGCCGCGGCGGCCCC:CGGCCGCGGCTGCCGCGGCGGCCCCGGCCGCGGCTGCCGCGGCGGCCCC
NM_177924.5(ASAH1):c.1186dup (p.Ter396LeuextTer?)	ASAH1		Farber lipogranulomatosis	Uncertain significance(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000812505	8	17915044 - 17915045	8	18057535 - 18057536	812505	800712	rs1588971545	NC_000008.11:18057535:A:AA
NM_177924.5(ASAH1):c.256dup (p.Thr86fs)	ASAH1	T21fs, T86fs, T102fs	Farber lipogranulomatosis	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000812502	8	17927347 - 17927348	8	18069838 - 18069839	812502	800739	rs1336696568	NC_000008.11:18069838:T:TT
NM_177924.5(ASAH1):c.223_224insC (p.Val75fs)	ASAH1	V75fs, V10fs, V91fs	Spinal muscular atrophy-progressive myoclonic epilepsy syndrome	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812500	8	17927380 - 17927381	8	18069871 - 18069872	812500	800740	rs1588990194	NC_000008.11:18069871::G
NM_177924.5(ASAH1):c.174dup (p.Tyr59fs)	ASAH1	Y75fs, Y82fs, Y59fs	Farber lipogranulomatosis	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812486	8	17928850 - 17928851	8	18071341 - 18071342	812486	800742	rs771718522	NC_000008.11:18071341:GGG:GGGG
NM_177924.5(ASAH1):c.594_599dup (p.Lys200_Ala201insAsnPhe)	ASAH1		Spinal muscular atrophy-progressive myoclonic epilepsy syndrome|Farber lipogranulomatosis	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812481	8	17919836 - 17919837	8	18062327 - 18062328	812481	800727	rs1588978684	NC_000008.11:18062327:TTGAAG:TTGAAGTTGAAG
NM_015338.6(ASXL1):c.2763_2770delinsCAA (p.Val922fs)	ASXL1	V861fs, V922fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000521462	20	31023278 - 31023285	20	32435475 - 32435482	521462	512445	rs1555912285	NC_000020.11:32435474:TGTTGAGC:CAA
NM_001940.4(ATN1):c.3177_3178insAACCTG (p.His1060_Leu1061insAsnLeu)	ATN1		not provided|Congenital hypotonia, epilepsy, developmental delay, and digital anomalies	Uncertain significance(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000421998	12	7048302 - 7048303	12	6939139 - 6939140	421998	408742	rs1064795494	NC_000012.12:6939139:G:GAACCTG
NM_000702.4(ATP1A2):c.2841-20dup	ATP1A2		not specified|not provided	Benign(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000204875	1	160109408 - 160109409	1	160139618 - 160139619	204875	201101	rs397775888	NC_000001.11:160139618:CC:CCC
NC_000019.10:g.(?_41966917)_(41978818_?)dup	ATP1A3		Dystonia 12	Uncertain significance(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000831836	19	42471069 - 42482970			831836	821260		
NM_152296.5(ATP1A3):c.2095-5_2095-4insCCCTTACCCTGCA	ATP1A3		Dystonia 12|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 3, 2021)	criteria provided, conflicting interpretations	VCV000644620	19	42479953 - 42479954	19	41975801 - 41975802	644620	653054	rs782804502	NC_000019.10:41975801:AGGG:AGGGTGCAGGGTAAGGG
NM_152296.5(ATP1A3):c.2512_2516delinsTC (p.Arg838_Leu839delinsSer)	ATP1A3		Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: Nov 7, 2014)	criteria provided, single submitter	VCV000369662	19	42474363 - 42474367	19	41970211 - 41970215	369662	353910	rs1057516032	NC_000019.10:41970210:AGTCT:GA
NM_003193.5(TBCE):c.1491_1491+4dup	B3GALNT2|TBCE		not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2020)	criteria provided, conflicting interpretations	VCV000520625	1	235611752 - 235611753	1	235448437 - 235448438	520625	511248	rs746593718	NC_000001.11:235448437:AAAGTAA:AAAGTAAAGTAA
NC_000006.11:g.(?_33388042)_(33756893_?)dup	BAK1|ITPR3|SYNGAP1|UQCC2|IP6K3|LEMD2|ZBTB9		Mental retardation, autosomal dominant 5	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001004060	6	33388042 - 33756893			1004060	986317		
NC_000006.12:g.(?_33391986)_(33672228_?)dup	BAK1|ITPR3|KIFC1|PHF1|SYNGAP1|CUTA|ZBTB9		Mental retardation, autosomal dominant 5	Uncertain significance(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000832257	6	33359763 - 33640005			832257	819684		
NM_024649.5(BBS1):c.1424dup (p.Ser476fs)	BBS1|ZDHHC24	S476fs	Bardet-Biedl syndrome	Pathogenic	no assertion criteria provided	VCV000266084	11	66297373 - 66297374	11	66529902 - 66529903	266084	260912	rs886039798	NC_000011.10:66529902:T:TT
NM_152743.4(BRAT1):c.453_454insGAGAAGAT (p.Leu152fs)	BRAT1	L152fs	Rigidity and multifocal seizure syndrome, lethal neonatal	Pathogenic(Last reviewed: Oct 3, 2012)	no assertion criteria provided	VCV000180136	7	2583573 - 2583574	7	2543939 - 2543940	180136	178317	rs1554296088	NC_000007.14:2543939::ATCTTCTC
NC_000007.13:g.(?_145813093)_(148544390_?)dup	C7orf33|EZH2|CNTNAP2|CUL1		Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001015724	7	145813093 - 148544390			1015724	1001551		
NC_000007.14:g.(?_146116001)_(148847318_?)dup	C7orf33|CNTNAP2|CUL1|EZH2		Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Sep 20, 2019)	criteria provided, single submitter	VCV000831861	7	145813093 - 148544410			831861	819843		
NM_001293675.1(CA2):c.-268_-266dup	CA2|CA3-AS1		Osteopetrosis with renal tubular acidosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363831	8	86376226 - 86376227	8	85463997 - 85463998	363831	305945	rs886063147	NC_000008.11:85463997:CCC:CCCCCC
NM_021098.3(CACNA1H):c.5174-4dup	CACNA1H		Hyperaldosteronism, familial, type IV|Idiopathic generalized epilepsy	Benign(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001169771	16	1265516 - 1265517	16	1215516 - 1215517	1169771	1157618		NC_000016.10:1215516:CCC:CCCC
NM_021098.3(CACNA1H):c.1120-3dup	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Benign(Last reviewed: Nov 25, 2020)	criteria provided, single submitter	VCV001165632	16	1250706 - 1250707	16	1200706 - 1200707	1165632	1157604		NC_000016.10:1200706:CCCCCCC:CCCCCCCC
NM_021098.3(CACNA1H):c.4929+7_4929+8delinsTG	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001126906	16	1263938 - 1263939	16	1213938 - 1213939	1126906	1124876		NC_000016.10:1213937:GC:TG
NC_000016.9:g.(?_1244962)_(1260981_?)dup	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Jun 18, 2020)	criteria provided, single submitter	VCV001056316	16	1244962 - 1260981			1056316	1039193		
NC_000016.9:g.(?_1248605)_(1270994_?)dup	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV001023830	16	1248605 - 1270994			1023830	1001768		
NM_021098.3(CACNA1H):c.1991_1992delinsCT (p.Val664Ala)	CACNA1H	V664A	Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000961897	16	1252441 - 1252442	16	1202441 - 1202442	961897	949141		NC_000016.10:1202440:TC:CT
NC_000016.10:g.(?_1214952)_(1221014_?)dup	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000833406	16	1264952 - 1271014			833406	820763		
NC_000016.10:g.(?_1194952)_(1221014_?)dup	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000832344	16	1244952 - 1271014			832344	820762		
NM_021098.3(CACNA1H):c.2002+11_2002+14dup	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Likely benign(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000796937	16	1252460 - 1252461	16	1202460 - 1202461	796937	788174	rs1489074089	NC_000016.10:1202460:CCAGCC:CCAGCCAGCC
NM_021098.3(CACNA1H):c.3422_3442dup (p.Arg1141_Ser1147dup)	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000644729	16	1259078 - 1259079	16	1209078 - 1209079	644729	643867	rs746597383	NC_000016.10:1209078:CTGGAGCAGCCGGCGCTCCAGCTGGAGCAGCC:CTGGAGCAGCCGGCGCTCCAGCTGGAGCAGCCGGCGCTCCAGCTGGAGCAGCC
NM_021098.3(CACNA1H):c.4318_4319delinsGC (p.Phe1440Ala)	CACNA1H	F1440A	Hyperaldosteronism, familial, type IV|Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: May 26, 2018)	criteria provided, single submitter	VCV000573104	16	1261262 - 1261263	16	1211262 - 1211263	573104	567630	rs1567541260	NC_000016.10:1211261:TT:GC
NM_021098.3(CACNA1H):c.4223+8dup	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV|not specified	Benign(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000529677	16	1260973 - 1260974	16	1210973 - 1210974	529677	529699	rs545116263	NC_000016.10:1210973:GGGGGG:GGGGGGG
NM_021098.3(CACNA1H):c.4780_4781delinsTT (p.Ala1594Phe)	CACNA1H	A1594F, A1588F	not provided|Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000460126	16	1263782 - 1263783	16	1213782 - 1213783	460126	465664	rs1555518356	NC_000016.10:1213781:GC:TT
NM_021098.3(CACNA1H):c.2209_2286delinsAGCAGA (p.Gly737_Arg761delinsSer)	CACNA1H		not provided|Epilepsy, childhood absence 6|Hyperaldosteronism, familial, type IV|Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Sep 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000423060	16	1254216 - 1254293	16	1204216 - 1204293	423060	409441	rs1555513044	
NC_000002.11:g.(?_152466313)_(152698612_?)dup	CACNB4|NEB|ARL5A		Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV000999127	2	152466313 - 152698612			999127	986182		
NM_000726.5(CACNB4):c.*151dup	CACNB4		Juvenile myoclonic epilepsy|Episodic ataxia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331628	2	152695481 - 152695482	2	151838967 - 151838968	331628	284930	rs79470866	NC_000002.12:151838967:TTTTTTTTTTT:TTTTTTTTTTTT
NM_000726.5(CACNB4):c.*454dup	CACNB4		Juvenile myoclonic epilepsy|Episodic ataxia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331623	2	152695178 - 152695179	2	151838664 - 151838665	331623	284501	rs879114509	NC_000002.12:151838664:TTTTTTTTTTTT:TTTTTTTTTTTTT
NM_000726.5(CACNB4):c.*1501dup	CACNB4		Juvenile myoclonic epilepsy|Episodic ataxia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331605	2	152694131 - 152694132	2	151837617 - 151837618	331605	282273	rs886054963	NC_000002.12:151837617:TTTTTTTTTTT:TTTTTTTTTTTT
NM_000726.5(CACNB4):c.*5995dup	CACNB4		Episodic ataxia|Juvenile myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331549	2	152689637 - 152689638	2	151833123 - 151833124	331549	284781	rs886054949	NC_000002.12:151833123:TTTTTT:TTTTTTT
NM_014008.5(CCDC22):c.514_515delinsAG (p.Pro172Arg)	CCDC22	P172R	Ritscher-schinzel syndrome 2	Uncertain significance(Last reviewed: Jan 27, 2021)	criteria provided, single submitter	VCV000995994	X	49099629 - 49099630	X	49243163 - 49243164	995994	983695		NC_000023.11:49243162:CC:AG
NC_000016.9:g.(?_2098597)_(2550979_?)dup	CCNF|ECI1|DNASE1L2|ABCA3|E4F1|NTN3|PKD1|TSC2|RNPS1|RAB26|TBC1D24|CASKIN1|MLST8|TEDC2|TRAF7|BRICD5|PGP|MIR1225		Epileptic encephalopathy, early infantile, 1|Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65	Uncertain significance(Last reviewed: Apr 13, 2020)	criteria provided, single submitter	VCV001010653	16	2098597 - 2550979			1010653	986566		
NM_001037343.1:c.100-?_744+?dup	CDKL5		Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Jan 20, 2017)	criteria provided, single submitter	VCV000813741					813741	802065		
NM_001323289.2(CDKL5):c.751delinsTC (p.Ala251fs)	CDKL5	A251fs	Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000523629	X	18613474	X	18595354	523629	514279	rs1555951141	NC_000023.11:18595353:G:TC
NM_001323289.2(CDKL5):c.275_276insAA (p.Glu93fs)	CDKL5	E93fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189584	X	18593603 - 18593604	X	18575483 - 18575484	189584	187586	rs786204982	NC_000023.11:18575483::AA
NM_001323289.2(CDKL5):c.1784dup (p.Leu596fs)	CDKL5	L596fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189566	X	18622826 - 18622827	X	18604706 - 18604707	189566	187618	rs786204974	NC_000023.11:18604706:GG:GGG
NM_001323289.2(CDKL5):c.2254dup (p.Arg752fs)	CDKL5	R752fs	not provided	Pathogenic(Last reviewed: Sep 5, 2013)	criteria provided, single submitter	VCV000156649	X	18631368 - 18631369	X	18613248 - 18613249	156649	166503	rs587783121	NC_000023.11:18613248:AAAAA:AAAAAA
NM_001323289.2(CDKL5):c.1795dup (p.Thr599fs)	CDKL5	T599fs	not provided	Pathogenic(Last reviewed: Dec 19, 2012)	criteria provided, single submitter	VCV000156644	X	18622838 - 18622839	X	18604718 - 18604719	156644	166498	rs587783116	NC_000023.11:18604718:A:AA
NM_001323289.2(CDKL5):c.808dup (p.Leu270fs)	CDKL5	L270fs	not provided	Pathogenic(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	VCV000156640	X	18613530 - 18613531	X	18595410 - 18595411	156640	166494	rs587783112	NC_000023.11:18595410:C:CC
NM_001323289.2(CDKL5):c.867dup (p.Gln290fs)	CDKL5	Q290fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143836	X	18616621 - 18616622	X	18598501 - 18598502	143836	153568	rs267608537	NC_000023.11:18598501:AA:AAA
NC_000012.12:g.(?_12717002)_(13982130_?)dup	CDKN1B|EMP1|GRIN2B|GPRC5A|HEBP1|DDX47|GPRC5D|FAM234B|APOLD1|GSG1		Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Uncertain significance(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000831573	12	12869936 - 14135064			831573	820453		
NC_000019.9:g.(?_19004205)_(19006901_?)dup	CERS1|GDF1		Epilepsy, progressive myoclonic 8	Uncertain significance(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV001023831	19	19004205 - 19006901			1023831	1001852		
NM_021267.5(CERS1):c.18_29dup (p.3AAGP[3])	CERS1|GDF1		Epilepsy, progressive myoclonic 8	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001017910	19	19006852 - 19006853	19	18896043 - 18896044	1017910	1013623		NC_000019.10:18896043:GGCCCCGCCGCGGGCCCCGCCGC:GGCCCCGCCGCGGGCCCCGCCGCGGGCCCCGCCGC
NM_017780.4(CHD7):c.5167dup (p.Gln1723fs)	CHD7	Q1723fs	Inborn genetic diseases	Pathogenic	criteria provided, single submitter	VCV000208735	8	61757923 - 61757924	8	60845364 - 60845365	208735	205257	rs797044919	NC_000008.11:60845364:CC:CCC
NM_000742.4(CHRNA2):c.1563_1564delinsCT (p.Pro522Ser)	CHRNA2	P324S, P363S, P507S, P522S	Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001057502	8	27319172 - 27319173	8	27461655 - 27461656	1057502	1045445		NC_000008.11:27461654:GC:AG
NC_000008.10:g.(?_27319126)_(27328595_?)dup	CHRNA2		Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV000999128	8	27319126 - 27328595			999128	986380		
NM_000742.4(CHRNA2):c.607_629delinsATAAGTCCAG (p.Ser203fs)	CHRNA2	S203fs, S188fs, S44fs, S5fs	Seizures|Autosomal dominant nocturnal frontal lobe epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: May 20, 2020)	criteria provided, conflicting interpretations	VCV000969097	8	27321331 - 27321353	8	27463814 - 27463836	969097	955387		NC_000008.11:27463813:TTGGCCTTGTCATAAGTCCAGGA:CTGGACTTAT
NM_000742.4(CHRNA2):c.1105dup (p.Ala369fs)	CHRNA2	A171fs, A210fs, A369fs, A354fs	Epilepsy, nocturnal frontal lobe, type 4|Seizures	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000587981	8	27320854 - 27320855	8	27463337 - 27463338	587981	579376	rs757376257	NC_000008.11:27463337:CCCCCC:CCCCCCC
NM_000742.4(CHRNA2):c.295-16_295-7dup	CHRNA2		not provided|Autosomal dominant nocturnal frontal lobe epilepsy	Benign(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000476991	8	27326902 - 27326903	8	27469385 - 27469386	476991	457736	rs776047724	NC_000008.11:27469385:CAGAGAGAGACAGAG:CAGAGAGAGACAGAGAGAGACAGAG
NM_000742.3(CHRNA2):c.-575_-574insAT	CHRNA2		Nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000362720	8	27336778 - 27336779	8	27479261 - 27479262	362720	308787	rs886062854	NC_000008.11:27479261:A:ATA
NM_000742.4(CHRNA2):c.557_558delinsCG (p.Asp186Ala)	CHRNA2	D186A, D27A, D171A	not specified	Uncertain significance(Last reviewed: Jul 28, 2014)	criteria provided, single submitter	VCV000204984	8	27321402 - 27321403	8	27463885 - 27463886	204984	202246	rs796052308	NC_000008.11:27463884:GT:CG
NM_000744.7(CHRNA4):c.1523_1525dup (p.Gly508dup)	CHRNA4		Autosomal dominant nocturnal frontal lobe epilepsy|not provided	Uncertain significance(Last reviewed: Apr 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV001058902	20	61981237 - 61981238	20	63349885 - 63349886	1058902	1051767		NC_000020.11:63349885:CGCCG:CGCCGCCG
NM_000744.7(CHRNA4):c.1030dup (p.Val344fs)	CHRNA4	V168fs, V344fs	Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001021605	20	61981732 - 61981733	20	63350380 - 63350381	1021605	1014191		NC_000020.11:63350380:CCC:CCCC
NM_000744.7(CHRNA4):c.1208_1209delinsT (p.Pro403fs)	CHRNA4	P403fs, P227fs	Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000969516	20	61981554 - 61981555	20	63350202 - 63350203	969516	958861		NC_000020.11:63350201:CG:A
NC_000020.10:g.(?_61977556)_(62159505_?)dup	CHRNA4|KCNQ2|PPDPF|EEF1A2		Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Nov 24, 2019)	criteria provided, single submitter	VCV000831460	20	61977556 - 62159505			831460	821310		
NC_000020.11:g.(?_63346204)_(63361854_?)dup	CHRNA4		Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000831209	20	61977556 - 61993206			831209	821337		
NM_000744.7(CHRNA4):c.29_43dup (p.Arg10_Pro14dup)	CHRNA4|LOC100130587		Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000577933	20	61992474 - 61992475	20	63361122 - 63361123	577933	575129	rs777630161	NC_000020.11:63361122:GCGGCGGCAGCAGCCGCGGCG:GCGGCGGCAGCAGCCGCGGCGGCAGCAGCCGCGGCG
NM_000744.7(CHRNA4):c.1178dup (p.Ala394fs)	CHRNA4	A218fs, A394fs	Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000477000	20	61981584 - 61981585	20	63350232 - 63350233	477000	470970	rs1435638963	NC_000020.11:63350232:GGGGG:GGGGGG
NM_000744.7(CHRNA4):c.38_52dup (p.Pro13_Leu17dup)	CHRNA4|LOC100130587		not specified|Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000447035	20	61992465 - 61992466	20	63361113 - 63361114	447035	442307	rs771936944	NC_000020.11:63361113:GCAGCAGCAGCGGCGGCAGCAGC:GCAGCAGCAGCGGCGGCAGCAGCAGCGGCGGCAGCAGC
NM_000744.7(CHRNA4):c.38_49dup (p.Pro13_Leu16dup)	CHRNA4|LOC100130587		Autosomal dominant nocturnal frontal lobe epilepsy|Seizures|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 16, 2021)	criteria provided, conflicting interpretations	VCV000420173	20	61992468 - 61992469	20	63361116 - 63361117	420173	410811	rs1064794327	NC_000020.11:63361116:GCAGCAGCGGCGGCAGCAGC:GCAGCAGCGGCGGCAGCAGCGGCGGCAGCAGC
NM_000744.7(CHRNA4):c.1158_1160delinsGGG (p.Glu387Gly)	CHRNA4	E387G, E211G	not specified	Uncertain significance(Last reviewed: Apr 26, 2013)	criteria provided, single submitter	VCV000205048	20	61981603 - 61981605	20	63350251 - 63350253	205048	203659	rs796052320	NC_000020.11:63350250:TCG:CCC
CHRNA4, 3-BP INS, 776GCT	CHRNA4		Epilepsy, nocturnal frontal lobe, type 1	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000017499					17499	32538		
Single allele	CHRNA7		Epilepsy|Autism spectrum disorder	Uncertain significance(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000223111	15	31956036 - 32511581			223111	224837		
Single allele	CHRNA7		Epilepsy|Autism spectrum disorder	Uncertain significance(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000223110	15	32024192 - 32509926			223110	224836		
NM_000748.3(CHRNB2):c.1035_1036delinsTT (p.Ala345_Leu346=)	CHRNB2		Autosomal dominant nocturnal frontal lobe epilepsy	Likely benign(Last reviewed: Jun 27, 2020)	criteria provided, single submitter	VCV000762054	1	154544334 - 154544335	1	154571858 - 154571859	762054	761232	rs1571022654	NC_000001.11:154571857:GC:TT
NM_004366.6(CLCN2):c.1113delinsACTGCTCAT (p.Ser375fs)	CLCN2	S331fs, S375fs	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000217787	3	184073539	3	184355751	217787	214437	rs863225251	NC_000003.12:184355750:G:ATGAGCAGT
NM_004366.6(CLCN2):c.828dup (p.Arg277fs)	CLCN2	R233fs, R277fs	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000100632	3	184075219 - 184075220	3	184357431 - 184357432	100632	106504	rs587777112	NC_000003.12:184357431:CC:CCC
NM_004366.6(CLCN2):c.597dup (p.Met200fs)	CLCN2	M156fs, M200fs	Leukoencephalopathy with ataxia|Epilepsy, juvenile myoclonic 8	Conflicting interpretations of pathogenicity(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000009035	3	184075767 - 184075768	3	184357979 - 184357980	9035	24074	rs515726131	NC_000003.12:184357979:CCC:CCCC
NC_000016.10:g.(?_28475343)_(28477877_?)dup	CLN3		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000832660	16	28486664 - 28489198			832660	820815		
NC_000016.9:g.(?_28486664)_(28489218_?)dup	CLN3		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000652953	16	28486664 - 28489218	16	28475343 - 28477897	652953	652835		
NC_000016.9:g.(?_28488817)_(28489218_?)dup	CLN3		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000642645	16	28488817 - 28489218	16	28477496 - 28477897	642645	652618		
NC_000016.9:g.(?_28486664)_(28503100_?)dup	CLN3		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000583689	16	28486664 - 28503100	16	28475343 - 28491779	583689	573657		
NC_000016.9:g.(?_28499892)_(28503100_?)dup	CLN3		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000583552	16	28499892 - 28503100	16	28488571 - 28491779	583552	573659		
NM_001042432.2(CLN3):c.569dup (p.Ala191fs)	CLN3	A113fs, A91fs, A191fs, A137fs, A167fs	not provided|Neuronal ceroid lipofuscinosis 3|Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457954	16	28497775 - 28497776	16	28486454 - 28486455	457954	466315	rs386833732	NC_000016.10:28486454:CCCCC:CCCCCC
NM_001042432.2(CLN3):c.375-19_375-4dup	CLN3		not specified|Neuronal ceroid lipofuscinosis	Likely benign(Last reviewed: Nov 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457952	16	28498865 - 28498866	16	28487544 - 28487545	457952	466595	rs755313503	NC_000016.10:28487544:AGGGGGTGAGAAGGGAAGGG:AGGGGGTGAGAAGGGAAGGGGGTGAGAAGGGAAGGG
NM_001042432.2(CLN3):c.944dup (p.His315fs)	CLN3	H315fs, H215fs, H237fs, H261fs, H291fs	Neuronal ceroid lipofuscinosis 3|Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Aug 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056292	16	28493665 - 28493666	16	28482344 - 28482345	56292	70931	rs386833740	NC_000016.10:28482344:T:TT
NM_001042432.2(CLN3):c.622dup (p.Ser208fs)	CLN3	S130fs, S184fs, S208fs, S108fs, S154fs	Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 3	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000056287	16	28497722 - 28497723	16	28486401 - 28486402	56287	70926	rs386833736	NC_000016.10:28486401:A:AA
NM_006493.4(CLN5):c.955_956delinsCG (p.Lys319Arg)	CLN5|FBXL3	K319R	not provided|Neuronal ceroid lipofuscinosis	Benign/Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV001093126	13	77574982 - 77574983	13	77000847 - 77000848	1093126	1080185		NC_000013.11:77000846:AA:CG
NM_006493.4(CLN5):c.84_96dup (p.Leu33fs)	CLN5	L33fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Aug 29, 2020)	criteria provided, single submitter	VCV001069801	13	77566312 - 77566313	13	76992177 - 76992178	1069801	1063036		NC_000013.11:76992177:GCTGGGCCCTGGCGCTG:GCTGGGCCCTGGCGCTGGGCCCTGGCGCTG
NM_006493.4(CLN5):c.844_845dup (p.Thr283fs)	CLN5|FBXL3	T283fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000950549	13	77574870 - 77574871	13	77000735 - 77000736	950549	926951		NC_000013.11:77000735:AA:AAAA
NC_000013.11:g.(?_76995053)_(76995238_?)dup	CLN5		Neuronal ceroid lipofuscinosis	Likely pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000832645	13	77569188 - 77569373			832645	820590		
NC_000013.11:g.(?_76991932)_(77000989_?)dup	CLN5		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000832490	13	77566067 - 77575124			832490	820589		
NM_006493.4(CLN5):c.112_113insATCCGGGCTGG (p.Val38fs)	CLN5	V38fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000527726	13	77566342 - 77566343	13	76992207 - 76992208	527726	528169	rs1555273604	NC_000013.11:76992207:TGG:TGGATCCGGGCTGG
NM_006493.4(CLN5):c.565+3_565+4dup	CLN5|FBXL3		not provided|Neuronal ceroid lipofuscinosis	Conflicting interpretations of pathogenicity(Last reviewed: Sep 9, 2020)	criteria provided, conflicting interpretations	VCV000457967	13	77570264 - 77570265	13	76996129 - 76996130	457967	463376	rs745312608	NC_000013.11:76996129:AA:AAAA
NM_006493.4(CLN5):c.522dup (p.Trp175fs)	CLN5|FBXL3	W175fs	Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 5	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056543	13	77570218 - 77570219	13	76996083 - 76996084	56543	71182	rs386833979	NC_000013.11:76996083:C:CC
NM_006493.4(CLN5):c.144dup (p.Ser49fs)	CLN5	S49fs	Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis	Likely pathogenic(Last reviewed: May 23, 2021)	criteria provided, single submitter	VCV000056532	13	77566373 - 77566374	13	76992238 - 76992239	56532	71171	rs386833970	NC_000013.11:76992238:CCCC:CCCCC
NM_017882.3(CLN6):c.218_220dup (p.Trp73dup)	CLN6		Neuronal ceroid lipofuscinosis 6	Pathogenic(Last reviewed: Jul 26, 2021)	no assertion criteria provided	VCV001184729	15	68506704 - 68506705	15	68214366 - 68214367	1184729	1174643		NC_000015.10:68214366:ACCAC:ACCACCAC
NM_017882.3(CLN6):c.196dup (p.Met66fs)	CLN6	M66fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Aug 8, 2020)	criteria provided, single submitter	VCV001075854	15	68510875 - 68510876	15	68218537 - 68218538	1075854	1063401		NC_000015.10:68218537:T:TT
NM_017882.3(CLN6):c.712_713delinsAC (p.Phe238Thr)	CLN6	F238T	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jun 4, 2020)	criteria provided, single submitter	VCV001072428	15	68500701 - 68500702	15	68208363 - 68208364	1072428	1063399		NC_000015.10:68208362:AA:GT
NC_000015.9:g.(?_68500478)_(68521922_?)dup	CLN6		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001047554	15	68500478 - 68521922			1047554	1022358		
NM_017882.3(CLN6):c.61_62insCGG (p.Gly21_Ala22insAla)	CLN6		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000241228	15	68521861 - 68521862	15	68229523 - 68229524	241228	242108	rs878855040	NC_000015.10:68229523:CC:CCGCC
NM_017882.3(CLN6):c.268_271dup (p.Val91fs)	CLN6	V91fs	Neuronal ceroid lipofuscinosis 6|Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Mar 25, 2020)	criteria provided, single submitter	VCV000004086	15	68506653 - 68506654	15	68214315 - 68214316	4086	19125	rs786205067	NC_000015.10:68214315:CGTT:CGTTCGTT
NM_018941.4(CLN8):c.593_596dup (p.Met200fs)	CLN8	M200fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000952744	8	1728463 - 1728464	8	1780297 - 1780298	952744	925138		NC_000008.11:1780297:ATTCA:ATTCATTCA
NC_000008.10:g.(?_1719201)_(1728753_?)dup	CLN8		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000457934	8	1719201 - 1728753	8	1771035 - 1780587	457934	458115		
NM_018941.4(CLN8):c.-125_-124+19dup	CLN8|CLN8-AS1		not specified|Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418138	8	1712044 - 1712045	8	1763878 - 1763879	418138	407350	rs1064793088	NC_000008.11:1763878:AGCCCAGGTGAGCGCTCAGGGAGCCC:AGCCCAGGTGAGCGCTCAGGGAGCCCAGGTGAGCGCTCAGGGAGCCC
NM_001258392.3(CLPB):c.221dup (p.Gly76fs)	CLPB	G76fs	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Likely pathogenic(Last reviewed: Apr 30, 2021)	criteria provided, single submitter	VCV001172515	11	72145297 - 72145298	11	72434253 - 72434254	1172515	1161628		NC_000011.10:72434253:T:TT
NM_001258392.3(CLPB):c.1293dup (p.Asp432fs)	CLPB	D403fs, D417fs, D432fs, D462fs	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, single submitter	VCV001074465	11	72012882 - 72012883	11	72301838 - 72301839	1074465	1062503		NC_000011.10:72301838:T:TT
NM_001258392.3(CLPB):c.449_451delinsAATAT (p.Val150fs)	CLPB	S69fs, V150fs	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000972600	11	72141360 - 72141362	11	72430316 - 72430318	972600	956663		NC_000011.10:72430315:TGA:ATATT
NM_001258392.3(CLPB):c.1474_1475delinsTG (p.Ala492Cys)	CLPB	A477C, A522C, A463C, A492C	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia|not provided	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000542782	11	72006547 - 72006548	11	72295503 - 72295504	542782	526524	rs1555085159	NC_000011.10:72295502:GC:CA
NM_001258392.3(CLPB):c.1847dup (p.Cys617fs)	CLPB	C588fs, C602fs, C617fs, C647fs	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000279612	11	72004597 - 72004598	11	72293553 - 72293554	279612	263873	rs886041119	NC_000011.10:72293553:CCCCC:CCCCCC
NM_005076.5(CNTN2):c.2273_2274delinsAT (p.Trp758Tyr)	CNTN2	W758Y	Epilepsy, familial adult myoclonic, 5|not provided	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000423039	1	205039031 - 205039032	1	205069903 - 205069904	423039	405020	rs1064796187	NC_000001.11:205069902:GG:AT
NC_000007.13:g.(?_146740989)_(146997392_?)dup	CNTNAP2		Pitt-Hopkins-like syndrome 1	Likely pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001066418	7	146740989 - 146997392			1066418	1054424		
NC_000007.13:g.(?_146740979)_(146741166_?)dup	CNTNAP2		Pitt-Hopkins-like syndrome 1	Likely pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV001066417	7	146740979 - 146741166			1066417	1054423		
NC_000007.13:g.(?_145813093)_(147092892_?)dup	CNTNAP2		Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV001015725	7	145813093 - 147092892			1015725	1001550		
NC_000007.13:g.(?_147600637)_(148112728_?)dup	CNTNAP2		Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV001007963	7	147600637 - 148112728			1007963	986346		
NC_000007.13:g.(?_147336188)_(147336408_?)dup	CNTNAP2		Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001004172	7	147336188 - 147336408			1004172	986345		
NM_014141.6(CNTNAP2):c.5_8dup (p.Ala4fs)	CNTNAP2	A4fs	Pitt-Hopkins-like syndrome 1	Likely pathogenic	criteria provided, single submitter	VCV000974853	7	145813970 - 145813971	7	146116878 - 146116879	974853	963145		NC_000007.14:146116878:GCAGGC:GCAGGCAGGC
NM_014141.6(CNTNAP2):c.481dup (p.Ile161fs)	CNTNAP2	I161fs	Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000947629	7	146741076 - 146741077	7	147043984 - 147043985	947629	924733		NC_000007.14:147043984:A:AA
NC_000007.14:g.(?_147977842)_(147978009_?)dup	CNTNAP2		Pitt-Hopkins-like syndrome 1	Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000832667	7	147674934 - 147675101			832667	819848		
NC_000007.14:g.(?_146116001)_(146116993_?)dup	CNTNAP2		Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000832646	7	145813093 - 145814085			832646	819841		
NM_014141.6(CNTNAP2):c.3716-7_3716-6insTTCC	CNTNAP2		Pitt-Hopkins-like syndrome 1	Likely benign(Last reviewed: Jul 2, 2020)	criteria provided, single submitter	VCV000705611	7	148106476 - 148106477	7	148409384 - 148409385	705611	695355	rs1585354260	NC_000007.14:148409384::TTCC
NC_000007.13:g.(?_147600637)_(147844821_?)dup	CNTNAP2		Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Dec 29, 2018)	criteria provided, single submitter	VCV000663425	7	147600637 - 147844821	7	147903545 - 148147729	663425	651652		
NC_000007.13:g.(?_145813093)_(146537016_?)dup	CNTNAP2		Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000584067	7	145813093 - 146537016	7	146116001 - 146839924	584067	563845		
NC_000007.13:g.(?_147259210)_(147259369_?)dup	CNTNAP2		Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000536343	7	147259210 - 147259369	7	147562118 - 147562277	536343	522253		
NM_014141.6(CNTNAP2):c.3716-7_3716-6insTT	CNTNAP2		Pitt-Hopkins-like syndrome 1|not provided	Benign(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000516869	7	148106475 - 148106476	7	148409383 - 148409384	516869	501917	rs72268642	NC_000007.14:148409383:T:TTT
NM_014141.6(CNTNAP2):c.3716-5_3716-4insGT	CNTNAP2		Pitt-Hopkins-like syndrome 1|not provided	Benign(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000468432	7	148106477 - 148106478	7	148409385 - 148409386	468432	456450	rs60451214	NC_000007.14:148409385:T:TGT
NM_014141.6(CNTNAP2):c.3922_3970dup (p.Glu1324delinsGlyArgArgHisHisGluGlnArgProGlnLeuHisArgAspHisTer)	CNTNAP2		Pitt-Hopkins-like syndrome 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2020)	criteria provided, conflicting interpretations	VCV000451490	7	148112632 - 148112633	7	148415540 - 148415541	451490	444093	rs757043221	NC_000007.14:148415540:GGACGCCGCCATCATGAACAACGACCCCAACTTCACAGAGACCATTGATG:GGACGCCGCCATCATGAACAACGACCCCAACTTCACAGAGACCATTGATGGACGCCGCCATCATGAACAACGACCCCAACTTCACAGAGACCATTGATG
NM_014141.6(CNTNAP2):c.*3999dup	CNTNAP2		Pitt-Hopkins-like syndrome 1|Pitt-Hopkins-like syndrome|not provided	Benign(Last reviewed: May 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000359261	7	148116692 - 148116693	7	148419600 - 148419601	359261	310143	rs35835723	NC_000007.14:148419600:TTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTT
NM_014141.6(CNTNAP2):c.*2875dup	CNTNAP2		Pitt-Hopkins-like syndrome 1|Pitt-Hopkins-like syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359238	7	148115582 - 148115583	7	148418490 - 148418491	359238	302136	rs138367128	NC_000007.14:148418490:G:GG
NM_014141.6(CNTNAP2):c.*1397_*1398dup	CNTNAP2		Pitt-Hopkins-like syndrome 1|Pitt-Hopkins-like syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359218	7	148114104 - 148114105	7	148417012 - 148417013	359218	305307	rs886062062	NC_000007.14:148417012:AT:ATAT
NM_014141.6(CNTNAP2):c.*1276_*1280dup	CNTNAP2		Pitt-Hopkins-like syndrome 1|Pitt-Hopkins-like syndrome|not provided	Benign/Likely benign(Last reviewed: May 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000359217	7	148113980 - 148113981	7	148416888 - 148416889	359217	310101	rs369615005	NC_000007.14:148416888:TTAGTTTA:TTAGTTTAGTTTA
NM_014141.6(CNTNAP2):c.*818dup	CNTNAP2		Pitt-Hopkins-like syndrome 1|Pitt-Hopkins-like syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359206	7	148113520 - 148113521	7	148416428 - 148416429	359206	302123	rs145690138	NC_000007.14:148416428:TTTTTT:TTTTTTT
NM_014141.6(CNTNAP2):c.*174_*175dup	CNTNAP2		Pitt-Hopkins-like syndrome 1|Pitt-Hopkins-like syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359200	7	148112872 - 148112873	7	148415780 - 148415781	359200	302122	rs61125105	NC_000007.14:148415780:AAAAAAAAAAA:AAAAAAAAAAAAA
NM_014141.6(CNTNAP2):c.*175dup	CNTNAP2		Pitt-Hopkins-like syndrome 1|Pitt-Hopkins-like syndrome|not provided	Benign(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000359199	7	148112872 - 148112873	7	148415780 - 148415781	359199	305292	rs61125105	NC_000007.14:148415780:AAAAAAAAAAA:AAAAAAAAAAAA
NM_014141.5(CNTNAP2):c.-331dupT	CNTNAP2		Pitt-Hopkins-like syndrome 1|Pitt-Hopkins-like syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359163	7	145813627 - 145813628	7	146116535 - 146116536	359163	305261	rs886062041	NC_000007.14:146116535:TTTTTTTTTTT:TTTTTTTTTTTT
NM_014141.6(CNTNAP2):c.551-11_551-10insG	CNTNAP2		Pitt-Hopkins-like syndrome 1|Pitt-Hopkins-like syndrome|not specified|not provided	Benign(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095576	7	146805228 - 146805229	7	147108136 - 147108137	95576	101474	rs35167289	NC_000007.14:147108136::G
NC_000006.11:g.(?_33131435)_(33419703_?)dup	COL11A2|DAXX|KIFC1|PHF1|RGL2|RING1|RPS18|RXRB|VPS52|TAPBP|SLC39A7|HSD17B8|B3GALT4|SYNGAP1|WDR46|ZBTB22|PFDN6|CUTA|MIR219A1|HCG25|MIR5004|MIR6834|MIR6873|SMIM40		Mental retardation, autosomal dominant 5	Uncertain significance(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000660703	6	33131435 - 33419703	6	33163658 - 33451926	660703	651550		
NM_000090.4(COL3A1):c.479dup (p.Lys161fs)	COL3A1	K161fs	Polymicrogyria with or without vascular-type ehlers-danlos syndrome	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000029638	2	189851815 - 189851816	2	188987089 - 188987090	29638	38592	rs397509377	NC_000002.12:188987089:T:TT
NM_001320.7(CSNK2B):c.268dup (p.Thr90fs)	CSNK2B	T90fs	CSNK2B-related intellectual disability with or without epilepsy	Pathogenic(Last reviewed: Nov 24, 2020)	criteria provided, single submitter	VCV001199211	6	31636407 - 31636408	6	31668630 - 31668631	1199211	1189209		NC_000006.12:31668630:A:AA
NM_001320.7(CSNK2B):c.108dup (p.Thr37fs)	CSNK2B	T37fs	Poirier-Bienvenu neurodevelopmental syndrome|Intellectual disability and seizures	Pathogenic(Last reviewed: Jan 15, 2020)	no assertion criteria provided	VCV000430724	6	31635678 - 31635679	6	31667901 - 31667902	430724	424262	rs1131692161	NC_000006.12:31667901:TT:TTT
NC_000002.11:g.(?_166152314)_(167108415_?)dup	CSRNP3|GALNT3|LOC100506124|LOC102724058|SCN1A|SCN1A-AS1|SCN2A|SCN9A|TTC21B|TTC21B-AS1		Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA|Early infantile epileptic encephalopathy with suppression bursts	Uncertain significance(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000655230	2	166152314 - 167108415	2	165295804 - 166251905	655230	650780		
NC_000021.8:g.(?_44838130)_(45196150_?)dup	CSTB|PDXK|HSF2BP|RRP1B|SIK1		Epileptic encephalopathy, early infantile, 30|Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001055976	21	44838130 - 45196150			1055976	1039245		
NC_000021.9:g.(?_43772665)_(43777375_?)dup	CSTB		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000832805	21	45192546 - 45197256			832805	821377		
NC_000021.8:g.(?_44838120)_(45629566_?)dup	CSTB|PWP2|TRAPPC10|GATD3A|PDXK|RRP1|HSF2BP|RRP1B|AGPAT3|SIK1		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000832239	21	44838120 - 45629566			832239	821357		
NM_000100.4(CSTB):c.200_203dup (p.Val69fs)	CSTB	V69fs	Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000659184	21	45194176 - 45194177	21	43774295 - 43774296	659184	649021	rs1601855887	NC_000021.9:43774295:CGCA:CGCACGCA
NC_000021.8:g.(?_45194063)_(45196170_?)dup	CSTB		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000584212	21	45194063 - 45196170	21	43774182 - 43776289	584212	573008		
NM_000100.4(CSTB):c.1_2insAT (p.Met1fs)	CSTB	M1fs	Progressive myoclonic epilepsy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2021)	criteria provided, conflicting interpretations	VCV000423466	21	45196149 - 45196150	21	43776268 - 43776269	423466	410883	rs1044894207	NC_000021.9:43776268::AT
NM_000100.4(CSTB):c.168+2_168+21delinsAA	CSTB		Unverricht-Lundborg syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000161421	21	45194518 - 45194537	21	43774637 - 43774656	161421	171260	rs864309482	NC_000021.9:43774636:CTCCTGAGGCCCACACTCTA:TT
NC_000011.9:g.(?_1774733)_(1785089_?)dup	CTSD		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001010767	11	1774733 - 1785089			1010767	986465		
NM_001909.5(CTSD):c.464_465delinsGC (p.Thr155Ser)	CTSD	T155S	Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000855671	11	1780205 - 1780206	11	1758975 - 1758976	855671	838152		NC_000011.10:1758974:AG:GC
NM_001909.5(CTSD):c.268dup (p.Gln90fs)	CTSD	Q90fs	not provided	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000430138	11	1780829 - 1780830	11	1759599 - 1759600	430138	421842	rs752612332	NC_000011.10:1759599:GGGGGGG:GGGGGGGG
NM_018122.5(DARS2):c.228-21_228-20delinsC	DARS2		Hypertensive disorder|Clubfoot|Sensorimotor neuropathy|Cerebral cortical atrophy|EMG: axonal abnormality|Gout|Abnormality of the foot|CNS demyelination|Difficulty walking|Impaired vibration sensation in the lower limbs|Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|Gait imbalance|Dysmetria|Gait ataxia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000001057	1	173797450 - 173797451	1	173828312 - 173828313	1057	16096	rs1553201258	NC_000001.11:173828311:TT:C
NM_001242896.3(DEPDC5):c.1725dup (p.His576fs)	DEPDC5	H548fs, H576fs	Epilepsy, familial focal, with variable foci 1	Likely pathogenic(Last reviewed: Sep 24, 2021)	criteria provided, single submitter	VCV001299332	22	32215063 - 32215064	22	31819077 - 31819078	1299332	1289191		NC_000022.11:31819077:TTT:TTTT
NM_001242896.3(DEPDC5):c.1082-3dup	DEPDC5		Familial focal epilepsy with variable foci	Benign(Last reviewed: Jun 5, 2020)	criteria provided, single submitter	VCV001170666	22	32200138 - 32200139	22	31804152 - 31804153	1170666	1159109		NC_000022.11:31804152:TTTTTTT:TTTTTTTT
NM_001242896.3(DEPDC5):c.2304_2305dup (p.Asp769fs)	DEPDC5	D691fs, D741fs, D760fs, D769fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001076718	22	32233090 - 32233091	22	31837104 - 31837105	1076718	1065029		NC_000022.11:31837104:TG:TGTG
NM_001242896.3(DEPDC5):c.176dup (p.Glu60fs)	DEPDC5	E60fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Apr 23, 2020)	criteria provided, single submitter	VCV001074536	22	32156669 - 32156670	22	31760683 - 31760684	1074536	1065017		NC_000022.11:31760683:AA:AAA
NM_001242896.3(DEPDC5):c.305dup (p.Leu102fs)	DEPDC5	L102fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jun 18, 2020)	criteria provided, single submitter	VCV001073683	22	32162594 - 32162595	22	31766608 - 31766609	1073683	1065021		NC_000022.11:31766608:TT:TTT
NM_001242896.3(DEPDC5):c.2094dup (p.Ser699fs)	DEPDC5	S671fs, S699fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001072903	22	32218765 - 32218766	22	31822779 - 31822780	1072903	1065026		NC_000022.11:31822779:C:CC
NM_001242896.3(DEPDC5):c.2958_2959insTTTTTTTTTTTTTTTTNNNNNNNNNNTTTTTTTTTTTTTTTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCCAGGCTGGAGTGCAGTGGCGGGATCTCGGCTCACTGCAAGCTCCGCCTCCTGGATGGTTTT (p.Val987delinsPhePhePhePhePheXaaXaaXaaXaaPhePhePhePhePhePhePhePhePheTer)	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001070820	22	32241145 - 32241146	22	31845159 - 31845160	1070820	1065034		
NM_001242896.3(DEPDC5):c.2548dup (p.Asp850fs)	DEPDC5	D772fs, D822fs, D841fs, D850fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV001069373	22	32239111 - 32239112	22	31843125 - 31843126	1069373	1065032		NC_000022.11:31843125:GG:GGG
NM_001242896.3(DEPDC5):c.2196dup (p.Val733fs)	DEPDC5	V655fs, V705fs, V733fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001069325	22	32232982 - 32232983	22	31836996 - 31836997	1069325	1065027		NC_000022.11:31836996:A:AA
NC_000022.10:g.(?_32156622)_(32162674_?)dup	DEPDC5		Familial focal epilepsy with variable foci	Likely pathogenic(Last reviewed: Feb 25, 2020)	criteria provided, single submitter	VCV001067647	22	32156622 - 32162674			1067647	1054679		
NC_000022.10:g.(?_32210968)_(32211208_?)dup	DEPDC5		Familial focal epilepsy with variable foci	Likely pathogenic(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001067646	22	32210968 - 32211208			1067646	1054680		
NC_000022.10:g.(?_32150888)_(32164869_?)dup	DEPDC5		Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001035632	22	32150888 - 32164869			1035632	1022428		
NC_000022.10:g.(?_32150888)_(32154639_?)dup	DEPDC5		Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV001022723	22	32150888 - 32154639			1022723	1001905		
NM_001242896.3(DEPDC5):c.425_427dup (p.Gly142dup)	DEPDC5		not provided|Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Sep 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV001015069	22	32174093 - 32174094	22	31778107 - 31778108	1015069	1014557		NC_000022.11:31778107:TGGTG:TGGTGGTG
NM_001242896.3(DEPDC5):c.3455_3457dup (p.Tyr1153_Ser1154insCys)	DEPDC5		Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV001008897	22	32266699 - 32266700	22	31870713 - 31870714	1008897	999434		NC_000022.11:31870713:GCT:GCTGCT
NM_001242896.3(DEPDC5):c.4748_4788delinsC (p.Arg1583fs)	DEPDC5	R1552fs, R1555fs, R1483fs, R1505fs, R1561fs, R1574fs, R1583fs	Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000966400	22	32302419 - 32302459	22	31906433 - 31906473	966400	959084		NC_000022.11:31906432:GTGACAACCGGCTGGTCACGTTCTGGACAAGTTGCCTGGAG:C
NM_001242896.3(DEPDC5):c.1121_1122dup (p.His375fs)	DEPDC5	H375fs, H347fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000935012	22	32200186 - 32200187	22	31804200 - 31804201	935012	939279		NC_000022.11:31804200:TA:TATA
NM_001242896.3(DEPDC5):c.1395dup (p.Val466fs)	DEPDC5	V438fs, V466fs	Epilepsy, familial focal, with variable foci 1	Likely pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000931213	22	32206575 - 32206576	22	31810589 - 31810590	931213	919948		NC_000022.11:31810589:AA:AAA
NM_001242896.3(DEPDC5):c.198dup (p.Ile67fs)	DEPDC5	I67fs	Epilepsy, familial focal, with variable foci 1	Pathogenic	criteria provided, single submitter	VCV000916700	22	32160964 - 32160965	22	31764978 - 31764979	916700	905031		NC_000022.11:31764978:T:TT
NM_001242896.3(DEPDC5):c.3655dup (p.Glu1219fs)	DEPDC5	E1188fs, E1191fs, E1210fs, E1141fs, E1119fs, E1197fs, E1219fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000848497	22	32270348 - 32270349	22	31874362 - 31874363	848497	849281		NC_000022.11:31874362:GG:GGG
NM_001242896.3(DEPDC5):c.677dup (p.Tyr226Ter)	DEPDC5	Y198*, Y226*	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Feb 17, 2019)	criteria provided, single submitter	VCV000842113	22	32188070 - 32188071	22	31792084 - 31792085	842113	849257		NC_000022.11:31792084:A:AA
NC_000022.11:g.(?_31764955)_(31768883_?)dup	DEPDC5		Familial focal epilepsy with variable foci	Likely pathogenic(Last reviewed: Jun 1, 2019)	criteria provided, single submitter	VCV000832362	22	32160941 - 32164869			832362	821453		
NM_001242896.3(DEPDC5):c.422_423insCTGG (p.Gly142fs)	DEPDC5	G114fs, G142fs	Epilepsy, familial focal, with variable foci 1	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000666321	22	32174093 - 32174094	22	31778107 - 31778108	666321	653899	rs1601755632	NC_000022.11:31778107::CTGG
NM_001242896.3(DEPDC5):c.4446dup (p.Val1483fs)	DEPDC5	V1383fs, V1455fs, V1452fs, V1461fs, V1483fs, V1405fs, V1474fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000655956	22	32301976 - 32301977	22	31905990 - 31905991	655956	649447	rs1603014297	NC_000022.11:31905990:TTT:TTTT
NM_001242896.3(DEPDC5):c.1234_1235delinsTA (p.Ser412Tyr)	DEPDC5	S412Y, S384Y	Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV000654370	22	32202124 - 32202125	22	31806138 - 31806139	654370	649417	rs1602010588	NC_000022.11:31806137:AG:TA
NM_001242896.3(DEPDC5):c.1936dup (p.Ser646fs)	DEPDC5	S618fs, S646fs	Epilepsy, familial focal, with variable foci 1	Pathogenic	no assertion criteria provided	VCV000626285	22	32217552 - 32217553	22	31821566 - 31821567	626285	614608	rs1569012755	NC_000022.11:31821566:A:AA
NM_001242896.3(DEPDC5):c.4692_4693delinsTTT (p.Asp1565fs)	DEPDC5	D1565fs, D1534fs, D1556fs, D1537fs, D1543fs, D1465fs, D1487fs	Epilepsy, familial focal, with variable foci 1	Uncertain significance(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000576543	22	32302363 - 32302364	22	31906377 - 31906378	576543	571975	rs1569255986	NC_000022.11:31906376:GG:TTT
NM_001242896.3(DEPDC5):c.4501_4502dup (p.Gln1501fs)	DEPDC5	Q1473fs, Q1401fs, Q1492fs, Q1501fs, Q1470fs, Q1479fs, Q1423fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000572846	22	32302033 - 32302034	22	31906047 - 31906048	572846	575267	rs1569254004	NC_000022.11:31906047:CA:CACA
NM_001242896.3(DEPDC5):c.2694_2703delinsGGACA (p.Asp898fs)	DEPDC5	D889fs, D820fs, D870fs, D898fs	Epilepsy, familial focal, with variable foci 1	Likely pathogenic(Last reviewed: May 28, 2018)	criteria provided, single submitter	VCV000560710	22	32239691 - 32239700	22	31843705 - 31843714	560710	551798	rs1569083500	NC_000022.11:31843704:CTCAGAGTTC:GGACA
NC_000022.10:g.(?_32253411)_(32302503_?)dup	DEPDC5		Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000534828	22	32253411 - 32302503	22	31857425 - 31906517	534828	534036		
NM_001242896.3(DEPDC5):c.3486-5dup	DEPDC5		Familial focal epilepsy with variable foci|not provided	Likely benign(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000534809	22	32269234 - 32269235	22	31873248 - 31873249	534809	534296	rs1555914747	NC_000022.11:31873248:TT:TTT
NC_000022.10:g.(?_32297708)_(32302503_?)dup	DEPDC5		Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000466447	22	32297708 - 32302503			466447	469863		
NM_001242896.3(DEPDC5):c.2492_2493insAGA (p.Ser831delinsArgAsp)	DEPDC5		Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433143	22	32234808 - 32234809	22	31838822 - 31838823	433143	426706	rs1555897392	NC_000022.11:31838822::AGA
NM_001242896.3(DEPDC5):c.1093_1099dup (p.Val367fs)	DEPDC5	V367fs, V339fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264728	22	32200157 - 32200158	22	31804171 - 31804172	264728	259349	rs886039258	NC_000022.11:31804171:GGATTTGG:GGATTTGGGATTTGG
NM_001242896.3(DEPDC5):c.132dup (p.Asn45fs)	DEPDC5	N45fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264713	22	32154601 - 32154602	22	31758615 - 31758616	264713	259329	rs886039244	NC_000022.11:31758615:CCCC:CCCCC
NC_000016.10:g.(?_3727698)_(4802591_?)dup	DNAJA3|CORO7|UBALD1|CDIP1|C16orf96|ADCY9|NUDT16L1|ZNF500|ROGDI|NMRAL1|ANKS3|SRL|SEPTIN12|MGRN1|SMIM22|CORO7-PAM16|PAM16|HMOX2|GLIS2|VASN|CREBBP|TFAP4|DNAAF8		Amelocerebrohypohidrotic syndrome	Uncertain significance(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000831384	16	3777699 - 4852592			831384	820830		
NM_025219.3(DNAJC5):c.322-3dup	DNAJC5		Neuronal ceroid lipofuscinosis	Benign(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001169728	20	62562195 - 62562196	20	63930842 - 63930843	1169728	1158940		NC_000020.11:63930842:CCCCCC:CCCCCCC
NC_000020.10:g.(?_62559679)_(62562941_?)dup	DNAJC5		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000584180	20	62559679 - 62562941	20	63928326 - 63931588	584180	572846		
NC_000020.10:g.(?_62559688)_(62567384_?)dup	DNAJC5		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000417347	20	62559688 - 62567384	20	63928335 - 63936031	417347	404151		
NM_001347721.2(DYRK1A):c.1214_1217dup (p.Tyr406Ter)	DYRK1A	Y377*, Y406*, Y415*	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319230	21	38877586 - 38877587	21	37505283 - 37505284	1319230	1309483		NC_000021.9:37505283:AGTA:AGTAAGTA
NC_000021.8:g.(?_37833274)_(39212984_?)dup	DYRK1A|HLCS|KCNJ6|SIM2|TTC3|VPS26C|CLDN14|PIGP|RIPPLY3		Mental retardation, autosomal dominant 7	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001061008	21	37833274 - 39212984			1061008	1039244		
NM_001347721.2(DYRK1A):c.2220dup (p.Met741fs)	DYRK1A	M712fs, M750fs, M741fs	not provided|Mental retardation, autosomal dominant 7	Uncertain significance(Last reviewed: Jun 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV001047506	21	38884784 - 38884785	21	37512481 - 37512482	1047506	1034923		NC_000021.9:37512481:CCCCC:CCCCCC
NM_001347721.2(DYRK1A):c.208dup (p.Arg70fs)	DYRK1A	R41fs, R70fs, R79fs	Mental retardation, autosomal dominant 7	Likely pathogenic	no assertion criteria provided	VCV000977916	21	38850509 - 38850510	21	37478207 - 37478208	977916	966014		NC_000021.9:37478207:A:AA
NM_001347721.2(DYRK1A):c.1212_1213insTAA (p.Glu405Ter)	DYRK1A	E376*, E405*, E414*	Mental retardation, autosomal dominant 7	Likely pathogenic	no assertion criteria provided	VCV000977903	21	38877585 - 38877586	21	37505282 - 37505283	977903	966045		NC_000021.9:37505282::TAA
NM_001347721.2(DYRK1A):c.980_981insCCCA (p.Met327fs)	DYRK1A	M298fs, M327fs, M336fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Oct 23, 2019)	no assertion criteria provided	VCV000976471	21	38865374 - 38865375	21	37493072 - 37493073	976471	964736		NC_000021.9:37493072::CCCA
NM_001347721.2(DYRK1A):c.1357_1358insTC (p.Tyr453fs)	DYRK1A	Y424fs, Y453fs, Y462fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000931056	21	38877730 - 38877731	21	37505427 - 37505428	931056	919936		NC_000021.9:37505427::TC
NC_000021.8:g.(?_38791602)_(38888679_?)dup	DYRK1A		Mental retardation, autosomal dominant 7	Uncertain significance(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000832806	21	38791602 - 38888679			832806	821353		
NM_001347721.2(DYRK1A):c.507dup (p.Arg170fs)	DYRK1A	R179fs, R141fs, R170fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000577532	21	38858785 - 38858786	21	37486483 - 37486484	577532	573129	rs1569370887	NC_000021.9:37486483:T:TT
NM_001347721.2(DYRK1A):c.284dup (p.Tyr95Ter)	DYRK1A	Y104*, Y95*, Y66*	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000472250	21	38850585 - 38850586	21	37478283 - 37478284	472250	470660	rs1555979158	NC_000021.9:37478283:A:AA
NC_000021.8:g.(?_38792657)_(38884854_?)dup	DYRK1A		Mental retardation, autosomal dominant 7	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000472238	21	38792657 - 38884854			472238	471076		
NM_001347721.2(DYRK1A):c.449dup (p.Tyr150Ter)	DYRK1A	Y159*, Y150*, Y121*	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000369658	21	38853087 - 38853088	21	37480785 - 37480786	369658	353886	rs1057516030	NC_000021.9:37480785:A:AA
NM_001347721.2(DYRK1A):c.1271_1272insT (p.Pro425fs)	DYRK1A	P434fs, P396fs, P425fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jun 25, 2015)	criteria provided, single submitter	VCV000210890	21	38877644 - 38877645	21	37505341 - 37505342	210890	208718	rs797045539	NC_000021.9:37505341::T
NM_001347721.2(DYRK1A):c.1135dup (p.Ala379fs)	DYRK1A	A388fs, A350fs, A379fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Nov 7, 2013)	criteria provided, single submitter	VCV000209151	21	38868482 - 38868483	21	37496180 - 37496181	209151	205794	rs797045042	NC_000021.9:37496180:G:GG
NM_001347721.2(DYRK1A):c.425dup (p.Asn142fs)	DYRK1A	N113fs, N142fs, N151fs	not provided|Mental retardation, autosomal dominant 7|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000204008	21	38853058 - 38853059	21	37480756 - 37480757	204008	200401	rs797044523	NC_000021.9:37480756:AAAAAA:AAAAAAA
NM_004425.4(ECM1):c.93_94delinsTT (p.Arg31_Gln32delinsSerTer)	ECM1		Lipid proteinosis	Pathogenic(Last reviewed: Nov 19, 2015)	no assertion criteria provided	VCV000222949	1	150482029 - 150482030	1	150509553 - 150509554	222949	224664	rs869025567	NC_000001.11:150509552:GC:TT
NM_004425.4(ECM1):c.506dup (p.Gly170fs)	ECM1	G170fs, G197fs	not provided|Lipid proteinosis	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000222945	1	150483466 - 150483467	1	150510990 - 150510991	222945	224659	rs869025564	NC_000001.11:150510990:CCCCCC:CCCCCCC
NM_018100.4(EFHC1):c.1091_1092insGGTATTACCTGATTTGGTAATTTGGTAATTACTGATTTGGTAATTTGGAATT (p.Pro365_Arg366insValLeuProAspLeuValIleTrpTer)	EFHC1		Typical absence seizures|Juvenile myoclonic epilepsy	Uncertain significance(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV001006195	6	52329865 - 52329866	6	52465067 - 52465068	1006195	991549		
NM_018100.4(EFHC1):c.663dup (p.Lys222Ter)	EFHC1	K222*, K203*	Typical absence seizures|Juvenile myoclonic epilepsy	Uncertain significance(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV000969853	6	52317574 - 52317575	6	52452776 - 52452777	969853	954500		NC_000006.12:52452776:T:TT
NM_018100.4(EFHC1):c.1288dup (p.Ile430fs)	EFHC1	I411fs, I430fs	Typical absence seizures|Juvenile myoclonic epilepsy	Uncertain significance(Last reviewed: Oct 20, 2019)	criteria provided, single submitter	VCV000954888	6	52343843 - 52343844	6	52479045 - 52479046	954888	945069		NC_000006.12:52479045:A:AA
NM_018100.4(EFHC1):c.723+18_723+19insG	EFHC1		Juvenile myoclonic epilepsy	association	no assertion criteria provided	VCV000830042	6	52317653 - 52317654	6	52452855 - 52452856	830042	818378	rs1581829739	NC_000006.12:52452855::G
NM_018100.4(EFHC1):c.666_674delinsAAG (p.Tyr223_Thr225delinsSer)	EFHC1		Juvenile myoclonic epilepsy|Epilepsy, juvenile absence, susceptibility to, 1	Uncertain significance(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000534109	6	52317578 - 52317586	6	52452780 - 52452788	534109	522396	rs1554259746	NC_000006.12:52452779:GTATGTCAC:AAG
NM_018100.4(EFHC1):c.1549_1559delinsTTTTGAAATACA (p.Glu517_Ala520delinsPheTer)	EFHC1		Juvenile myoclonic epilepsy|Typical absence seizures	Uncertain significance(Last reviewed: May 11, 2019)	criteria provided, single submitter	VCV000534105	6	52344494 - 52344504	6	52479696 - 52479706	534105	522073	rs1554261668	NC_000006.12:52479695:GAGAGCAACGC:TTTTGAAATACA
NM_018100.4(EFHC1):c.1221dup (p.Asp408fs)	EFHC1	D389fs, D408fs	Juvenile myoclonic epilepsy|Epilepsy, juvenile absence, susceptibility to, 1	Uncertain significance(Last reviewed: Nov 19, 2016)	criteria provided, single submitter	VCV000411571	6	52334207 - 52334208	6	52469409 - 52469410	411571	395192	rs754483740	NC_000006.12:52469409:AAAAAAA:AAAAAAAA
NM_018100.4(EFHC1):c.*1813dup	EFHC1		Juvenile myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000357518	6	52358946 - 52358947	6	52494148 - 52494149	357518	300734	rs201262358	NC_000006.12:52494148:AAAAAA:AAAAAAA
NM_018100.4(EFHC1):c.*1749_*1750insAC	EFHC1		Juvenile myoclonic epilepsy	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000357517	6	52358887 - 52358888	6	52494089 - 52494090	357517	308241	rs58779695	NC_000006.12:52494089:C:CAC
NM_018100.4(EFHC1):c.*1325dup	EFHC1		Juvenile myoclonic epilepsy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000357513	6	52358453 - 52358454	6	52493655 - 52493656	357513	300723	rs35994917	NC_000006.12:52493655:AAAAAAAAAAA:AAAAAAAAAAAA
NM_018100.4(EFHC1):c.*1045delinsATATATATATATATATATATATATATATATATA	EFHC1		Juvenile myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000357510	6	52358184	6	52493386	357510	308233	rs886061633	NC_000006.12:52493385:T:ATATATATATATATATATATATATATATATATA
NM_018100.4(EFHC1):c.*1045delinsATATATATATATA	EFHC1		Juvenile myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000357509	6	52358184	6	52493386	357509	303671	rs886061633	NC_000006.12:52493385:T:ATATATATATATA
NM_004247.4(EFTUD2):c.334dup (p.Thr112fs)	EFTUD2	T112fs, T77fs	Mandibulofacial dysostosis-microcephaly syndrome	Likely pathogenic	no assertion criteria provided	VCV000977870	17	42962639 - 42962640	17	44885271 - 44885272	977870	966004		NC_000017.11:44885271:T:TT
NM_004247.4(EFTUD2):c.426+1dup	EFTUD2		Mandibulofacial dysostosis-microcephaly syndrome	Likely pathogenic	no assertion criteria provided	VCV000977822	17	42961015 - 42961016	17	44883647 - 44883648	977822	966043		NC_000017.11:44883647:CC:CCC
NM_004247.4(EFTUD2):c.764dup (p.Cys256fs)	EFTUD2	C256fs, C221fs, C246fs	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: May 18, 2015)	no assertion criteria provided	VCV000203386	17	42953406 - 42953407	17	44876038 - 44876039	203386	199808	rs794729651	NC_000017.11:44876038:A:AA
NM_024757.5(EHMT1):c.21+30_21+40dup	EHMT1		Kleefstra syndrome 1	Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, single submitter	VCV001160712	9	140513520 - 140513521	9	137619068 - 137619069	1160712	1140395		NC_000009.12:137619068:GGGGGCGGCGCGGGGGCGGCG:GGGGGCGGCGCGGGGGCGGCGCGGGGGCGGCG
NM_024757.5(EHMT1):c.21+14_21+22dup	EHMT1		Kleefstra syndrome 1	Likely benign(Last reviewed: Nov 20, 2020)	criteria provided, single submitter	VCV001097641	9	140513508 - 140513509	9	137619056 - 137619057	1097641	1076319		NC_000009.12:137619056:GCGGGGCCGGCGGGG:GCGGGGCCGGCGGGGCCGGCGGGG
NM_024757.5(EHMT1):c.2825dup (p.Leu943fs)	EHMT1	L936fs, L943fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Jul 3, 2020)	criteria provided, single submitter	VCV001074863	9	140706023 - 140706024	9	137811571 - 137811572	1074863	1061656		NC_000009.12:137811571:CC:CCC
NC_000009.11:g.(?_140605409)_(140605492_?)dup	EHMT1		Kleefstra syndrome 1	Likely pathogenic(Last reviewed: Jun 8, 2020)	criteria provided, single submitter	VCV001067492	9	140605409 - 140605492			1067492	1054464		
NM_024757.5(EHMT1):c.1321_1322delinsAA (p.Ala441Asn)	EHMT1	A410N, A441N, A434N	Kleefstra syndrome 1	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001035027	9	140648695 - 140648696	9	137754243 - 137754244	1035027	1029111		NC_000009.12:137754242:GC:AA
NM_024757.5(EHMT1):c.1922_1924dup (p.Thr641dup)	EHMT1		Kleefstra syndrome 1	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001021198	9	140671197 - 140671198	9	137776745 - 137776746	1021198	1008563		NC_000009.12:137776745:GACGA:GACGACGA
NC_000009.12:g.137729445_137745564dup	EHMT1		Kleefstra syndrome 1	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV000988097			9	137729444 - 137745563	988097	976027		
NM_024757.5(EHMT1):c.3627_3633dup (p.Val1212fs)	EHMT1	V1205fs, V1212fs	Kleefstra syndrome 1	Likely pathogenic(Last reviewed: Jun 23, 2020)	criteria provided, single submitter	VCV000977309	9	140728885 - 140728886	9	137834433 - 137834434	977309	965439		NC_000009.12:137834433:CCGTGCGC:CCGTGCGCCGTGCGC
NM_024757.5(EHMT1):c.2079dup (p.Glu694fs)	EHMT1	E687fs, E694fs, E663fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000973221	9	140672391 - 140672392	9	137777939 - 137777940	973221	961615		NC_000009.12:137777939:CCC:CCCC
NM_024757.5(EHMT1):c.870dup (p.Arg291fs)	EHMT1	R260fs, R284fs, R291fs	Kleefstra syndrome 1	Likely pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000973220	9	140637863 - 140637864	9	137743411 - 137743412	973220	961614		NC_000009.12:137743411:AAAAAA:AAAAAAA
NM_024757.5(EHMT1):c.3174_3175delinsCG (p.Leu1059Val)	EHMT1	L1052V, L1059V	Kleefstra syndrome 1	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000934083	9	140707976 - 140707977	9	137813524 - 137813525	934083	934703		NC_000009.12:137813523:TC:CG
NM_024757.5(EHMT1):c.40dup (p.Glu14fs)	EHMT1	E14fs	Kleefstra syndrome 1|not provided	Pathogenic(Last reviewed: Aug 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000852882	9	140605431 - 140605432	9	137710979 - 137710980	852882	835952		NC_000009.12:137710979:GGGGGG:GGGGGGG
NM_024757.5(EHMT1):c.1590_1607dup (p.Glu531_Ala536dup)	EHMT1		Kleefstra syndrome 1	Uncertain significance(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000846685	9	140657214 - 140657215	9	137762762 - 137762763	846685	835967		NC_000009.12:137762762:AGAGATCACCACACTGGC:AGAGATCACCACACTGGCAGAGATCACCACACTGGC
NC_000009.12:g.(?_137743351)_(137744110_?)dup	EHMT1		Kleefstra syndrome 1	Likely pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000831964	9	140637803 - 140638562			831964	820107		
NM_024757.5(EHMT1):c.1042_1043dup (p.Asp349fs)	EHMT1	D342fs, D318fs, D349fs	Kleefstra syndrome 1	Likely pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000666585	9	140638412 - 140638413	9	137743960 - 137743961	666585	654132	rs1588481921	NC_000009.12:137743960:CTC:CTCTC
NC_000009.11:g.(?_140728781)_(140729425_?)dup	EHMT1		Kleefstra syndrome 1	Uncertain significance(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000663957	9	140728781 - 140729425	9	137834329 - 137834973	663957	652061		
NC_000009.11:g.(?_140605399)_(140652483_?)dup	EHMT1		Kleefstra syndrome 1	Likely pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000662276	9	140605399 - 140652483	9	137710947 - 137758031	662276	652052		
NC_000009.11:g.(?_140695312)_(140729425_?)dup	EHMT1		Kleefstra syndrome 1	Uncertain significance(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000584119	9	140695312 - 140729425	9	137800860 - 137834973	584119	563238		
NM_024757.5(EHMT1):c.193_198dup (p.Ser65_His66dup)	EHMT1		Kleefstra syndrome 1	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000574421	9	140611184 - 140611185	9	137716732 - 137716733	574421	563110	rs756643740	NC_000009.12:137716732:AGTCAT:AGTCATAGTCAT
NM_024757.5(EHMT1):c.1456_1457delinsAA (p.Ser486Asn)	EHMT1	S455N, S486N, S479N	Kleefstra syndrome 1	Uncertain significance(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000569906	9	140652418 - 140652419	9	137757966 - 137757967	569906	563140	rs1564704339	NC_000009.12:137757965:TC:AA
NM_024757.5(EHMT1):c.396_397delinsTG (p.Gln133Glu)	EHMT1	Q133E, Q102E	Kleefstra syndrome 1	Uncertain significance(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000462999	9	140611388 - 140611389	9	137716936 - 137716937	462999	459060	rs1554846569	NC_000009.12:137716935:AC:TG
NM_024757.5(EHMT1):c.128_129delinsGT (p.Ala43Gly)	EHMT1	A12G, A43G	Kleefstra syndrome 1	Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, single submitter	VCV000462976	9	140611120 - 140611121	9	137716668 - 137716669	462976	459369	rs386739686	NC_000009.12:137716667:CA:GT
NM_024757.5(EHMT1):c.2214_2230dup (p.Phe744fs)	EHMT1	F713fs, F744fs, F737fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Mar 14, 2017)	no assertion criteria provided	VCV000438289	9	140674107 - 140674108	9	137779655 - 137779656	438289	431918	rs1554880275	NC_000009.12:137779655:CCCAAAGCAGCTGTACT:CCCAAAGCAGCTGTACTCCCAAAGCAGCTGTACT
NM_024757.5(EHMT1):c.*971dup	EHMT1		Kleefstra syndrome 1	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366044	9	140730368 - 140730369	9	137835916 - 137835917	366044	318172	rs563102749	NC_000009.12:137835916:TTTTTTTT:TTTTTTTTT
NM_024757.5(EHMT1):c.298_299delinsAT (p.Asp100Ile)	EHMT1	D69I, D100I	not provided|Kleefstra syndrome 1	Uncertain significance(Last reviewed: Jun 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000196521	9	140611290 - 140611291	9	137716838 - 137716839	196521	193682	rs797044709	NC_000009.12:137716837:GA:AT
NM_024757.5(EHMT1):c.2028dup (p.Pro677fs)	EHMT1	P677fs, P646fs, P670fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000065730	9	140672340 - 140672341	9	137777888 - 137777889	65730	76638	rs1554879411	NC_000009.12:137777888:GGG:GGGG
NC_000009.11:g.(?_140657107)_(140685442_?)dup	EHMT1-IT1|EHMT1|LOC651337		Kleefstra syndrome 1	Likely pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000583643	9	140657107 - 140685442	9	137762655 - 137790990	583643	562597		
NM_005670.4(EPM2A):c.159_160delinsGT (p.Ala53_Leu54=)	EPM2A|FBXO30-DT		Progressive myoclonic epilepsy	Likely benign(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV001133175	6	146056475 - 146056476	6	145735339 - 145735340	1133175	1116460		NC_000006.12:145735338:GG:AC
NM_005670.4(EPM2A):c.211_231dup (p.Ala71_Glu77dup)	EPM2A|FBXO30-DT		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001058333	6	146056403 - 146056404	6	145735267 - 145735268	1058333	1043988		NC_000006.12:145735267:CTCCGCCCCGTCCTGCGCCGCCTCC:CTCCGCCCCGTCCTGCGCCGCCTCCGCCCCGTCCTGCGCCGCCTCC
NM_005670.4(EPM2A):c.112_153dup (p.Val38_Ala51dup)	EPM2A|FBXO30-DT		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV000845081	6	146056481 - 146056482	6	145735345 - 145735346	845081	831643		NC_000006.12:145735345:GGCCCCGTCGCCCGCCGCGGTGCCGGCCGGCCTCAGGCGGACGGC:GGCCCCGTCGCCCGCCGCGGTGCCGGCCGGCCTCAGGCGGACGGCCCCGTCGCCCGCCGCGGTGCCGGCCGGCCTCAGGCGGACGGC
NM_005670.4(EPM2A):c.206_207delinsGC (p.Glu69Gly)	EPM2A|FBXO30-DT	E69G	Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000665213	6	146056428 - 146056429	6	145735292 - 145735293	665213	634672	rs1583156284	NC_000006.12:145735291:CT:GC
NM_005670.4(EPM2A):c.157_159delinsACG (p.Ala53Thr)	EPM2A|FBXO30-DT	A53T	not specified	Uncertain significance(Last reviewed: May 16, 2014)	criteria provided, single submitter	VCV000205450	6	146056476 - 146056478	6	145735340 - 145735342	205450	201939	rs796052439	NC_000006.12:145735339:GGC:CGT
NM_005670.4(EPM2A):c.639_640delinsAA (p.Pro214Thr)	EPM2A	P76T, P60T, P214T	Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000205445	6	145956459 - 145956460	6	145635323 - 145635324	205445	201928	rs796052435	NC_000006.12:145635322:GA:TT
NM_005670.4(EPM2A):c.953dup (p.Gln319fs)	EPM2A	Q319fs, Q181fs, Q165fs	Lafora disease	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000003106	6	145948594 - 145948595	6	145627458 - 145627459	3106	18145	rs587776554	NC_000006.12:145627458:AAAAAA:AAAAAAA
NM_005670.4(EPM2A):c.335dup (p.Tyr112Ter)	EPM2A	Y112*	Lafora disease	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000003101	6	146007398 - 146007399	6	145686262 - 145686263	3101	18140	rs587776553	NC_000006.12:145686262:T:TT
NM_002693.3(POLG):c.3644-9_3644-6dup	FANCI|POLG		Progressive sclerosing poliodystrophy	Likely benign(Last reviewed: Jun 24, 2020)	criteria provided, single submitter	VCV000696413	15	89860063 - 89860064	15	89316832 - 89316833	696413	685410	rs1361303371	NC_000015.10:89316832:AGATAG:AGATAGATAG
NM_002693.3(POLG):c.3673dup (p.Glu1225fs)	FANCI|POLG	E1225fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619449	15	89860028 - 89860029	15	89316797 - 89316798	619449	610699	rs1567183122	NC_000015.10:89316797:C:CC
NM_000142.5(FGFR3):c.1921_1922delinsAT (p.Asp641Ile)	FGFR3	D529I, D641I, D642I, D643I	Hypochondroplasia	Uncertain significance(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000976408	4	1807862 - 1807863	4	1806135 - 1806136	976408	964231		NC_000004.12:1806134:GA:AT
NC_000023.10:g.(?_135080257)_(135292184_?)dup	FHL1|SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001036230	X	135080257 - 135292184			1036230	1022433		
NM_014845.6(FIG4):c.446+32dup	FIG4		Polymicrogyria, bilateral temporooccipital|not provided|Charcot-Marie-Tooth disease|Yunis-Varon syndrome|Charcot-Marie-Tooth disease, type 4J|Amyotrophic lateral sclerosis type 11	Benign(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000917314	6	110048489 - 110048490	6	109727286 - 109727287	917314	905582		NC_000006.12:109727286:TTTTTTTTTTT:TTTTTTTTTTTT
NM_014845.6(FIG4):c.447-3dup	FIG4		Polymicrogyria, bilateral temporooccipital|Yunis-Varon syndrome|not specified|Charcot-Marie-Tooth disease, type 4J|Amyotrophic lateral sclerosis type 11|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Benign(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000694980	6	110053824 - 110053825	6	109732621 - 109732622	694980	683117	rs11377100	NC_000006.12:109732621:TTTTTTTTTTTTT:TTTTTTTTTTTTTT
NM_001079802.2(FKTN):c.642dup (p.Asp215Ter)	FKTN	D192*, D215*, D83*	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4|not provided|Walker-Warburg congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093523	9	108366764 - 108366765	9	105604483 - 105604484	93523	99428	rs398123557	NC_000009.12:105604483:TTTT:TTTTT
NC_000014.8:g.(?_29236466)_(29237975_?)dup	FOXG1		Rett syndrome, congenital variant	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000471463	14	29236466 - 29237975	14	28767260 - 28768769	471463	462969		
NM_005249.5(FOXG1):c.225_226delinsACCG (p.Pro77fs)	FOXG1	P77fs	not provided	Pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	VCV000205511	14	29236710 - 29236711	14	28767504 - 28767505	205511	202807	rs796052485	NC_000014.9:28767503:GC:ACCG
NM_005249.5(FOXG1):c.383dup (p.Glu129fs)	FOXG1	E129fs	not provided	Pathogenic(Last reviewed: Aug 12, 2013)	criteria provided, single submitter	VCV000205502	14	29236865 - 29236866	14	28767659 - 28767660	205502	202814	rs796052476	NC_000014.9:28767659:GGG:GGGG
NM_005249.5(FOXG1):c.239dup (p.Ala81fs)	FOXG1	A81fs	not provided	Pathogenic(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	VCV000205500	14	29236719 - 29236720	14	28767513 - 28767514	205500	202808	rs796052474	NC_000014.9:28767513:CCCCC:CCCCCC
NM_017547.4(FOXRED1):c.612_615dup (p.Ala206fs)	FOXRED1	A206fs	Leigh syndrome|not provided|Mitochondrial complex 1 deficiency, nuclear type 19|Mitochondrial complex I deficiency, nuclear type 1|Mitochondrial complex I deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Sep 15, 2021)	criteria provided, conflicting interpretations	VCV000095754	11	126144895 - 126144896	11	126275000 - 126275001	95754	101651	rs398124308	NC_000011.10:126275000:GAGTG:GAGTGAGTG
NC_000009.11:g.(?_138594085)_(140062314_?)dup	FUT7|GRIN1|ENTR1|MAN1B1|TMEM141|SAPCD2|PAXX|LCN15|TMEM250|CAMSAP1|C9orf163|UAP1L1|NACC2|RABL6|INPP5E|NPDC1|KCNT1|SNHG7|LCN8|DIPK1B|MAMDC4|LCN6|QSOX2|LCN12|SNAPC4|TRAF2|LHX3|EDF1|CLIC3|SEC16A|UBAC1|AGPAT2|PMPCA|GPSM1|PHPT1|CARD9|CCDC183|DPP7|EGFL7|AJM1|LCNL1|LINC02908|MIR126|LCN10|ABCA2|DNLZ|C8G|ENTPD2|FBXW5|NOTCH1|PTGDS		Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Uncertain significance(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV001008189	9	138594085 - 140062314			1008189	986405		
NM_001127644.2(GABRA1):c.1321_1324delinsC (p.Thr441_Tyr442delinsHis)	GABRA1		Idiopathic generalized epilepsy|Epilepsy, juvenile myoclonic 5|Epilepsy, childhood absence 4	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000970934	5	161324378 - 161324381	5	161897372 - 161897375	970934	954105		NC_000005.10:161897371:ACGT:C
NM_001127644.2(GABRA1):c.74+3_74+4delinsAT	GABRA1		Idiopathic generalized epilepsy|Epilepsy, childhood absence 4|Epilepsy, juvenile myoclonic 5	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000969559	5	161277893 - 161277894	5	161850887 - 161850888	969559	960559		NC_000005.10:161850886:GG:AT
NM_001127644.2(GABRA1):c.1354_1356dup (p.Pro452dup)	GABRA1		Epilepsy, juvenile myoclonic 5|Epilepsy, childhood absence 4|Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000963369	5	161324408 - 161324409	5	161897402 - 161897403	963369	944522		NC_000005.10:161897402:CCCCC:CCCCCCCC
NM_000806.5(GABRA1):c.-442dup	GABRA1		Juvenile myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000352580	5	161274215 - 161274216	5	161847209 - 161847210	352580	298623	rs201310567	NC_000005.10:161847209:GGGGGGGG:GGGGGGGGG
NC_000005.10:g.162537506_162537507insTGTTTACTAAACAAAAAGAAAGAGC	GABRA1		Epilepsy, juvenile myoclonic 5	risk factor(Last reviewed: Jul 1, 2011)	no assertion criteria provided	VCV000127231	5	161964512 - 161964513	5	162537506 - 162537507	127231	132687	rs587777363	NC_000005.10:162537506::TGTTTACTAAACAAAAAGAAAGAGC
Single allele	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD115-1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000666599	15	23810928 - 28544664			666599	654159		
NC_000015.9:g.(?_26792940)_(27018109_?)dup	GABRB3		Epilepsy, childhood absence 1|Epilepsy, childhood absence 5	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001062435	15	26792940 - 27018109			1062435	1039181		
NC_000015.9:g.(?_26792940)_(27020442_?)dup	GABRB3		Epilepsy, childhood absence 5|Epilepsy, childhood absence 1	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001027351	15	26792940 - 27020442			1027351	1001747		
NM_000814.6(GABRB3):c.782_783delinsTA (p.Ser261Leu)	GABRB3	S190L, S176L, S261L	Epilepsy, childhood absence 1|Epilepsy, childhood absence 5	Uncertain significance(Last reviewed: Apr 27, 2020)	criteria provided, single submitter	VCV000969775	15	26812780 - 26812781	15	26567633 - 26567634	969775	957368		NC_000015.10:26567632:CG:TA
NC_000015.9:g.(?_27017808)_(27020442_?)dup	GABRB3		Epilepsy, childhood absence 5|Epilepsy, childhood absence 1	Uncertain significance(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000654110	15	27017808 - 27020442	15	26772661 - 26775295	654110	652637		
NC_000015.9:g.(?_26792920)_(27018162_?)dup	GABRB3		Epilepsy, childhood absence 1|Epilepsy, childhood absence 5	Uncertain significance(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000583530	15	26792920 - 27018162	15	26547773 - 26773015	583530	569194		
NM_000814.6(GABRB3):c.682_682+3dup	GABRB3		Epilepsy, childhood absence 5|Epilepsy, childhood absence 1	Uncertain significance(Last reviewed: Mar 6, 2017)	criteria provided, single submitter	VCV000469575	15	26825462 - 26825463	15	26580315 - 26580316	469575	464806	rs1254941219	NC_000015.10:26580315:CACC:CACCCACC
NC_000015.9:g.(?_26792920)_(27020442_?)dup	GABRB3		Epilepsy, childhood absence 5|Epilepsy, childhood absence 1	Uncertain significance(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000469569			15	26547773 - 26775295	469569	464510		
NM_000815.5(GABRD):c.691+27_691+28insGCGCGCCCGCCGCCCCTTCCGCGCGCGCCCGCCGCCCCTTCCGC	GABRD		Idiopathic generalized epilepsy	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001143601	1	1959740 - 1959741	1	2028301 - 2028302	1143601	1130795		NC_000001.11:2028301:GCCCGCCGCCCCTTCCGC:GCCCGCCGCCCCTTCCGCGCGCGCCCGCCGCCCCTTCCGCGCGCGCCCGCCGCCCCTTCCGC
NM_000815.5(GABRD):c.691+27_691+28insGCGCGCCCGCCGCCCCTTCCGC	GABRD		Idiopathic generalized epilepsy	Likely benign(Last reviewed: Nov 16, 2020)	criteria provided, single submitter	VCV001119321	1	1959740 - 1959741	1	2028301 - 2028302	1119321	1088385		NC_000001.11:2028301:GCCCGCCGCCCCTTCCGC:GCCCGCCGCCCCTTCCGCGCGCGCCCGCCGCCCCTTCCGC
NM_000815.5(GABRD):c.651dup (p.Ser218fs)	GABRD	S218fs	Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV001063927	1	1959689 - 1959690	1	2028250 - 2028251	1063927	1039727		NC_000001.11:2028250:CC:CCC
NC_000001.11:g.(?_2024922)_(2030302_?)dup	GABRD		Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000830812	1	1956361 - 1961741			830812	818896		
NC_000001.10:g.(?_1950843)_(1961741_?)dup	GABRD		Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000459999	1	1950843 - 1961741	1	2019404 - 2030302	459999	446922		
NM_198904.4(GABRG2):c.1224_1225insCA (p.Asp409fs)	GABRG2	D261fs, D269fs, D306fs, D379fs, D380fs, D387fs, D400fs, D401fs, D406fs, D408fs, D409fs, D422fs, D441fs, D449fs	Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV001075793	5	161580169 - 161580170	5	162153163 - 162153164	1075793	1060339		NC_000005.10:162153163:A:ACA
NM_198904.4(GABRG2):c.429dup (p.Lys144fs)	GABRG2	K115fs, K122fs, K141fs, K144fs, K49fs, K4fs	Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Apr 9, 2020)	criteria provided, single submitter	VCV001071103	5	161524741 - 161524742	5	162097735 - 162097736	1071103	1060338		NC_000005.10:162097735:GGGG:GGGGG
NC_000005.9:g.(?_161528235)_(161580379_?)dup	GABRG2		Epilepsy, childhood absence 2|Familial febrile seizures 8	Uncertain significance(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV001062436	5	161528235 - 161580379			1062436	1039072		
NM_198904.4(GABRG2):c.1415dup (p.Tyr472Ter)	GABRG2	Y442*, Y464*, Y469*, Y471*, Y324*, Y332*, Y369*, Y443*, Y485*, Y504*, Y512*, Y450*, Y463*, Y472*	Epilepsy, childhood absence 2|Familial febrile seizures 8	Uncertain significance(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000646021	5	161580360 - 161580361	5	162153354 - 162153355	646021	633713	rs1210628894	NC_000005.10:162153354:A:AA
NC_000005.9:g.(?_161528241)_(161582545_?)dup	GABRG2		Familial febrile seizures 8|Epilepsy, childhood absence 2	Uncertain significance(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000417425	5	161528241 - 161582545	5	162101235 - 162155539	417425	394173		
NM_198904.4(GABRG2):c.-4dup	GABRG2		Seizures|Generalized epilepsy with febrile seizures plus|Severe myoclonic epilepsy in infancy	Conflicting interpretations of pathogenicity(Last reviewed: Jul 19, 2017)	criteria provided, conflicting interpretations	VCV000352636	5	161494990 - 161494991	5	162067984 - 162067985	352636	302896	rs771282908	NC_000005.10:162067984:AAAAAAAAAAAA:AAAAAAAAAAAAA
NC_000011.10:g.(?_68684904)_(68691007_?)dup	GAL		Epilepsy, familial temporal lobe, 8	Uncertain significance(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000831647	11	68452372 - 68458475			831647	820412		
NM_001482.3(GATM):c.979-18dup	GATM		not specified	Benign(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	VCV000205605	15	45657068 - 45657069	15	45364870 - 45364871	205605	202850	rs202176047	NC_000015.10:45364870:AAAAAAAA:AAAAAAAAA
NM_004483.5(GCSH):c.293-16dup	GCSH		not provided|Non-ketotic hyperglycinemia	Benign(Last reviewed: May 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000235601	16	81118208	16	81084602 - 81084603	235601	237282	rs202181338	NC_000016.10:81084602:AAAAAAAA:AAAAAAAAA
NM_021267.5(CERS1):c.*1011dup	GDF1|CERS1	L248fs	Epilepsy, progressive myoclonic 8	Pathogenic(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001074441	19	18979782 - 18979783	19	18868973 - 18868974	1074441	1064683		NC_000019.10:18868973:GGGGG:GGGGGG
NM_021267.5(CERS1):c.71_72delinsCC (p.Gln24Pro)	GDF1|CERS1	Q24P	Epilepsy, progressive myoclonic 8	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001053870	19	19006810 - 19006811	19	18896001 - 18896002	1053870	1051177		NC_000019.10:18896000:CT:GG
NM_021267.5(CERS1):c.102_103insTCG (p.Arg35_Gly36insSer)	GDF1|CERS1		Epilepsy, progressive myoclonic 8	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001051292	19	19006779 - 19006780	19	18895970 - 18895971	1051292	1051176		NC_000019.10:18895970:CG:CGACG
NM_021267.5(CERS1):c.*1309_*1320dup	GDF1|CERS1		Epilepsy, progressive myoclonic 8	Uncertain significance(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV000998691	19	18979473 - 18979474	19	18868664 - 18868665	998691	998468		NC_000019.10:18868664:CAAAGAAGAGCAC:CAAAGAAGAGCACAAAGAAGAGCAC
NM_021267.5(CERS1):c.219_220insGGCTGGACCGCGCTG (p.Gly69_Leu73dup)	GDF1|CERS1		Epilepsy, progressive myoclonic 8	Uncertain significance(Last reviewed: Aug 17, 2019)	criteria provided, single submitter	VCV000947261	19	19006662 - 19006663	19	18895853 - 18895854	947261	928901		NC_000019.10:18895853:CAG:CAGCGCGGTCCAGCCCAG
NM_000170.3(GLDC):c.1576_1577insCAC (p.Asn526delinsThrHis)	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001068918	9	6589198 - 6589199	9	6589198 - 6589199	1068918	1061714		NC_000009.12:6589198::GTG
NC_000009.11:g.(?_6550793)_(6550924_?)dup	GLDC		Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001066623	9	6550793 - 6550924			1066623	1054472		
NC_000009.11:g.(?_6620164)_(6645499_?)dup	GLDC		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001022279	9	6620164 - 6645499			1022279	1001621		
NM_000170.3(GLDC):c.969_970dup (p.Leu324fs)	GLDC	L324fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000953835	9	6604675 - 6604676	9	6604675 - 6604676	953835	946662		NC_000009.12:6604675:GTG:GTGTG
NC_000009.12:g.(?_6532997)_(6540166_?)dup	GLDC		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000831538	9	6532997 - 6540166			831538	820147		
NM_000170.3(GLDC):c.2316-13_2316-12dup	GLDC		not provided|Non-ketotic hyperglycinemia	Benign/Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000705437	9	6553514 - 6553515	9	6553514 - 6553515	705437	695445	rs3215923	NC_000009.12:6553514:TTTTTTTT:TTTTTTTTTT
NC_000009.11:g.(?_6587121)_(6645519_?)dup	GLDC|LOC113839554		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000663414	9	6587121 - 6645519	9	6587121 - 6645519	663414	651864		
NC_000009.11:g.(?_6620184)_(6720997_?)dup	GLDC|KDM4C|LINC02851|LOC111413010		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000583506	9	6620184 - 6720997	9	6620184 - 6720997	583506	568324		
NM_000170.3(GLDC):c.411_412insAATA (p.Tyr138fs)	GLDC	Y138fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000583199	9	6620242 - 6620243	9	6620242 - 6620243	583199	565963	rs1563864784	NC_000009.12:6620242::TATT
NM_000170.3(GLDC):c.439_441dup (p.Ile147dup)	GLDC		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000570665	9	6620212 - 6620213	9	6620212 - 6620213	570665	569149	rs1157234920	NC_000009.12:6620212:AAT:AATAAT
NM_000170.3(GLDC):c.2278dup (p.His760fs)	GLDC	H760fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000565866	9	6554705 - 6554706	9	6554705 - 6554706	565866	564104	rs1563834980	NC_000009.12:6554705:GGGG:GGGGG
NM_000170.3(GLDC):c.2888dup (p.Tyr964fs)	GLDC	Y964fs	Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000558248	9	6534738 - 6534739	9	6534738 - 6534739	558248	545300	rs1554641737	NC_000009.12:6534738:GG:GGG
NM_000170.3(GLDC):c.2124_2126dup (p.Asn709_Ile710insLys)	GLDC		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000557710	9	6556228 - 6556229	9	6556228 - 6556229	557710	544951	rs1554643929	NC_000009.12:6556228:TTCT:TTCTTCT
NM_000170.3(GLDC):c.2423_2426dup (p.Ile810fs)	GLDC	I810fs	Non-ketotic hyperglycinemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000495699	9	6553398 - 6553399	9	6553398 - 6553399	495699	487389	rs755313904	NC_000009.12:6553398:GAAC:GAACGAAC
NM_000170.3(GLDC):c.197_198delinsAA (p.Arg66Lys)	GLDC	R66K	Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000462864	9	6645302 - 6645303	9	6645302 - 6645303	462864	459665	rs1554652780	NC_000009.12:6645301:CC:TT
NC_000009.11:g.(?_6620164)_(6645519_?)dup	GLDC		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000462850	9	6620164 - 6645519	9	6620164 - 6645519	462850	458662		
NC_000009.11:g.(?_6565334)_(6565449_?)dup	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000462849	9	6565334 - 6565449	9	6565334 - 6565449	462849	458739		
NM_000170.3(GLDC):c.2316-6dup	GLDC		Non-ketotic hyperglycinemia|not specified|not provided	Benign/Likely benign(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000255454	9	6553514 - 6553515	9	6553514 - 6553515	255454	253564	rs3215923	NC_000009.12:6553514:TTTTTTTT:TTTTTTTTT
NM_000170.3(GLDC):c.2891dup (p.Tyr964Ter)	GLDC	Y964*	Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Jul 22, 2016)	criteria provided, single submitter	VCV000056172	9	6534735 - 6534736	9	6534735 - 6534736	56172	70811	rs386833572	NC_000009.12:6534735:T:TT
NM_000170.3(GLDC):c.2153_2155delinsTCCTGGTTTA (p.His718_Gln719delinsLeuLeuValTer)	GLDC		Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056060	9	6556200 - 6556202	9	6556200 - 6556202	56060	70699	rs386833541	NC_000009.12:6556199:GAT:TAAACCAGGA
NM_000170.3(GLDC):c.1444dup (p.Asp482fs)	GLDC	D482fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV000056045	9	6592180 - 6592181	9	6592180 - 6592181	56045	70684	rs386833526	NC_000009.12:6592180:CC:CCC
NM_000170.3(GLDC):c.1285_1286insCAAA (p.Leu429fs)	GLDC	L429fs	Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056041	9	6592966 - 6592967	9	6592966 - 6592967	56041	70680	rs386833522	NC_000009.12:6592966::TTTG
NM_000170.3(GLDC):c.1002dup (p.Ala335fs)	GLDC	A335fs	Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056035	9	6604643 - 6604644	9	6604643 - 6604644	56035	70674	rs386833516	NC_000009.12:6604643:AAAAAA:AAAAAAA
NM_000824.5(GLRB):c.1431_1452dup (p.Phe485fs)	GLRB	F485fs	Hyperekplexia 2	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000970188	4	158091813 - 158091814	4	157170661 - 157170662	970188	953707		NC_000004.12:157170661:TGCAAGAGCATTGTTTCCTTTCTGC:TGCAAGAGCATTGTTTCCTTTCTGCAAGAGCATTGTTTCCTTTCTGC
NM_000824.5(GLRB):c.448dup (p.Ser150fs)	GLRB	S150fs	Hyperekplexia 2	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000574411	4	158057765 - 158057766	4	157136613 - 157136614	574411	563549	rs1560962569	NC_000004.12:157136613:AAAAAA:AAAAAAA
NM_000824.5(GLRB):c.1221dup (p.Val408fs)	GLRB	V408fs	Hyperekplexia 2	Uncertain significance(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000540368	4	158091601 - 158091602	4	157170449 - 157170450	540368	520102	rs746631259	NC_000004.12:157170449:AAAAAA:AAAAAAA
NM_000824.5(GLRB):c.798_800delinsGATGATGGGGGT (p.Gly267delinsMetMetGlyVal)	GLRB		Hyperekplexia 2	Uncertain significance(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000540367	4	158065005 - 158065007	4	157143853 - 157143855	540367	519795	rs1553998291	NC_000004.12:157143852:CGG:GATGATGGGGGT
NM_000824.5(GLRB):c.*467dup	GLRB		Hyperekplexia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000347937	4	158092346 - 158092347	4	157171194 - 157171195	347937	297436	rs371032369	NC_000004.12:157171194:A:AA
NC_000017.10:g.(?_45000559)_(45016126_?)dup	GOSR2		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV001041931	17	45000559 - 45016126			1041931	1022387		
NM_004287.5(GOSR2):c.199_200delinsCA (p.Arg67Gln)	GOSR2|LRRC37A2	R49Q, R67Q, R66Q	not provided|Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jan 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000498891	17	45008569 - 45008570	17	46931203 - 46931204	498891	490315	rs1555709548	NC_000017.11:46931202:AG:CA
NM_004287.5(GOSR2):c.22dup (p.Thr8fs)	GOSR2|LRRC37A2	T8fs	Progressive myoclonic epilepsy|Muscular dystrophy	Uncertain significance(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000405440	17	45000577 - 45000578	17	46923211 - 46923212	405440	402756	rs746855352	NC_000017.11:46923211:AAA:AAAA
NM_004287.5(GOSR2):c.*288_*296dup	GOSR2|LRRC37A2		not provided|Progressive myoclonic epilepsy	Benign/Likely benign(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000323828	17	45016412 - 45016413	17	46939046 - 46939047	323828	346313	rs376212419	NC_000017.11:46939046:TGGCTTTGTT:TGGCTTTGTTGGCTTTGTT
NM_004287.5(GOSR2):c.478-20dup	GOSR2|LRRC37A2		not specified	Benign(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000205625	17	45015936 - 45015937	17	46938570 - 46938571	205625	203465	rs552913709	NC_000017.11:46938570:TTTTTTTTT:TTTTTTTTTT
NM_003801.4(GPAA1):c.160_161delinsAA (p.Ala54Asn)	GPAA1	A54N	Glycosylphosphatidylinositol biosynthesis defect 15	Uncertain significance(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000453252	8	145138112 - 145138113	8	144083209 - 144083210	453252	446834	rs1554763777	NC_000008.11:144083208:GC:AA
NC_000006.11:g.(?_24495205)_(24505233_?)dup	GPLD1|ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Uncertain significance(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000584364	6	24495205 - 24505233	6	24494977 - 24505005	584364	560513		
NM_007327.4(GRIN1):c.1114-8dup	GRIN1		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV001149561	9	140053064 - 140053065	9	137158612 - 137158613	1149561	1140387		NC_000009.12:137158612:A:AA
NC_000009.11:g.(?_140033939)_(140034216_?)dup	GRIN1		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, single submitter	VCV001148453	9	140033939 - 140034216			1148453	1130076		
NC_000009.11:g.(?_140059618)_(140062314_?)dup	GRIN1		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Likely benign(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV001086698	9	140059618 - 140062314			1086698	1065902		
NC_000009.12:g.(?_137139467)_(137139764_?)dup	GRIN1		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000832429	9	140033919 - 140034216			832429	820104		
NC_000009.12:g.(?_137139467)_(137167862_?)dup	GRIN1		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Uncertain significance(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000830810	9	140033919 - 140062314			830810	820105		
NM_007327.4(GRIN1):c.968+10dup	GRIN1		not specified|not provided|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000421255	9	140051495 - 140051496	9	137157043 - 137157044	421255	407629	rs777548072	NC_000009.12:137157043:GGGG:GGGGG
NM_007327.4(GRIN1):c.1854_1859dup (p.Ile619_Gly620dup)	GRIN1		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000397504	9	140056954 - 140056955	9	137162502 - 137162503	397504	384406	rs1554770185	NC_000009.12:137162502:CGGCATCGG:CGGCATCGGCATCGG
NM_007327.4(GRIN1):c.1679_1681dup (p.Ser560dup)	GRIN1		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Mar 11, 2011)	no assertion criteria provided	VCV000029726	9	140056668 - 140056669	9	137162216 - 137162217	29726	38681	rs1554770064	NC_000009.12:137162216:AGCA:AGCAGCA
NC_000016.9:g.(?_10273845)_(10274268_?)dup	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Likely benign(Last reviewed: Nov 4, 2020)	criteria provided, single submitter	VCV001160094	16	10273845 - 10274268			1160094	1130077		
NM_001134407.3(GRIN2A):c.1329-7dup	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Likely benign(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV001154237	16	9934965 - 9934966	16	9841108 - 9841109	1154237	1146809		NC_000016.10:9841108:AAA:AAAA
NC_000016.9:g.(?_9916101)_(9923529_?)dup	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV001073744	16	9916101 - 9923529			1073744	1057848		
NM_001134407.3(GRIN2A):c.2833_2834insTTCAG (p.Asp945fs)	GRIN2A	D945fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV001069106	16	9858567 - 9858568	16	9764710 - 9764711	1069106	1063834		NC_000016.10:9764710:CTGA:CTGAACTGA
NM_001134407.3(GRIN2A):c.2335_2336delinsAG (p.Leu779Arg)	GRIN2A	L779R	Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000976247	16	9892154 - 9892155	16	9798297 - 9798298	976247	964464		NC_000016.10:9798296:AA:CT
NM_001134407.3(GRIN2A):c.176_179dup (p.Ala61fs)	GRIN2A	A61fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	VCV000975936	16	10274089 - 10274090	16	10180232 - 10180233	975936	964440		NC_000016.10:10180232:GCCTGC:GCCTGCCTGC
NM_001134407.3(GRIN2A):c.1788_1789insGTG (p.Pro597_Ser598insVal)	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV000975553	16	9923498 - 9923499	16	9829641 - 9829642	975553	963823		NC_000016.10:9829641:C:CACC
NM_001134407.3(GRIN2A):c.1244dup (p.Phe416fs)	GRIN2A	F416fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV000955660	16	9943696 - 9943697	16	9849839 - 9849840	955660	949687		NC_000016.10:9849839:GGGG:GGGGG
NC_000016.10:g.(?_9763129)_(10180431_?)dup	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000832875	16	9856986 - 10274288			832875	820963		
NC_000016.10:g.(?_9890966)_(9938571_?)dup	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000832000	16	9984823 - 10032428			832000	820967		
NM_001134407.3(GRIN2A):c.1529dup (p.Ser511fs)	GRIN2A	S511fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000813782	16	9934625 - 9934626	16	9840768 - 9840769	813782	802016		NC_000016.10:9840768:CC:CCC
NM_001134407.3(GRIN2A):c.1946_1947delinsCT (p.Leu649Pro)	GRIN2A	L649P	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: Jun 7, 2016)	criteria provided, single submitter	VCV000813733	16	9923340 - 9923341	16	9829483 - 9829484	813733	802015		NC_000016.10:9829482:CA:AG
NM_001134407.3(GRIN2A):c.3317_3318insTTTTTTTTTTAAT (p.Lys1107fs)	GRIN2A	K1107fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803216	16	9858083 - 9858084	16	9764226 - 9764227	803216	791669	rs1419346546	NC_000016.10:9764226:A:ATTAAAAAAAAAAA
NM_001134407.3(GRIN2A):c.3321_3322insCGGCG (p.Thr1108fs)	GRIN2A	T1108fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803214	16	9858079 - 9858080	16	9764222 - 9764223	803214	791667	rs1215972111	NC_000016.10:9764222::CGCCG
NM_001134407.3(GRIN2A):c.58_67dup (p.Pro23fs)	GRIN2A	P23fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000664825	16	10274201 - 10274202	16	10180344 - 10180345	664825	643763	rs1596587476	NC_000016.10:10180344:GCGCCGGACCGCGCC:GCGCCGGACCGCGCCGGACCGCGCC
NM_001134407.3(GRIN2A):c.1264_1308delinsGTCAAAGTTCCGTGGAAA (p.Ile422_Cys436delinsValLysValProTrpLys)	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000639911	16	9943633 - 9943677	16	9849776 - 9849820	639911	645263	rs1596494678	NC_000016.10:9849775:ACATGGCACGGTGTTCCTCACACACGTCTCGGTCAGGGGGTCTAT:TTTCCACGGAACTTTGAC
NC_000016.9:g.(?_10273835)_(10274288_?)dup	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000583749	16	10273835 - 10274288	16	10179978 - 10180431	583749	567460		
Single allele	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000560130	16	10106138 - 10417597			560130	550846		
NM_001134407.3(GRIN2A):c.*2771_*2774dup	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000321563	16	9854231 - 9854232	16	9760374 - 9760375	321563	326987	rs35189803	NC_000016.10:9760374:TTTTTTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTTTTTTTT
NM_001134407.3(GRIN2A):c.*2773_*2774dup	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000321562	16	9854231 - 9854232	16	9760374 - 9760375	321562	336916	rs35189803	NC_000016.10:9760374:TTTTTTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTTTTTT
NM_001134407.3(GRIN2A):c.*2775_*2776insA	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000321561	16	9854230 - 9854231	16	9760373 - 9760374	321561	343149	rs886052539	NC_000016.10:9760373::T
NM_001134407.3(GRIN2A):c.*5775dup	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000321523	16	9851230 - 9851231	16	9757373 - 9757374	321523	326953	rs202247656	NC_000016.10:9757373:AAAAAA:AAAAAAA
NM_001134407.3(GRIN2A):c.*8536_*8537insC	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000321470	16	9848469 - 9848470	16	9754612 - 9754613	321470	326927	rs59371229	NC_000016.10:9754612::G
NM_000834.5(GRIN2B):c.2172-15dup	GRIN2B		Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Benign(Last reviewed: Aug 29, 2020)	criteria provided, single submitter	VCV001166602	12	13722960 - 13722961	12	13570026 - 13570027	1166602	1156947		NC_000012.12:13570026:AAAAAA:AAAAAAA
NM_000834.5(GRIN2B):c.3702_3705dup (p.Arg1236fs)	GRIN2B	R1236fs	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV000975555	12	13716466 - 13716467	12	13563532 - 13563533	975555	963749		NC_000012.12:13563532:GCCCG:GCCCGCCCG
NM_000834.5(GRIN2B):c.2834_2837dup (p.Cys946Ter)	GRIN2B	C946*	Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Uncertain significance(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000971807	12	13717334 - 13717335	12	13564400 - 13564401	971807	956824		NC_000012.12:13564400:CAGTCAG:CAGTCAGTCAG
NM_000834.5(GRIN2B):c.2914_2919dup (p.Asn972_Leu973dup)	GRIN2B		Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Uncertain significance(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000834243	12	13717252 - 13717253	12	13564318 - 13564319	834243	839706		NC_000012.12:13564318:CAGGTTC:CAGGTTCAGGTTC
NM_000834.5(GRIN2B):c.2011-2_2038dup	GRIN2B		Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802824	12	13724870 - 13724871	12	13571936 - 13571937	802824	791218	rs1591612370	NC_000012.12:13571936:GGGGTGAGAAGTCATTAGGTCTCTGGAACTGG:GGGGTGAGAAGTCATTAGGTCTCTGGAACTGGGGTGAGAAGTCATTAGGTCTCTGGAACTGG
NM_000834.5(GRIN2B):c.4309_4310delinsAT (p.Ala1437Ile)	GRIN2B	A1437I	Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Likely benign(Last reviewed: Jun 1, 2019)	criteria provided, single submitter	VCV000765967	12	13715862 - 13715863	12	13562928 - 13562929	765967	769021	rs1591604894	NC_000012.12:13562927:GC:AT
NM_000834.5(GRIN2B):c.99dup (p.Ser34fs)	GRIN2B	S34fs	not provided|Mental retardation, autosomal dominant 6|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000430527	12	14019043 - 14019044	12	13866109 - 13866110	430527	421913	rs398122823	NC_000012.12:13866109:GGGGGGG:GGGGGGGG
NC_000011.9:g.(?_17552691)_(19213995_?)dup	GTF2H1|KCNC1|LDHA|LDHC|MYOD1|SAA1|SAA2|SAA4|TPH1|TSG101|CSRP3|USH1C|HPS5|SERGEF|ZDHHC13|UEVLD|PTPN5|SAAL1|MRGPRX2|MRGPRX3|MRGPRX4|SPTY2D1|TMEM86A|LDHAL6A|MRGPRX1|IGSF22|OTOG|SAA2-SAA4		Epilepsy, progressive myoclonic 7	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000999235	11	17552691 - 19213995			999235	986463		
NC_000020.10:g.(?_60831241)_(62664346_?)dup	HAR1A|SLC17A9|GID8|MIR1-1|PPDPF|TPD52L2|DIDO1|GATA5|EEF1A2|SLC2A4RG|OGFR|RTEL1|HELZ2|YTHDF1|ARFGAP1|DNAJC5|NTSR1|GMEB2|ZGPAT|COL9A3|BIRC7|ABHD16B|PRPF6|SLCO4A1|STMN3|TCFL5|LAMA5|HAR1B|RBBP8NL|ARFRP1|SAMD10|ADRM1|UCKL1|MIR1-1HG|CHRNA4|CABLES2|MRGBP|TNFRSF6B|MIR133A2|ZNF512B|LIME1|FNDC11|OSBPL2|KCNQ2|NKAIN4|PTK6|BHLHE23|ZBTB46|SRMS|RPS21|COL20A1		Early infantile epileptic encephalopathy with suppression bursts|Neuronal ceroid lipofuscinosis|Epileptic encephalopathy, early infantile, 33	Uncertain significance(Last reviewed: Jun 9, 2020)	criteria provided, single submitter	VCV000999459	20	60831241 - 62664346			999459	986672		
NM_001077350.3(NPRL3):c.726dup (p.Ile243fs)	HBA-LCR|NPRL3	I165fs, I218fs, I243fs, I64fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Aug 10, 2020)	criteria provided, single submitter	VCV001069967	16	150410 - 150411	16	100412 - 100413	1069967	1063487		NC_000016.10:100412:C:CC
NM_001077350.3(NPRL3):c.1111_1122dup (p.Pro371_Leu374dup)	HBA-LCR|NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV000957562	16	142632 - 142633	16	92634 - 92635	957562	949673		NC_000016.10:92634:CAAGGAGACCGGCAAGGAGA:CAAGGAGACCGGCAAGGAGACCGGCAAGGAGA
NM_001077350.3(NPRL3):c.1025dup (p.Cys343fs)	HBA-LCR|NPRL3	C164fs, C343fs, C265fs, C318fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000859188	16	143222 - 143223	16	93224 - 93225	859188	844642		NC_000016.10:93224:A:AA
NM_001077350.3(NPRL3):c.1332_1333dup (p.Leu445fs)	HBA-LCR|NPRL3	L266fs, L420fs, L445fs, L367fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Jun 9, 2019)	criteria provided, single submitter	VCV000854706	16	139728 - 139729	16	89730 - 89731	854706	844507		NC_000016.10:89730:GGG:GGGGG
NM_001077350.3(NPRL3):c.1280_1283delinsTCCC (p.Asp427_Val428delinsValPro)	HBA-LCR|NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000666209	16	139779 - 139782	16	89781 - 89784	666209	645188	rs1596496451	NC_000016.10:89780:ACGT:GGGA
NC_000016.9:g.(?_188129)_(188286_?)dup	HBA-LCR|NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000660705	16	188129 - 188286	16	138130 - 138287	660705	652452		
NC_000016.9:g.(?_180501)_(188286_?)dup	HBA-LCR|NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000641549	16	180501 - 188286	16	130502 - 138287	641549	652451		
NM_001077350.3(NPRL3):c.1270dup (p.Arg424fs)	HBA-LCR|NPRL3	R346fs, R399fs, R245fs, R424fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000566936	16	139791 - 139792	16	89793 - 89794	566936	574225	rs1567129567	NC_000016.10:89793:G:GG
NC_000016.9:g.(?_167280)_(188286_?)dup	HBA-LCR|NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000542813	16	167280 - 188286	16	117281 - 138287	542813	529545		
NM_001077350.3(NPRL3):c.922_923dup (p.Gln308fs)	HBA-LCR|NPRL3	Q283fs, Q308fs, Q230fs, Q129fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV000542798	16	148143 - 148144	16	98145 - 98146	542798	530799	rs1555441032	NC_000016.10:98145:TG:TGTG
NM_001077350.3(NPRL3):c.1514_1518delinsTTCTGGGGCT (p.Gln505fs)	HBA-LCR|NPRL3	Q505fs, Q480fs, Q326fs, Q427fs	Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000542797	16	138723 - 138727	16	88724 - 88728	542797	530919	rs1555439541	NC_000016.10:88723:GTTCT:AGCCCCAGAA
NM_001077350.3(NPRL3):c.1375_1376dup (p.Ser460fs)	HBA-LCR|NPRL3	S460fs, S281fs, S435fs, S382fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Sep 22, 2016)	no assertion criteria provided	VCV000254359	16	138863 - 138864	16	88865 - 88866	254359	248899	rs886037960	NC_000016.10:88865:GTG:GTGTG
NM_001077350.3(NPRL3):c.1352-4_1352-1delinsTGACCCATCC	HBA-LCR|NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Sep 21, 2016)	no assertion criteria provided	VCV000254358	16	138889 - 138892	16	88891 - 88894	254358	248898	rs886037959	NC_000016.10:88890:CTGT:GGATGGGTCA
NM_001077350.3(NPRL3):c.835dup (p.Ser279fs)	HBA-LCR|NPRL3	S100fs, S201fs, S279fs, S254fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Sep 21, 2016)	no assertion criteria provided	VCV000254357	16	148231 - 148232	16	98233 - 98234	254357	248897	rs886037958	NC_000016.10:98233:A:AA
Single allele	HCN1		Generalized epilepsy with febrile seizures plus, type 10	Uncertain significance(Last reviewed: Jul 3, 2020)	criteria provided, single submitter	VCV001184324			5	45270314 - 46227325	1184324	1174073		
NC_000005.9:g.(?_45396584)_(45696195_?)dup	HCN1		Early infantile epileptic encephalopathy with suppression bursts	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001047657	5	45396584 - 45696195			1047657	1022261		
NC_000005.9:g.(?_45396574)_(45696215_?)dup	HCN1		Early infantile epileptic encephalopathy with suppression bursts	Uncertain significance(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000461207			5	45396472 - 45696113	461207	454065		
NM_021072.3(HCN1):c.-25_1230+?dup1255	HCN1		Early infantile epileptic encephalopathy with suppression bursts	Uncertain significance(Last reviewed: Oct 6, 2016)	criteria provided, single submitter	VCV000254077	5	45396594 - 45696220	5	45396492 - 45696118	254077	248493		
NC_000020.10:g.(?_61977556)_(62562941_?)dup	HELZ2|TNFRSF6B|STMN3|FNDC11|ZGPAT|KCNQ2|GMEB2|ARFRP1|SLC2A4RG|EEF1A2|LIME1|SRMS|CHRNA4|RTEL1|PTK6|DNAJC5|ZBTB46|TPD52L2|ABHD16B|PPDPF		Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000833250	20	61977556 - 62562941			833250	821312		
NM_152722.5(HEPACAM):c.*116dup	HEPACAM		Megalencephalic leukoencephalopathy with subcortical cysts	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000303317	11	124790917 - 124790918	11	124921021 - 124921022	303317	319154	rs886047930	NC_000011.10:124921021:CCCCCCC:CCCCCCCC
NM_152722.5(HEPACAM):c.*363dup	HEPACAM		Megalencephalic leukoencephalopathy with subcortical cysts	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000303312	11	124790670 - 124790671	11	124920774 - 124920775	303312	326099	rs577667880	NC_000011.10:124920774:A:AA
NM_152722.5(HEPACAM):c.*459_*460insCC	HEPACAM		Megalencephalic leukoencephalopathy with subcortical cysts	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000303307	11	124790574 - 124790575	11	124920678 - 124920679	303307	325272	rs886047925	NC_000011.10:124920678::GG
NM_031844.3(HNRNPU):c.16delinsATT (p.Val6fs)	HNRNPU	V6fs	Epileptic encephalopathy, early infantile, 54	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431120	1	245027594	1	244864292	431120	424638	rs1135401794	NC_000001.11:244864291:C:AAT
NC_000018.9:g.(?_44682528)_(44702668_?)dup	IER3IP1		Microcephaly, epilepsy, and diabetes syndrome	Uncertain significance(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000539836	18	44682528 - 44702668	18	47156157 - 47176297	539836	532238		
NM_021999.5(ITM2B):c.787_796dup (p.Ser266fs)	ITM2B	S266fs	ADan amyloidosis	Pathogenic(Last reviewed: Apr 25, 2000)	no assertion criteria provided	VCV000005980	13	48835344 - 48835345	13	48261208 - 48261209	5980	21019	rs606231166	NC_000013.11:48261208:TTTAATTTGTT:TTTAATTTGTTTTAATTTGTT
NM_015443.4(KANSL1):c.1657_1658insTTGTAT (p.Gln553delinsLeuValTer)	KANSL1		Koolen-de Vries syndrome	Pathogenic(Last reviewed: Sep 16, 2020)	criteria provided, single submitter	VCV001071483	17	44144093 - 44144094	17	46066727 - 46066728	1071483	1064251		NC_000017.11:46066727::ATACAA
NM_015443.4(KANSL1):c.517_518delinsAT (p.Ser173Ile)	KANSL1	S173I	Koolen-de Vries syndrome	Uncertain significance(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV001016363	17	44248992 - 44248993	17	46171626 - 46171627	1016363	1012826		NC_000017.11:46171625:GA:AT
NC_000017.10:g.(?_44073755)_(44159918_?)dup	KANSL1|MAPT|STH		Koolen-de Vries syndrome	Uncertain significance(Last reviewed: Aug 29, 2020)	criteria provided, single submitter	VCV001010652	17	44073755 - 44159918			1010652	986611		
NM_015443.4(KANSL1):c.3049dup (p.Asp1017fs)	KANSL1	D1016fs, D1017fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV000981161	17	44109453 - 44109454	17	46032087 - 46032088	981161	969247		NC_000017.11:46032087:CC:CCC
NM_015443.4(KANSL1):c.1768_1769delinsAG (p.Ala590Arg)	KANSL1	A590R	Koolen-de Vries syndrome	Likely pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000936637	17	44143982 - 44143983	17	46066616 - 46066617	936637	937996		NC_000017.11:46066615:GC:CT
NC_000017.11:g.(?_46031456)_(46067687_?)dup	KANSL1		Koolen-de Vries syndrome	Uncertain significance(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000832068	17	44108822 - 44145053			832068	821099		
NC_000017.10:g.(?_44108822)_(44128090_?)dup	KANSL1		Koolen-de Vries syndrome	Uncertain significance(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000583790	17	44108822 - 44128090	17	46031456 - 46050724	583790	568641		
NM_015443.4(KANSL1):c.1463dup (p.Glu489fs)	KANSL1	E489fs	Koolen-de Vries syndrome	Likely pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000547838	17	44159876 - 44159877	17	46082510 - 46082511	547838	538467	rs1555753569	NC_000017.11:46082510:GGGGG:GGGGGG
NM_015443.4(KANSL1):c.2132dup (p.Met711fs)	KANSL1	M711fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000468402	17	44117138 - 44117139	17	46039772 - 46039773	468402	467813	rs1555734136	NC_000017.11:46039772:A:AA
NC_000012.12:g.(?_4911359)_(4912886_?)dup	KCNA1		Episodic ataxia type 1	Uncertain significance(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000831572	12	5020525 - 5022052			831572	820504		
NM_000217.3(KCNA1):c.868_872delinsTC (p.Ile290_Leu291delinsSer)	KCNA1		Episodic ataxia type 1	Uncertain significance(Last reviewed: Jun 24, 2017)	criteria provided, single submitter	VCV000463866	12	5021412 - 5021416	12	4912246 - 4912250	463866	462258	rs1555085756	NC_000012.12:4912245:ATCCT:TC
NC_000011.10:g.(?_17735983)_(17781754_?)dup	KCNC1		Epilepsy, progressive myoclonic 7	Uncertain significance(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000832039	11	17757530 - 17803301			832039	820345		
NM_000238.4(KCNH2):c.2769_2771delinsAGC (p.Gly924Ala)	KCNH2	G924A, G584A	Arrhythmia	Uncertain significance(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000920801	7	150644888 - 150644890	7	150947800 - 150947802	920801	910710		NC_000007.14:150947799:CCC:GCT
NM_002241.5(KCNJ10):c.934_935delinsTT (p.Thr312Leu)	KCNJ10	T312L	EAST syndrome	Uncertain significance(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000663852	1	160011388 - 160011389	1	160041598 - 160041599	663852	626984	rs1571265205	NC_000001.11:160041597:GT:AA
NC_000001.10:g.(?_160011163)_(160111132_?)dup	KCNJ9|IGSF8|ATP1A2|KCNJ10		Familial hemiplegic migraine|EAST syndrome	Uncertain significance(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000470189	1	160011163 - 160111132			470189	446919		
NM_001161352.2(KCNMA1):c.302dup (p.Leu102fs)	KCNMA1	L102fs	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Pathogenic(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV001072449	10	79397098 - 79397099	10	77637340 - 77637341	1072449	1061973		NC_000010.11:77637340:CCCCC:CCCCCC
NC_000010.10:g.(?_79396125)_(79397420_?)dup	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV001062516	10	79396125 - 79397420			1062516	1039148		
NM_001161352.2(KCNMA1):c.30_56dup (p.Ser11_Gly19dup)	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001053529	10	79397344 - 79397345	10	77637586 - 77637587	1053529	1046769		NC_000010.11:77637586:CCGCCGCCGCCGCCGCCGCCGCTGCTGCCGCCGCCGCCGCCGCC:CCGCCGCCGCCGCCGCCGCCGCTGCTGCCGCCGCCGCCGCCGCCGCCGCTGCTGCCGCCGCCGCCGCCGCC
NC_000010.10:g.(?_79163610)_(79397400_?)dup	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001003535	10	79163610 - 79397400			1003535	986442		
NM_001161352.2(KCNMA1):c.55_60dup (p.Gly19_Gly20dup)	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000951436	10	79397340 - 79397341	10	77637582 - 77637583	951436	925942		NC_000010.11:77637582:GCCTCCGCC:GCCTCCGCCTCCGCC
NM_001161352.2(KCNMA1):c.31_48dup (p.Ser11_Gly16dup)	KCNMA1		not provided|Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: Oct 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000497141	10	79397352 - 79397353	10	77637594 - 77637595	497141	488565	rs759136661	NC_000010.11:77637594:GCCGCCGCCGCCGCTGCTGCCGCCGCCGCCGC:GCCGCCGCCGCCGCTGCTGCCGCCGCCGCCGCTGCTGCCGCCGCCGCCGC
NM_001161352.2(KCNMA1):c.31_34delinsG (p.Ser11_Ser12delinsGly)	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy|not provided	Uncertain significance(Last reviewed: May 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000464297	10	79397367 - 79397370	10	77637609 - 77637612	464297	460171	rs1555528807	NC_000010.11:77637608:TGCT:C
NM_001161352.2(KCNMA1):c.-104_-96dup	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300979	10	79397495 - 79397496	10	77637737 - 77637738	300979	322562	rs1555529241	NC_000010.11:77637737:GCTGCCGCCGC:GCTGCCGCCGCTGCCGCCGC
NM_001161352.2(KCNMA1):c.-101_-96dup	KCNMA1		not provided|Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Benign/Likely benign(Last reviewed: Jul 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000300978	10	79397495 - 79397496	10	77637737 - 77637738	300978	323299	rs545094311	NC_000010.11:77637737:GCTGCCGC:GCTGCCGCTGCCGC
NM_001161352.2(KCNMA1):c.15_16insAGC (p.Gly6_Gly7insSer)	KCNMA1		not provided|Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 15, 2020)	criteria provided, conflicting interpretations	VCV000300975	10	79397385 - 79397386	10	77637627 - 77637628	300975	316488	rs780558929	NC_000010.11:77637627:GC:GCTGC
NM_001161352.2(KCNMA1):c.1131+11dup	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300968	10	78869919 - 78869920	10	77110161 - 77110162	300968	322557	rs545073914	NC_000010.11:77110161:TTTTTTTTT:TTTTTTTTTT
NM_001161352.2(KCNMA1):c.*113dup	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300957	10	78646910 - 78646911	10	76887152 - 76887153	300957	323291	rs144100057	NC_000010.11:76887152:AAAAAAAAA:AAAAAAAAAA
NM_001161352.2(KCNMA1):c.*2373dup	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300920	10	78644650 - 78644651	10	76884892 - 76884893	300920	322527	rs552322812	NC_000010.11:76884892:TTTTTTTTT:TTTTTTTTTT
NM_172107.4(KCNQ2):c.1160dup (p.Leu388fs)	KCNQ2	L378fs, L388fs	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV001034352	20	62059776 - 62059777	20	63428423 - 63428424	1034352	1022026		NC_000020.11:63428423:GGGGGG:GGGGGGG
NC_000020.10:g.(?_61990880)_(62078210_?)dup	KCNQ2|CHRNA4		Autosomal dominant nocturnal frontal lobe epilepsy|Early infantile epileptic encephalopathy with suppression bursts	Uncertain significance(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV001008528	20	61990880 - 62078210			1008528	986674		
NM_172107.4(KCNQ2):c.696_698dup (p.Val233dup)	KCNQ2		Benign familial neonatal seizures 1	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803622	20	62073876 - 62073877	20	63442523 - 63442524	803622	791999	rs1600767259	NC_000020.11:63442523:ACCA:ACCACCA
NM_172107.4(KCNQ2):c.1956dup (p.Thr653fs)	KCNQ2	T625fs, T635fs, T622fs, T653fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803619	20	62038659 - 62038660	20	63407306 - 63407307	803619	791996	rs1601545088	NC_000020.11:63407306:C:CC
NM_172107.4(KCNQ2):c.958_993dup (p.Val320_Lys331dup)	KCNQ2		Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Oct 24, 2018)	no assertion criteria provided	VCV000617505	20	62070007 - 62070008	20	63438654 - 63438655	617505	608865	rs1568925507	NC_000020.11:63438654:CTTCTCAAAGTGCTTCTGCCTGTGCTGCTCCTGAACCTTC:CTTCTCAAAGTGCTTCTGCCTGTGCTGCTCCTGAACCTTCTCAAAGTGCTTCTGCCTGTGCTGCTCCTGAACCTTC
NM_172107.4(KCNQ2):c.1229dup (p.Pro411fs)	KCNQ2	P401fs, P411fs	Seizures|not provided|Early infantile epileptic encephalopathy with suppression bursts|Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Feb 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000422786	20	62055547 - 62055548	20	63424194 - 63424195	422786	410821	rs886041339	NC_000020.11:63424194:GGGGGG:GGGGGGG
NM_172107.4(KCNQ2):c.1680_1684dup (p.Tyr562fs)	KCNQ2	Y531fs, Y544fs, Y562fs, Y534fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000375002	20	62044881 - 62044882	20	63413528 - 63413529	375002	361908	rs118192231	NC_000020.11:63413528:AGGGC:AGGGCAGGGC
NM_172107.4(KCNQ2):c.2318dup (p.Cys774fs)	KCNQ2	C774fs, C756fs, C746fs, C743fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369814	20	62038297 - 62038298	20	63406944 - 63406945	369814	354043	rs1555850512	NC_000020.11:63406944:CCC:CCCC
NM_172107.4(KCNQ2):c.592_594delinsA (p.Arg198fs)	KCNQ2	R198fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369752	20	62076108 - 62076110	20	63444755 - 63444757	369752	354024	rs1057516084	NC_000020.11:63444754:CCG:T
NM_172107.4(KCNQ2):c.1930dup (p.Tyr644fs)	KCNQ2	Y616fs, Y626fs, Y613fs, Y644fs	not provided	Pathogenic(Last reviewed: Jan 24, 2013)	criteria provided, single submitter	VCV000205943	20	62038685 - 62038686	20	63407332 - 63407333	205943	203711	rs796052666	NC_000020.11:63407332:A:AA
NM_172107.4(KCNQ2):c.1734_1735delinsAA (p.Met578_Leu579delinsIleMet)	KCNQ2		Early infantile epileptic encephalopathy 7|not provided	Pathogenic(Last reviewed: Jul 30, 2014)	criteria provided, single submitter	VCV000205942	20	62044831 - 62044832	20	63413478 - 63413479	205942	203721	rs796052665	NC_000020.11:63413477:GC:TT
NM_172107.4(KCNQ2):c.1302-18_1302-17insTCTGTCTT	KCNQ2		not specified|not provided	Benign(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	VCV000205846	20	62046496 - 62046497	20	63415143 - 63415144	205846	203739	rs1555854853	NC_000020.11:63415143:GA:GAAAGACAGA
NM_172107.4(KCNQ2):c.1302-18_1302-17insTGTCTGTT	KCNQ2		not specified|not provided	Benign(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	VCV000205845	20	62046496 - 62046497	20	63415143 - 63415144	205845	203738	rs1555854850	NC_000020.11:63415143::AACAGACA
NM_172107.3(KCNQ2):c.1302-18_1302-17insTGTCTGCC	KCNQ2		not specified|not provided	Benign(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	VCV000205844	20	62046496 - 62046497	20	63415143 - 63415144	205844	203744	rs1555854852	NC_000020.11:63415143:G:GGCAGACAG
NM_172107.4(KCNQ2):c.1302-18_1302-17insTCTGTCTC	KCNQ2		not specified	Benign(Last reviewed: Feb 14, 2014)	criteria provided, single submitter	VCV000205842	20	62046496 - 62046497	20	63415143 - 63415144	205842	203743	rs1555854853	NC_000020.11:63415143:GA:GAGAGACAGA
NM_172107.3(KCNQ2):c.1302-18_1302-17insTGTCCGTC	KCNQ2		not specified|not provided	Benign(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	VCV000205841	20	62046496 - 62046497	20	63415143 - 63415144	205841	203742	rs1555854855	NC_000020.11:63415143:GAC:GACGGACAGAC
NM_172107.3(KCNQ2):c.1302-18_1302-17insTGCCTGTC	KCNQ2		not provided|not specified	Benign(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	VCV000205840	20	62046496 - 62046497	20	63415143 - 63415144	205840	203741	rs1555854856	NC_000020.11:63415143:GACAG:GACAGGCAGACAG
NM_172107.3(KCNQ2):c.1302-18_1302-17insCGTCTGTC	KCNQ2		not specified|not provided	Benign(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	VCV000205839	20	62046496 - 62046497	20	63415143 - 63415144	205839	203740	rs1555854857	NC_000020.11:63415143:GACAGAC:GACAGACGGACAGAC
NM_172107.4(KCNQ2):c.1302-20_1302-19insCTGTCTGC	KCNQ2		not specified	Benign(Last reviewed: Oct 22, 2013)	criteria provided, single submitter	VCV000205837	20	62046498 - 62046499	20	63415145 - 63415146	205837	203747	rs796052609	NC_000020.11:63415145:CAGACAG:CAGACAGGCAGACAG
NM_172107.4(KCNQ2):c.698_699insACC (p.Thr234_Ala235insPro)	KCNQ2		Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000202170	20	62073876 - 62073877	20	63442523 - 63442524	202170	198642	rs794729197	NC_000020.11:63442523::GGT
NM_172107.4(KCNQ2):c.939dup (p.Ser314fs)	KCNQ2	S314fs	Benign familial neonatal seizures 2	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021807	20	62070061 - 62070062	20	63438708 - 63438709	21807	34659	rs118192213	NC_000020.11:63438708:CCCC:CCCCC
NM_172107.4(KCNQ2):c.847_848insGT (p.Lys283fs)	KCNQ2	K283fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021804	20	62071030 - 62071031	20	63439677 - 63439678	21804	34656	rs118192210	NC_000020.11:63439677::AC
NM_172107.4(KCNQ2):c.585dup (p.Ala196fs)	KCNQ2	A196fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021791	20	62076116 - 62076117	20	63444763 - 63444764	21791	34643	rs118192198	NC_000020.11:63444763:A:AA
NM_172107.4(KCNQ2):c.204dup (p.Lys69fs)	KCNQ2	K69fs	not provided|Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Dec 24, 2014)	criteria provided, single submitter	VCV000021776	20	62103612 - 62103613	20	63472259 - 63472260	21776	34628	rs118192188	NC_000020.11:63472259:GGGGGG:GGGGGGG
KCNQ2, 10-BP DEL/1-BP INS, NT761	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000007387					7387	22426		
NM_004519.4(KCNQ3):c.1583_1585dup (p.Arg528dup)	KCNQ3		Benign familial neonatal seizures	Uncertain significance(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001043542	8	133150246 - 133150247	8	132137999 - 132138000	1043542	1028287		NC_000008.11:132137999:GACG:GACGACG
NM_004519.4(KCNQ3):c.50_58dup (p.Asp17_Gly19dup)	KCNQ3		Benign familial neonatal seizures|not provided	Uncertain significance(Last reviewed: Apr 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV001022291	8	133492721 - 133492722	8	132480474 - 132480475	1022291	1007771		NC_000008.11:132480474:CGCCCCCGTCGCC:CGCCCCCGTCGCCCCCGTCGCC
NM_004519.4(KCNQ3):c.2078dup (p.Glu694fs)	KCNQ3	E694fs, E574fs	Benign familial neonatal seizures	Uncertain significance(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000945911	8	133142049 - 133142050	8	132129802 - 132129803	945911	925013		NC_000008.11:132129802:GGGGGG:GGGGGGG
NM_004519.4(KCNQ3):c.2329dup (p.Arg777fs)	KCNQ3	R657fs, R777fs	Benign familial neonatal seizures	Uncertain significance(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000944506	8	133141798 - 133141799	8	132129551 - 132129552	944506	925012		NC_000008.11:132129551:GGGGGG:GGGGGGG
NC_000008.11:g.(?_132180137)_(132186201_?)dup	KCNQ3		Benign familial neonatal seizures	Likely pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000831959	8	133192384 - 133198448			831959	819946		
NC_000008.11:g.(?_132129252)_(132186191_?)dup	KCNQ3		Benign familial neonatal seizures	Uncertain significance(Last reviewed: Oct 16, 2019)	criteria provided, single submitter	VCV000831015	8	133141499 - 133198438			831015	819945		
NM_004519.4(KCNQ3):c.116_148dup (p.Glu39_Asp49dup)	KCNQ3		Benign familial neonatal seizures	Uncertain significance(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV000580117	8	133492631 - 133492632	8	132480384 - 132480385	580117	564639	rs746906634	NC_000008.11:132480384:CGTCGCCGGGCGCCAGCCCCACTTTCCGCTCCTCGTCGCCGG:CGTCGCCGGGCGCCAGCCCCACTTTCCGCTCCTCGTCGCCGGGCGCCAGCCCCACTTTCCGCTCCTCGTCGCCGG
NM_004519.4(KCNQ3):c.2139dup (p.Ala714fs)	KCNQ3	A594fs, A714fs	Benign familial neonatal seizures	Uncertain significance(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000567399	8	133141988 - 133141989	8	132129741 - 132129742	567399	561944	rs1554621412	NC_000008.11:132129741:AAAAAA:AAAAAAA
NM_004519.4(KCNQ3):c.1685dup (p.Tyr563fs)	KCNQ3	Y563fs, Y443fs	Benign familial neonatal seizures	Uncertain significance(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000566195	8	133150146 - 133150147	8	132137899 - 132137900	566195	562362	rs1563767053	NC_000008.11:132137899:TTT:TTTT
NM_004519.4(KCNQ3):c.1249_1250delinsAT (p.Glu417Met)	KCNQ3	E417M, E297M	Benign familial neonatal seizures 2|not specified	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000450849	8	133175727 - 133175728	8	132163480 - 132163481	450849	444213	rs1554625699	NC_000008.11:132163479:TC:AT
NM_004519.4(KCNQ3):c.1885-5dup	KCNQ3		not provided|Benign familial neonatal seizures	Benign/Likely benign(Last reviewed: Aug 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000421841	8	133142247 - 133142248	8	132130000 - 132130001	421841	407310	rs769845388	NC_000008.11:132130000:AAAA:AAAAA
NM_004519.4(KCNQ3):c.-148_-147insTG	KCNQ3		Benign Neonatal Epilepsy|Benign familial neonatal seizures	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361898	8	133492926 - 133492927	8	132480679 - 132480680	361898	313042	rs886062698	NC_000008.11:132480679::CA
NM_004519.4(KCNQ3):c.-140_-139insTG	KCNQ3		Benign familial neonatal seizures|Benign Neonatal Epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361896	8	133492918 - 133492919	8	132480671 - 132480672	361896	313017	rs886062697	NC_000008.11:132480671:C:CAC
NM_004519.4(KCNQ3):c.-141_-139dup	KCNQ3		Benign familial neonatal seizures|not provided|Benign Neonatal Epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: Aug 6, 2019)	criteria provided, conflicting interpretations	VCV000361894	8	133492917 - 133492918	8	132480670 - 132480671	361894	313018	rs879019805	NC_000008.11:132480670:CCCCCCCCC:CCCCCCCCCCCC
NM_004519.4(KCNQ3):c.-140_-139dup	KCNQ3		not provided|Benign familial neonatal seizures|Benign Neonatal Epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2019)	criteria provided, conflicting interpretations	VCV000361893	8	133492917 - 133492918	8	132480670 - 132480671	361893	307908	rs879019805	NC_000008.11:132480670:CCCCCCCCC:CCCCCCCCCCC
NM_004519.4(KCNQ3):c.-139dup	KCNQ3		not provided|Benign familial neonatal seizures|Benign Neonatal Epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2019)	criteria provided, conflicting interpretations	VCV000361892	8	133492917 - 133492918	8	132480670 - 132480671	361892	313038	rs879019805	NC_000008.11:132480670:CCCCCCCCC:CCCCCCCCCC
NM_004519.4(KCNQ3):c.-136_-134dup	KCNQ3		Benign Neonatal Epilepsy|Benign familial neonatal seizures	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361890	8	133492912 - 133492913	8	132480665 - 132480666	361890	307900	rs886062695	NC_000008.11:132480665:CCCC:CCCCCCC
NM_004519.4(KCNQ3):c.-135_-134dup	KCNQ3		Benign Neonatal Epilepsy|Benign familial neonatal seizures	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361889	8	133492912 - 133492913	8	132480665 - 132480666	361889	304274	rs886062695	NC_000008.11:132480665:CCCC:CCCCCC
NM_004519.4(KCNQ3):c.-134dup	KCNQ3		Benign Neonatal Epilepsy|Benign familial neonatal seizures	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361888	8	133492912 - 133492913	8	132480665 - 132480666	361888	313005	rs886062695	NC_000008.11:132480665:CCCC:CCCCC
NM_004519.4(KCNQ3):c.-130_-129dup	KCNQ3		Benign Neonatal Epilepsy|Benign familial neonatal seizures	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361887	8	133492907 - 133492908	8	132480660 - 132480661	361887	312983	rs886062694	NC_000008.11:132480660:CCCC:CCCCCC
NM_004519.4(KCNQ3):c.*716_*717insAACA	KCNQ3		Benign familial neonatal seizures|Benign Neonatal Epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361868	8	133140792 - 133140793	8	132128545 - 132128546	361868	313008	rs886062688	NC_000008.11:132128545:T:TGTTT
NM_004519.4(KCNQ3):c.*4746_*4747insACAG	KCNQ3		Benign Neonatal Epilepsy|Benign familial neonatal seizures	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361802	8	133136762 - 133136763	8	132124515 - 132124516	361802	304197	rs112550767	NC_000008.11:132124515:CT:CTGTCT
NM_004519.4(KCNQ3):c.*7980dup	KCNQ3		Benign Neonatal Epilepsy|Benign familial neonatal seizures	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361746	8	133133528 - 133133529	8	132121281 - 132121282	361746	312901	rs886062659	NC_000008.11:132121281:AAAAAAAA:AAAAAAAAA
NM_004519.4(KCNQ3):c.2469dup (p.Ser824fs)	KCNQ3	S824fs, S704fs	not provided	Uncertain significance(Last reviewed: Aug 24, 2016)	criteria provided, single submitter	VCV000279820	8	133141658 - 133141659	8	132129411 - 132129412	279820	264359	rs886041208	NC_000008.11:132129411:CCCCCC:CCCCCCC
NM_004519.4(KCNQ3):c.63_71dup (p.Gly22_Gly24dup)	KCNQ3		not specified|Benign familial neonatal seizures	Uncertain significance(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000206001	8	133492708 - 133492709	8	132480461 - 132480462	206001	202190	rs748459358	NC_000008.11:132480461:CCGCCGCCTCCGCCGCC:CCGCCGCCTCCGCCGCCTCCGCCGCC
NM_004519.4(KCNQ3):c.1599dup (p.Phe534fs)	KCNQ3	F414fs, F534fs	Benign familial neonatal seizures|not provided|Intellectual disability|Seizures	Conflicting interpretations of pathogenicity(Last reviewed: Jul 16, 2020)	criteria provided, conflicting interpretations	VCV000205978	8	133150232 - 133150233	8	132137985 - 132137986	205978	202166	rs762289015	NC_000008.11:132137985:TTTTTTTTT:TTTTTTTTTT
NM_020822.3(KCNT1):c.35dup (p.Val13fs)	KCNT1	V13fs	Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001045803	9	138594133 - 138594134	9	135702287 - 135702288	1045803	1029007		NC_000009.12:135702287:GGGGGG:GGGGGGG
NM_020822.3(KCNT1):c.3502+2dup	KCNT1		Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001044458	9	138678368 - 138678369	9	135786522 - 135786523	1044458	1029032		NC_000009.12:135786522:T:TT
NM_020822.3(KCNT1):c.3178-5_3178-1dup	KCNT1		Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Uncertain significance(Last reviewed: May 24, 2020)	criteria provided, single submitter	VCV001017887	9	138678036 - 138678037	9	135786190 - 135786191	1017887	1008507		NC_000009.12:135786190:GCCCAG:GCCCAGCCCAG
NM_020822.3(KCNT1):c.3460_3461delinsGT (p.Lys1154Val)	KCNT1	K1109V, K1154V	not provided|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Uncertain significance(Last reviewed: Sep 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV001010946	9	138678325 - 138678326	9	135786479 - 135786480	1010946	993316		NC_000009.12:135786478:AA:GT
NM_020822.3(KCNT1):c.3177_3177+22dup	KCNT1		Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Uncertain significance(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000841877	9	138677170 - 138677171	9	135785324 - 135785325	841877	852174		NC_000009.12:135785324:GCCCAGGTAAGCAACCCCTCCGTGCCCA:GCCCAGGTAAGCAACCCCTCCGTGCCCAGGTAAGCAACCCCTCCGTGCCCA
NC_000009.12:g.(?_135769927)_(135792181_?)dup	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000832401	9	138661773 - 138684027			832401	820096		
NM_020822.3(KCNT1):c.600+71dup	KCNT1		Early infantile epileptic encephalopathy 14|not provided	Benign(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000802535	9	138648847 - 138648848	9	135757001 - 135757002	802535	790862	rs879903723	NC_000009.12:135757001:CC:CCC
NC_000009.11:g.(?_138594085)_(138606586_?)dup	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000662288	9	138594085 - 138606586	9	135702239 - 135714740	662288	651838		
NC_000009.11:g.(?_138651496)_(138651725_?)dup	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000583735	9	138651496 - 138651725	9	135759650 - 135759879	583735	568323		
NM_020822.3(KCNT1):c.1326_1327delinsAT (p.Met443Leu)	KCNT1	M398L, M443L	Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000540588	9	138657595 - 138657596	9	135765749 - 135765750	540588	524763	rs1554773537	NC_000009.12:135765748:CA:AT
NM_020822.3(KCNT1):c.82_85delinsC (p.Glu28_Phe29delinsLeu)	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000540574	9	138594186 - 138594189	9	135702340 - 135702343	540574	524597	rs1554760875	NC_000009.12:135702339:GAGT:C
NM_020822.3(KCNT1):c.1698_1699delinsTA (p.Met566_Gly567delinsIleSer)	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000540567	9	138662222 - 138662223	9	135770376 - 135770377	540567	524610	rs1554774874	NC_000009.12:135770375:GG:TA
NM_020822.3(KCNT1):c.2170_2184dup (p.Pro724_Leu728dup)	KCNT1		Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000429344	9	138664714 - 138664715	9	135772868 - 135772869	429344	421727	rs757605635	NC_000009.12:135772868:CCTGCTGCCCTGCGACCTGCTG:CCTGCTGCCCTGCGACCTGCTGCCCTGCGACCTGCTG
NM_020822.3(KCNT1):c.909_910delinsGA (p.Ser304Thr)	KCNT1	S304T, S259T	Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000412317	9	138651579 - 138651580	9	135759733 - 135759734	412317	396722	rs1060503697	NC_000009.12:135759732:CT:GA
NM_020822.3(KCNT1):c.254+18_254+19dup	KCNT1		Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not specified|Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14|not provided	Benign(Last reviewed: Aug 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000261362	9	138606581 - 138606582	9	135714735 - 135714736	261362	253460	rs141291153	NC_000009.12:135714735:GGGG:GGGGGG
NC_000007.13:g.(?_66103230)_(66104219_?)dup	KCTD7		Epilepsy, progressive myoclonic 3	Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, single submitter	VCV001148456	7	66103230 - 66104219			1148456	1130074		
NC_000007.13:g.(?_66094052)_(66104219_?)dup	KCTD7		Epilepsy, progressive myoclonic 3	Uncertain significance(Last reviewed: Jul 25, 2020)	criteria provided, single submitter	VCV001016282	7	66094052 - 66104219			1016282	1001569		
NC_000007.13:g.(?_66094032)_(66105401_?)dup	KCTD7		Epilepsy, progressive myoclonic 3	Uncertain significance(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000640465	7	66094032 - 66105401	7	66629045 - 66640414	640465	651687		
NC_000007.13:g.(?_66098242)_(66098451_?)dup	KCTD7		Epilepsy, progressive myoclonic 3	Likely pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000584347	7	66098242 - 66098451	7	66633255 - 66633464	584347	566143		
NM_153033.5(KCTD7):c.422_424dup (p.Glu142_Asn143insVal)	KCTD7		Epilepsy, progressive myoclonic 3	Uncertain significance(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000569269	7	66103346 - 66103347	7	66638359 - 66638360	569269	561729	rs747385800	NC_000007.14:66638359:TGG:TGGTGG
NM_153033.4:c.315-?_*3997+?dup	KCTD7		Epilepsy, progressive myoclonic 3	Likely benign(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000469098					469098	456487		
NC_000007.13:g.(?_66103220)_(66105401_?)dup	KCTD7		Epilepsy, progressive myoclonic 3	Likely benign(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000469097	7	66103220 - 66105401	7	66638233 - 66640414	469097	456846		
NM_153033.5(KCTD7):c.*2223_*2226dup	KCTD7		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000360617	7	66106439 - 66106440	7	66641452 - 66641453	360617	306637	rs886062422	NC_000007.14:66641452:CATGCA:CATGCATGCA
NM_153033.5(KCTD7):c.493+18_493+21dup	KCTD7		not specified|not provided|Epilepsy, progressive myoclonic 3	Benign(Last reviewed: Aug 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000262690	7	66103435 - 66103436	7	66638448 - 66638449	262690	252906	rs57580125	NC_000007.14:66638448:AGGA:AGGAAGGA
NM_004523.4(KIF11):c.2972dup (p.Ser992fs)	KIF11	S992fs	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495254	10	94410206 - 94410207	10	92650449 - 92650450	495254	486751	rs1554863246	NC_000010.11:92650449:T:TT
NM_012310.5(KIF4A):c.1489-8_1490delinsATAATGAAAG	KIF4A		Mental retardation, X-linked 100	Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000140729	X	69573464 - 69573473	X	70353614 - 70353623	140729	150443	rs1555949612	NC_000023.11:70353613:TTTTCCAGCA:ATAATGAAAG
NM_002296.4(LBR):c.1599_1605delinsCTAGAAG (p.Leu534_Leu535delinsTer)	LBR		Pelger-Hut anomaly|Greenberg dysplasia	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000009529	1	225592188 - 225592194	1	225404486 - 225404492	9529	24568	rs387906416	NC_000001.11:225404485:TAGAAGA:CTTCTAG
NM_005097.4(LGI1):c.432-6_432-5insAT	LGI1		Familial temporal lobe epilepsy 1	Likely benign(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001136283	10	95549849 - 95549850	10	93790092 - 93790093	1136283	1120866		NC_000010.11:93790092:T:TAT
NM_005097.4(LGI1):c.432-5_432-4insTTC	LGI1		Familial temporal lobe epilepsy 1	Likely benign(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001123112	10	95549851 - 95549852	10	93790094 - 93790095	1123112	1120867		NC_000010.11:93790094::TTC
NM_005097.4(LGI1):c.432-3dup	LGI1		Familial temporal lobe epilepsy 1	Uncertain significance(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV001058871	10	95549851 - 95549852	10	93790094 - 93790095	1058871	1046859		NC_000010.11:93790094:CC:CCC
NM_005097.4(LGI1):c.674-5dup	LGI1		not provided|Familial temporal lobe epilepsy 1	Likely benign(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000533339	10	95552933 - 95552934	10	93793176 - 93793177	533339	525623	rs1467827240	NC_000010.11:93793176:TTTTT:TTTTTT
NM_005097.4(LGI1):c.1158_1168dup (p.Thr390delinsLysTer)	LGI1		Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000533337	10	95557042 - 95557043	10	93797285 - 93797286	533337	525624	rs1554907767	NC_000010.11:93797285:AAATAGTCAGAA:AAATAGTCAGAAAATAGTCAGAA
Single allele	LIMS3|LIMS3-LOC440895|LINC01123|LOC107305686|MALL|MIR4267|MIR4436B1|MIR4436B2|MTLN|NPHP1|RGPD5		Epilepsy|Autism spectrum disorder	Uncertain significance(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000223120	2	110453976 - 111084885	2	109696399 - 110327308	223120	224846		
NC_000019.10:g.(?_2456650)_(2456953_?)dup	LMNB2		Epilepsy, progressive myoclonic, 9|Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000830908	19	2456648 - 2456951			830908	821246		
NM_000744.7(CHRNA4):c.52_57dup (p.Leu18_Leu19dup)	LOC100130587|CHRNA4		Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000851174	20	61992460 - 61992461	20	63361108 - 63361109	851174	848506		NC_000020.11:63361108:CAGAAGCAG:CAGAAGCAGAAGCAG
NM_001165963.4(SCN1A):c.5489dup (p.Phe1831fs)	LOC102724058|SCN1A	F1017fs, F1802fs, F1803fs, F1819fs, F1820fs, F1831fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jun 29, 2020)	no assertion criteria provided	VCV001300200	2	166848295 - 166848296	2	165991785 - 165991786	1300200	1290485		NC_000002.12:165991785:T:TT
NM_001165963.4(SCN1A):c.5114_5115delinsGT (p.Phe1705Cys)	LOC102724058|SCN1A	F1676C, F1677C, F1693C, F1694C, F1705C, F891C	Early infantile epileptic encephalopathy with suppression bursts	Likely pathogenic(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV000939736	2	166848670 - 166848671	2	165992160 - 165992161	939736	930919		NC_000002.12:165992159:GA:AC
NM_001165963.4(SCN1A):c.3531_3534dup (p.Ala1179fs)	LOC102724058|SCN1A	A1150fs, A1151fs, A365fs, A1167fs, A1168fs, A1179fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801800	2	166872132 - 166872133	2	166015622 - 166015623	801800	790097	rs1574069132	NC_000002.12:166015622:TTCT:TTCTTTCT
NM_001165963.4(SCN1A):c.3757_3763dup (p.Ala1255fs)	LOC102724058|SCN1A	A1243fs, A1244fs, A441fs, A1227fs, A1255fs, A1226fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801799	2	166868734 - 166868735	2	166012224 - 166012225	801799	790096	rs1574052179	NC_000002.12:166012224:CATATTCCA:CATATTCCATATTCCA
NM_001165963.4(SCN1A):c.4539dup (p.Leu1514fs)	LOC102724058|SCN1A	L1502fs, L1503fs, L1486fs, L1485fs, L1514fs, L700fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801793	2	166852564 - 166852565	2	165996054 - 165996055	801793	790090	rs1573973548	NC_000002.12:165996054:TTTTTT:TTTTTTT
NM_001165963.4(SCN1A):c.2616_3206delinsAAGTTGGCAAAA (p.Trp873_Ile1069delinsSerTrpGlnAsn)	LOC102724058|SCN1A		Generalized epilepsy with febrile seizures plus, type 2	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000690430	2	166892781 - 166894616	2	166036271 - 166038106	690430	678116		
NC_000002.11:g.(?_166847704)_(166930181_?)dup	LOC102724058|SCN1A		Severe myoclonic epilepsy in infancy	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495277	2	166847704 - 166930181	2	165991194 - 166073671	495277	486733		
NM_001165963.4(SCN1A):c.*172dup	LOC102724058|SCN1A		Epilepsy|not provided|Familial hemiplegic migraine	Benign/Likely benign(Last reviewed: Jun 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000331878	2	166847582 - 166847583	2	165991072 - 165991073	331878	285248	rs113696479	NC_000002.12:165991072:C:CC
NM_001165963.4(SCN1A):c.*878dup	LOC102724058|SCN1A		Familial hemiplegic migraine|Epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331872	2	166846876 - 166846877	2	165990366 - 165990367	331872	285241	rs886055037	NC_000002.12:165990366:AA:AAA
NM_001165963.4(SCN1A):c.4993_4996dup (p.Ser1666fs)	LOC102724058|SCN1A	S1654fs, S852fs, S1637fs, S1655fs, S1638fs, S1666fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189988	2	166848788 - 166848789	2	165992278 - 165992279	189988	187727	rs794726819	NC_000002.12:165992278:ACAT:ACATACAT
NM_001165963.4(SCN1A):c.5284_5291dup (p.Phe1764fs)	LOC102724058|SCN1A	F1736fs, F950fs, F1752fs, F1753fs, F1764fs, F1735fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189983	2	166848493 - 166848494	2	165991983 - 165991984	189983	187713	rs794726814	NC_000002.12:165991983:AAAATTCCAA:AAAATTCCAAAATTCCAA
NM_001165963.4(SCN1A):c.4611_4645dup (p.Ile1549delinsThrTer)	LOC102724058|SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189918	2	166850862 - 166850863	2	165994352 - 165994353	189918	187737	rs794726757	NC_000002.12:165994352:TCATGATGCTTATGTCAAAAACTTGTCTGGTTACG:TCATGATGCTTATGTCAAAAACTTGTCTGGTTACGTCATGATGCTTATGTCAAAAACTTGTCTGGTTACG
NM_001165963.4(SCN1A):c.5349_5352dup (p.Ile1785fs)	LOC102724058|SCN1A	I1756fs, I1757fs, I1773fs, I1774fs, I971fs, I1785fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189898	2	166848432 - 166848433	2	165991922 - 165991923	189898	187710	rs794726741	NC_000002.12:165991922:GACCG:GACCGACCG
NM_001165963.4(SCN1A):c.3726_3727insAT (p.Asp1243fs)	LOC102724058|SCN1A	D1231fs, D429fs, D1214fs, D1215fs, D1232fs, D1243fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189855	2	166868771 - 166868772	2	166012261 - 166012262	189855	187767	rs794726706	NC_000002.12:166012261:A:ATA
NM_001165963.4(SCN1A):c.5250_5251insGG (p.Ser1751fs)	LOC102724058|SCN1A	S1739fs, S1740fs, S1722fs, S1723fs, S1751fs, S937fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189850	2	166848534 - 166848535	2	165992024 - 165992025	189850	187716	rs794726702	NC_000002.12:165992024::CC
NM_001165963.4(SCN1A):c.4879_4883dup (p.Tyr1628Ter)	LOC102724058|SCN1A	Y1616*, Y814*, Y1599*, Y1617*, Y1600*, Y1628*	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189849	2	166848901 - 166848902	2	165992391 - 165992392	189849	187732	rs794726701	NC_000002.12:165992391:TACTTT:TACTTTACTTT
NM_207346.3(TSEN54):c.3_8dup (p.2_3EP[4])	LOC112533671|TSEN54		Pontoneocerebellar hypoplasia|not provided|not specified|Pontocerebellar hypoplasia type 4	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000096674	17	73512643 - 73512644	17	75516562 - 75516563	96674	102567	rs398124622	NC_000017.11:75516562:GGAGCC:GGAGCCGGAGCC
NC_000023.10:g.(?_47432243)_(47479147_?)dup	LOC119369039|SYN1|TIMP1|MIR4769		Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000533669	X	47432243 - 47479147	X	47572844 - 47619748	533669	534439		
NM_001040142.2(SCN2A):c.-51-1737_-51-1735dup	LOC120977013|SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331707	2	166150520 - 166150521	2	165294010 - 165294011	331707	285054	rs67417831	NC_000002.12:165294010:AAAAAAAAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
NM_001040142.2(SCN2A):c.-51-1736_-51-1735dup	LOC120977013|SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 21, 2020)	criteria provided, conflicting interpretations	VCV000331706	2	166150520 - 166150521	2	165294010 - 165294011	331706	282353	rs67417831	NC_000002.12:165294010:AAAAAAAAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
NM_016373.4(WWOX):c.1132_1133delinsTG (p.Asn378Cys)	MAF|WWOX	N265C, N378C	Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12	Uncertain significance(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV000839154	16	79245580 - 79245581	16	79211683 - 79211684	839154	844355		NC_000016.10:79211682:AA:TG
NM_001378120.1(MBD5):c.-831+9dup	MBD5		Intellectual Disability, Dominant|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	VCV000206049	2	148936370 - 148936371	2	148178801 - 148178802	206049	201179	rs796052705	NC_000002.12:148178801:T:TT
NM_024298.5(MBOAT7):c.680_690dup (p.Leu231fs)	MBOAT7	L158fs, L231fs	Mental retardation, autosomal recessive 57	Likely pathogenic(Last reviewed: Jun 5, 2020)	criteria provided, single submitter	VCV001120120	19	54684653 - 54684654	19	54180936 - 54180937	1120120	1108934		NC_000019.10:54180936:GCGGGCGGGCAGCGGGCGGGC:GCGGGCGGGCAGCGGGCGGGCAGCGGGCGGGC
NM_001110792.2(MECP2):c.1123_1124insC (p.Lys375fs)	MECP2	K363fs, K270fs, K375fs, K140fs	Rett syndrome	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495247	X	153296191 - 153296192	X	154030740 - 154030741	495247	486781	rs1557135929	NC_000023.11:154030740::G
NM_001110792.2(MECP2):c.1244dup (p.Pro415_Glu416insTer)	MECP2		Severe neonatal-onset encephalopathy with microcephaly|not provided|Autism, susceptibility to, X-linked 3	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429893	X	153296070 - 153296071	X	154030619 - 154030620	429893	422439	rs781843758	NC_000023.11:154030619:GGGGGG:GGGGGGG
NM_001110792.2(MECP2):c.1121_1222delinsAAGAAGGAGCACCACCACCATCACCACCACTCAGAGTCCCCAAAGGCCCCCGTGCCACTGCTCCCACCCCTGC (p.Pro374fs)	MECP2	P374fs, P269fs, P362fs, P139fs	not provided	Pathogenic(Last reviewed: Jul 31, 2013)	criteria provided, single submitter	VCV000156613	X	153296093 - 153296194	X	154030642 - 154030743	156613	166467	rs1557135516	
NM_001110792.2(MECP2):c.1043_1133delinsCTGTAAGTGCAC (p.Leu348fs)	MECP2	L243fs, L348fs, L113fs, L336fs	not provided	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000156611	X	153296182 - 153296272	X	154030731 - 154030821	156611	166465	rs1557135901	
NM_001110792.2(MECP2):c.746dup (p.Gly250fs)	MECP2	G145fs, G238fs, G250fs, G15fs	Rett syndrome	Pathogenic(Last reviewed: Jul 14, 2015)	criteria provided, multiple submitters, no conflicts	VCV000143666	X	153296568 - 153296569	X	154031117 - 154031118	143666	153398	rs61749743	NC_000023.11:154031117:CCCCCC:CCCCCCC
NM_002397.5(MEF2C):c.638-14dup	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Benign(Last reviewed: Aug 30, 2020)	criteria provided, single submitter	VCV001170294	5	88027726 - 88027727	5	88731909 - 88731910	1170294	1155225		NC_000005.10:88731909:AAAAAA:AAAAAAA
NM_002397.5(MEF2C):c.559dup (p.Thr187fs)	MEF2C	T139fs, T185fs, T187fs, T205fs, T45fs, T61fs	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001070711	5	88047703 - 88047704	5	88751886 - 88751887	1070711	1060517		NC_000005.10:88751886:TT:TTT
NM_002397.5(MEF2C):c.626_627insTCTCCAC (p.Thr210fs)	MEF2C	T162fs, T208fs, T210fs, T228fs, T68fs, T84fs	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Uncertain significance(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV001062175	5	88044897 - 88044898	5	88749080 - 88749081	1062175	1043784		NC_000005.10:88749080::GTGGAGA
NM_002397.5(MEF2C):c.1298_1303dup (p.Gly433_Ser434dup)	MEF2C|MEF2C-AS2		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Uncertain significance(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000856830	5	88018539 - 88018540	5	88722722 - 88722723	856830	831248		NC_000005.10:88722722:CGCTCCCG:CGCTCCCGCTCCCG
NM_002397.5(MEF2C):c.908dup (p.Leu303fs)	MEF2C	L177fs, L255fs, L303fs, L293fs, L295fs, L153fs, L313fs, L247fs	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000662628	5	88025090 - 88025091	5	88729273 - 88729274	662628	634466	rs1581338441	NC_000005.10:88729273:AAA:AAAA
NM_002397.5(MEF2C):c.192dup (p.Val65fs)	MEF2C	V65fs	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000639211	5	88100480 - 88100481	5	88804663 - 88804664	639211	634467	rs1580988138	NC_000005.10:88804663:TTT:TTTT
NC_000005.9:g.88142510_88347193del204684insG	MEF2C|MEF2C-AS1		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000598760	5	88142510 - 88347193	5	88846693 - 89051376	598760	589802		
NM_002397.5(MEF2C):c.780dup (p.Pro261fs)	MEF2C	P135fs, P259fs, P279fs, P119fs, P213fs, P261fs	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000570908	5	88027575 - 88027576	5	88731758 - 88731759	570908	563254	rs1561697465	NC_000005.10:88731758:T:TT
NM_002397.5(MEF2C):c.614_626delinsGTCTCCAC (p.Thr205fs)	MEF2C	T203fs, T205fs, T223fs, T157fs, T63fs, T79fs	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000487207	5	88044898 - 88044910	5	88749081 - 88749093	487207	455995	rs1554110298	NC_000005.10:88749080:CCTGCACCAGACG:GTGGAGAC
NM_001131005.2(MEF2C):c.-143+4248dup	MEF2C		Intellectual Disability, Stereotypic Movements, Epilepsy, and/or Cerebral Malformations|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 23, 2019)	criteria provided, conflicting interpretations	VCV000354599	5	88179070 - 88179071	5	88883253 - 88883254	354599	305082	rs144197632	NC_000005.10:88883253:GGGGGGGGG:GGGGGGGGGG
NM_002397.5(MEF2C):c.-208dup	MEF2C		Intellectual Disability, Stereotypic Movements, Epilepsy, and/or Cerebral Malformations	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000354592	5	88178836 - 88178837	5	88883019 - 88883020	354592	300691	rs886060864	NC_000005.10:88883019:AAAAAAAAAA:AAAAAAAAAAA
NM_002397.5(MEF2C):c.*2267dup	MEF2C|MEF2C-AS2		Intellectual Disability, Stereotypic Movements, Epilepsy, and/or Cerebral Malformations	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000354574	5	88016153 - 88016154	5	88720336 - 88720337	354574	305209	rs3841444	NC_000005.10:88720336:TTTTTTTTTTTT:TTTTTTTTTTTTT
NM_002397.5(MEF2C):c.*2877_*2878dup	MEF2C|MEF2C-AS2		Intellectual Disability, Stereotypic Movements, Epilepsy, and/or Cerebral Malformations	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000354562	5	88015542 - 88015543	5	88719725 - 88719726	354562	298362	rs886060856	NC_000005.10:88719725:CA:CACA
NM_002397.5(MEF2C):c.120_125dup (p.Asp40_Cys41dup)	MEF2C		not specified	Uncertain significance(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	VCV000206133	5	88100547 - 88100548	5	88804730 - 88804731	206133	201915	rs796052732	NC_000005.10:88804730:TCACAGTCACA:TCACAGTCACAGTCACA
NM_002397.5(MEF2C):c.99dup (p.Glu34Ter)	MEF2C	E34*	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000040215	5	88100573 - 88100574	5	88804756 - 88804757	40215	48700		NC_000005.10:88804756:A:AA
NM_002397.5(MEF2C):c.*2266_*2267dup	MEF2C-AS2|MEF2C		Intellectual Disability, Stereotypic Movements, Epilepsy, and/or Cerebral Malformations	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000354575	5	88016153 - 88016154	5	88720336 - 88720337	354575	300655	rs3841444	NC_000005.10:88720336:TTTTTTTTTTTT:TTTTTTTTTTTTTT
NM_015166.4(MLC1):c.1052_1053insCGGGGAGGTGAGTGGCCTGTGGGGTGGGGGTGC (p.Ala355_Arg356insSerGlyLeuTrpGlyGlyGlyAlaGlyGluVal)	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided|Megalencephalic leukoencephalopathy with subcortical cysts	Benign/Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000770015	22	50502469 - 50502470	22	50064040 - 50064041	770015	706002	rs745656804	NC_000022.11:50064040:GC:GCACCCCCACCCCACAGGCCACTCACCTCCCCGGC
NM_015166.4(MLC1):c.423+2dup	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000558618	22	50518344 - 50518345	22	50079915 - 50079916	558618	549163	rs1555967668	NC_000022.11:50079915:A:AA
NM_015166.4(MLC1):c.771+2dup	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts 1	Uncertain significance(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000550174	22	50508953 - 50508954	22	50070524 - 50070525	550174	549159	rs1555965439	NC_000022.11:50070524:A:AA
NM_015166.4(MLC1):c.83dup (p.Tyr28Ter)	MLC1	Y28*	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	VCV000370169	22	50523248 - 50523249	22	50084819 - 50084820	370169	358671	rs1057516286	NC_000022.11:50084819:T:TT
NM_001376473.1(MLC1):c.-339dup	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000342119	22	50524250 - 50524251	22	50085821 - 50085822	342119	348156	rs137931	NC_000022.11:50085821:CC:CCC
NM_001376473.1(MLC1):c.-218+199_-218+201dup	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000342114	22	50523928 - 50523929	22	50085499 - 50085500	342114	348155	rs886057627	NC_000022.11:50085499:GAA:GAAGAA
NM_015166.4(MLC1):c.*377_*378insGGGGGTC	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000342100	22	50499634 - 50499635	22	50061205 - 50061206	342100	351818	rs141063000	NC_000022.11:50061205:G:GACCCCCG
NM_015166.4(MLC1):c.*1368dup	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000342082	22	50498643 - 50498644	22	50060214 - 50060215	342082	352665	rs200990035	NC_000022.11:50060214:TT:TTT
NM_015166.4(MLC1):c.*1981dup	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000342074	22	50498030 - 50498031	22	50059601 - 50059602	342074	348115	rs145385166	NC_000022.11:50059601:CCCC:CCCCC
MLC1, 17-BP DEL, G INS	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000004723					4723	19762		
NM_015166.4(MLC1):c.135dup (p.Cys46fs)	MLC1	C46fs	Megalencephalic leukoencephalopathy with subcortical cysts 1|Megalencephalic leukoencephalopathy with subcortical cysts|not provided	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004722	22	50523196 - 50523197	22	50084767 - 50084768	4722	19761	rs80358241	NC_000022.11:50084767:GGGGGG:GGGGGGG
NM_002449.5(MSX2):c.505_508dup (p.Ala170fs)	MSX2	A170fs	Parietal foramina with cleidocranial dysplasia	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000016967	5	174156286 - 174156287	5	174729283 - 174729284	16967	32006	rs1561643029	NC_000005.10:174729283:ATTG:ATTGATTG
NM_002449.5(MSX2):c.265_266delinsTA (p.Ala89Ter)	MSX2	A89*	Parietal foramina 1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000016965	5	174151927 - 174151928	5	174724924 - 174724925	16965	32004	rs121912971	NC_000005.10:174724923:GC:TA
NC_012920.1:m.7471dup	MT-TS1		Deafness, sensorineural, with neurologic features|Mitochondrial cytochrome c oxidase deficiency|Deafness, nonsyndromic sensorineural, mitochondrial|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000042226	MT	7465 - 7466	MT	7465 - 7466	42226	51396	rs111033319	NC_012920.1:7465:CCCCCC:CCCCCCC
NC_000011.9:g.(?_532616)_(2906985_?)dup	MUC5AC|CDHR5|LMNTD2-AS1|KRTAP5-5|MUC2|INS|LRRC56|TALDO1|TNNT3|MRPL23|PIDD1|HRAS|DEAF1|PNPLA2|EPS8L2|IRF7|IGF2|IGF2-AS|DRD4|CD81|RPLP2|CEND1|CRACR2B|MUC6|AP2A2|DUSP8|POLR2L|BRSK2|CTSD|CDKN1C|KRTAP5-2|SLC25A22|MUC5B|C11orf21|TSPAN4|KRTAP5-4|MIR210HG|KCNQ1OT1|IFITM10|TSPAN32|PHRF1|CHID1|LMNTD2|TNNI2|KRTAP5-3|RASSF7|SCT|TSSC4|KCNQ1|KCNQ1DN|SYT8|CD151|TOLLIP|MOB2|LSP1|TH|MIR210|GATD1|KRTAP5-1|INS-IGF2|KRTAP5-6|H19|ASCL2|TRPM5|TMEM80		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000832038	11	532616 - 2906985			832038	820432		
NM_000431.4(MVK):c.605dup (p.Val203fs)	MVK	V151fs, V203fs	Porokeratosis 3, disseminated superficial actinic type|Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV001071478	12	110023902 - 110023903	12	109586097 - 109586098	1071478	1062573		NC_000012.12:109586097:GG:GGG
NM_000431.4(MVK):c.*58dup	MVK		Hyperimmunoglobulin D with periodic fever|Porokeratosis 3, disseminated superficial actinic type|Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria|not provided|Mevalonic aciduria	Benign/Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000307102	12	110034435 - 110034436	12	109596630 - 109596631	307102	330430	rs397714540	NC_000012.12:109596630:GGGGG:GGGGGG
NM_000431.4(MVK):c.769-7dup	MVK		Hyperimmunoglobulin D with periodic fever	not provided	no assertion provided	VCV000097621	12	110029032 - 110029033	12	109591227 - 109591228	97621	103513	rs1555279054	NC_000012.12:109591227:TTTTTTT:TTTTTTTT
NM_000431.4(MVK):c.607dup (p.Val203fs)	MVK	V151fs, V203fs	Hyperimmunoglobulin D with periodic fever	not provided	no assertion provided	VCV000097600	12	110023905 - 110023906	12	109586100 - 109586101	97600	103492	rs104895374	NC_000012.12:109586100:G:GG
NM_000431.4(MVK):c.503_512delinsAC (p.Leu168fs)	MVK	L168fs	Hyperimmunoglobulin D with periodic fever	not provided	no assertion provided	VCV000097594	12	110019331 - 110019340	12	109581526 - 109581535	97594	103486	rs104895375	NC_000012.12:109581525:TGAAGGACGG:AC
NM_000431.3(MVK):c.421dupG (p.Ala141Glyfs)	MVK	A141fs	Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000088837	12	110019245 - 110019246	12	109581440 - 109581441	88837	94406	rs104895323	NC_000012.12:109581440:GGGG:GGGGG
NM_000431.4(MVK):c.72dup (p.Gly25fs)	MVK	G25fs	Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Porokeratosis 3, disseminated superficial actinic type|Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000088836	12	110012698 - 110012699	12	109574893 - 109574894	88836	94405	rs104895322	NC_000012.12:109574893:T:TT
NM_000431.4(MVK):c.417dup (p.Gly140fs)	MVK	G140fs	Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|not provided|Porokeratosis 3, disseminated superficial actinic type	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000039727	12	110019239 - 110019240	12	109581434 - 109581435	39727	48326	rs104895373	NC_000012.12:109581434:CCCCCC:CCCCCCC
NM_004544.4(NDUFA10):c.*1894_*1914delinsGGG	NDUFA10		Mitochondrial complex I deficiency|Leigh syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000335177	2	240898621 - 240898641	2	239959204 - 239959224	335177	285476	rs886055819	NC_000002.12:239959203:AGGGGATGATCAGAGCACCCG:CCC
NM_004544.4(NDUFA10):c.*1923_*1924insA	NDUFA10		Mitochondrial complex I deficiency|Leigh syndrome|not provided	Benign/Likely benign(Last reviewed: May 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000335175	2	240898611 - 240898612	2	239959194 - 239959195	335175	288894	rs138899326	NC_000002.12:239959194::T
NM_199069.2(NDUFAF3):c.180_181insT (p.Asp61Ter)	NDUFAF3	D4*, D61*	not provided|Mitochondrial complex I deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2018)	criteria provided, conflicting interpretations	VCV000208598	3	49059881 - 49059882	3	49022448 - 49022449	208598	205140	rs752864722	NC_000003.12:49022448::T
NM_014165.4(NDUFAF4):c.241-18dup	NDUFAF4		not provided|Mitochondrial complex I deficiency	Benign/Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000358272	6	97339275 - 97339276	6	96891399 - 96891400	358272	309036	rs34213186	NC_000006.12:96891399:AAAAAAAAAA:AAAAAAAAAAA
NC_000016.9:g.(?_624055)_(2550979_?)dup	NDUFB10|NPW|TPSAB1|BAIAP3|CHTF18|HS3ST6|E4F1|CLCN7|DNASE1L2|PTX4|GNPTG|CASKIN1|GNG13|C16orf91|MSRB1|ECI1|METTL26|CCDC78|SNHG9|NTN3|TSC2|MIR1225|TSR3|SYNGR3|TELO2|RPL3L|METRN|RNF151|MLST8|RAB26|CCNF|RAB40C|FBXL16|TMEM204|NME3|SSTR5|TEDC2|CCDC154|UNKL|STUB1|FAHD1|TPSB2|LMF1|HAGHL|MAPK8IP3|TBL3|BRICD5|IFT140|RPUSD1|CACNA1H|CIAO3|EME2|HAGH|SLC9A3R2|PKD1|WDR24|RNPS1|ZNF598|ABCA3|SOX8|PIGQ|MSLN|GFER|TBC1D24|CRAMP1|NUBP2|NTHL1|WFIKKN1|TRAF7|UBE2I|MRPS34|RHBDL1|ANTKMT|RPS2|MCRIP2|MEIOB|PRR25|IGFALS|JMJD8|PGP|TPSG1|TPSD1|NOXO1|RHOT2|WDR90|C1QTNF8|JPT2|SPSB3		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000833344	16	624055 - 2550979			833344	820975		
NM_005006.7(NDUFS1):c.262-15dup	NDUFS1		Leigh syndrome|Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333787	2	207013834 - 207013835	2	206149110 - 206149111	333787	287274	rs34184317	NC_000002.12:206149110:AAAAAAAAAAA:AAAAAAAAAAAA
NM_005006.7(NDUFS1):c.*93dup	NDUFS1		Leigh syndrome|Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333778	2	206988815 - 206988816	2	206124091 - 206124092	333778	284169	rs200446477	NC_000002.12:206124091:TTTTTTTTT:TTTTTTTTTT
NM_005006.7(NDUFS1):c.*846dup	NDUFS1		Leigh syndrome|Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333764	2	206988062 - 206988063	2	206123338 - 206123339	333764	287223	rs58253838	NC_000002.12:206123338:AAAAAAAAAAAA:AAAAAAAAAAAAA
NM_001377299.1(NDUFS2):c.*108_*109dup	NDUFS2		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000293287	1	161184089 - 161184090	1	161214299 - 161214300	293287	277894	rs886045468	NC_000001.11:161214299:TAT:TATAT
NM_001377299.1(NDUFS2):c.*71_*76delinsTGCGTCTGTGTGTG	NDUFS2		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000293283	1	161184054 - 161184059	1	161214264 - 161214269	293283	276897	rs886045465	NC_000001.11:161214263:GGCCTC:TGCGTCTGTGTGTG
NM_001377299.1(NDUFS2):c.702+14_702+17dup	NDUFS2		Mitochondrial complex I deficiency|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	VCV000293276	1	161179733 - 161179734	1	161209943 - 161209944	293276	277975	rs776704187	NC_000001.11:161209943:CCGGC:CCGGCCGGC
NM_002495.4(NDUFS4):c.512_514dup (p.Val172_Ser173insGly)	NDUFS4		Mitochondrial complex I deficiency|Leigh syndrome	Uncertain significance(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000557691	5	52979034 - 52979035	5	53683204 - 53683205	557691	543697	rs1425486695	NC_000005.10:53683204:GAG:GAGGAG
NM_002495.4(NDUFS4):c.424+19dup	NDUFS4		Mitochondrial complex I deficiency|not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000353891	5	52954468 - 52954469	5	53658638 - 53658639	353891	299993	rs140172554	NC_000005.10:53658638:TTTTT:TTTTTT
NM_001365902.3(NFIX):c.338_342dup (p.Arg116fs)	NFIX	R116fs, R124fs, R115fs, R108fs, R69fs, R132fs	Sotos syndrome 2	Pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	VCV000209174	19	13136144 - 13136145	19	13025330 - 13025331	209174	205791	rs797045056	NC_000019.10:13025330:AGATC:AGATCAGATC
NM_198586.3(NHLRC1):c.462dup (p.Asp155Ter)	NHLRC1	D155*	Lafora disease	Pathogenic(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV000663551	6	18122375 - 18122376	6	18122144 - 18122145	663551	634780	rs1157872508	NC_000006.12:18122144:AAAAA:AAAAAA
NM_198586.3(NHLRC1):c.4_5delinsAA (p.Ala2Lys)	NHLRC1	A2K	Lafora disease|not specified	Uncertain significance(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000206193	6	18122833 - 18122834	6	18122602 - 18122603	206193	201968	rs796052757	NC_000006.12:18122601:GC:TT
NC_000009.11:g.(?_138594085)_(139440258_?)dup	NOTCH1|SNAPC4|LHX3|SEC16A|UBAC1|ENTR1|PMPCA|GPSM1|INPP5E|KCNT1|CARD9|TMEM250|NACC2|CAMSAP1|C9orf163|QSOX2|DNLZ		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000660707	9	138594085 - 139440258			660707	651929		
NM_006545.5(NPRL2):c.491dup (p.Asp165fs)	NPRL2	D165fs	Epilepsy, familial focal, with variable foci 2	Likely pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV000931493	3	50386398 - 50386399	3	50348967 - 50348968	931493	918846		NC_000003.12:50348967:GG:GGG
NM_001077350.3(NPRL3):c.1468dup (p.Leu490fs)	NPRL3|HBA-LCR	L311fs, L412fs, L465fs, L490fs	Epilepsy, familial focal, with variable foci 3	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV001164852	16	138772 - 138773	16	88773 - 88774	1164852	1157890		NC_000016.10:88773:GG:GGG
NM_001077350.3(NPRL3):c.925-12dup	NPRL3|HBA-LCR		Epilepsy, familial focal, with variable foci 3	Likely benign(Last reviewed: Jun 9, 2020)	criteria provided, single submitter	VCV001078901	16	143331 - 143332	16	93333 - 93334	1078901	1082687		NC_000016.10:93333:AAAA:AAAAA
NC_000016.9:g.(?_148123)_(167394_?)dup	NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV001035532	16	148123 - 167394			1035532	1022363		
NC_000016.9:g.(?_136704)_(148309_?)dup	NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Aug 8, 2020)	criteria provided, single submitter	VCV001022608	16	136704 - 148309			1022608	1001771		
NC_000016.9:g.(?_150360)_(169264_?)dup	NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001022607	16	150360 - 169264			1022607	1001773		
NC_000016.9:g.(?_136684)_(139920_?)dup	NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV001022606	16	136684 - 139920			1022606	1001769		
NC_000016.9:g.(?_150360)_(150517_?)dup	NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001010552	16	150360 - 150517			1010552	986563		
NC_000016.9:g.(?_160513)_(188266_?)dup	NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV000999228	16	160513 - 188266			999228	986565		
NC_000016.9:g.(?_136684)_(160624_?)dup	NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000833196	16	136684 - 160624			833196	820969		
NC_000016.9:g.(?_150350)_(169274_?)dup	NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000832936	16	150350 - 169274			832936	820973		
NC_000016.9:g.(?_148123)_(162794_?)dup	NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000831815	16	148123 - 162794			831815	820971		
NC_000016.10:g.(?_86685)_(86890_?)dup	NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000831649	16	136684 - 136889			831649	820890		
NC_000016.9:g.(?_136684)_(188286_?)dup	NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000583978	16	136684 - 188286			583978	574242		
NC_000016.9:g.(?_160503)_(188286_?)dup	NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000583646	16	160503 - 188286			583646	570738		
NM_006186.4(NR4A2):c.327dup (p.Ser110fs)	NR4A2	S110fs, S47fs	Epilepsy	Likely pathogenic(Last reviewed: Jan 19, 2018)	no assertion criteria provided	VCV000545565	2	157186371 - 157186372	2	156329859 - 156329860	545565	536067	rs1553456695	NC_000002.12:156329859:C:CC
NM_001042424.3(NSD2):c.3223_3226dup (p.Gly1076fs)	NSD2	G1076fs	4p partial monosomy syndrome	Pathogenic(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001308650	4	1961431 - 1961432	4	1959704 - 1959705	1308650	1298919		NC_000004.12:1959704:GGGTGGG:GGGTGGGTGGG
NM_001042424.3(NSD2):c.1569dup (p.Lys524fs)	NSD2	K524fs	4p partial monosomy syndrome|Wolf-Hirschhorn like syndrome	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000599447	4	1936881 - 1936882	4	1935154 - 1935155	599447	590771	rs1560696317	NC_000004.12:1935154:GGG:GGGG
NM_001042424.3(NSD2):c.*2012dup	NSD2		4p partial monosomy syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000348488	4	1982645 - 1982646	4	1980918 - 1980919	348488	294542	rs766138833	NC_000004.12:1980918:GGG:GGGG
NM_001042424.3(NSD2):c.*1922dup	NSD2		4p partial monosomy syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000348485	4	1982557 - 1982558	4	1980830 - 1980831	348485	298033	rs886059331	NC_000004.12:1980830:T:TT
NM_001042424.3(NSD2):c.*1370dup	NSD2		4p partial monosomy syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000348474	4	1981999 - 1982000	4	1980272 - 1980273	348474	294525	rs886059325	NC_000004.12:1980272:TTTTTTT:TTTTTTTT
NM_001042424.3(NSD2):c.-29-6901dup	NSD2		4p partial monosomy syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000348402	4	1895445 - 1895446	4	1893718 - 1893719	348402	293096	rs886059308	NC_000004.12:1893718:TTTTTTT:TTTTTTTT
NM_025152.3(NUBPL):c.*1155dup	NUBPL		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000313061	14	32329536 - 32329537	14	31860330 - 31860331	313061	320434	rs886050467	NC_000014.9:31860330:GGGGG:GGGGGG
NM_025152.3(NUBPL):c.*1149_*1150insA	NUBPL		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000313060	14	32329535 - 32329536	14	31860329 - 31860330	313060	320430	rs886050466	NC_000014.9:31860329::A
NM_025152.3(NUBPL):c.*1147dup	NUBPL		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000313055	14	32329508 - 32329509	14	31860302 - 31860303	313055	335817	rs34847511	NC_000014.9:31860302:AAAAAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAAAAA
NM_025152.3(NUBPL):c.*1122dup	NUBPL		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000313053	14	32329507 - 32329508	14	31860301 - 31860302	313053	337687	rs886050459	NC_000014.9:31860301:C:CC
NM_025152.3(NUBPL):c.*1121dup	NUBPL		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000313051	14	32329506 - 32329507	14	31860300 - 31860301	313051	320428	rs886050457	NC_000014.9:31860300:T:TT
NM_025152.3(NUBPL):c.*1119_*1120insA	NUBPL		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000313050	14	32329505 - 32329506	14	31860299 - 31860300	313050	337676	rs886050456	NC_000014.9:31860299::A
NM_025152.3(NUBPL):c.*537dup	NUBPL		Mitochondrial complex I deficiency	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000313041	14	32328922 - 32328923	14	31859716 - 31859717	313041	335813	rs200626091	NC_000014.9:31859716:A:AA
Single allele	OPHN1		Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance	Pathogenic(Last reviewed: Jul 2, 2021)	no assertion criteria provided	VCV001251919			X	68119248 - 68212212	1251919	1241868		
NC_000011.9:g.(?_5709028)_(6640651_?)dup	OR52W1|OR56B1|CNGA4|OR56A5|ILK|ARFIP2|OR52B2|OR52E4|OR52N4|TIMM10B|SMPD1|OR52E6|OR56A3|FHIP1B|CAVIN3|TPP1|DNHD1|HPX|TRIM22|RRP8|OR52E8|TRIM3|OR52N2|APBB1|OR56A4|OR52N1|OR56B4|OR56A1|CCKBR|TAF10|OR52N5|OR52L1|C11orf42		Neuronal ceroid lipofuscinosis|not provided	Uncertain significance(Last reviewed: Sep 16, 2020)	criteria provided, single submitter	VCV001027249	11	5709028 - 6640651			1027249	1001676		
NM_177939.3(P4HTM):c.286dup (p.Gln96fs)	P4HTM	Q96fs	Intellectual disability|Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities	Uncertain significance(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000635796	3	49027971 - 49027972	3	48990538 - 48990539	635796	623628	rs1576601503	NC_000003.12:48990538:CCCC:CCCCC
NM_001184880.2(PCDH19):c.600_603dup (p.Ser202fs)	PCDH19	S202fs	Early infantile epileptic encephalopathy 9	Pathogenic	no assertion criteria provided	VCV001264344	X	99662992 - 99662993	X	100407994 - 100407995	1264344	1254244		NC_000023.11:100407994:CTGC:CTGCCTGC
NM_001184880.2(PCDH19):c.807_810dup (p.Gly271fs)	PCDH19	G271fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 6, 2020)	criteria provided, single submitter	VCV001075007	X	99662785 - 99662786	X	100407787 - 100407788	1075007	1065093		NC_000023.11:100407787:GTTGGT:GTTGGTTGGT
NM_001184880.2(PCDH19):c.2662dup (p.His888fs)	PCDH19	H841fs, H888fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001071820	X	99605656 - 99605657	X	100350658 - 100350659	1071820	1065077		NC_000023.11:100350658:GGG:GGGG
NM_001184880.2(PCDH19):c.291dup (p.Lys98fs)	PCDH19	K98fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001070981	X	99663304 - 99663305	X	100408306 - 100408307	1070981	1065097		NC_000023.11:100408306:GGGG:GGGGG
NM_001184880.2(PCDH19):c.1639_1640delinsTT (p.Ala547Phe)	PCDH19	A547F	Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001042374	X	99661956 - 99661957	X	100406958 - 100406959	1042374	1035282		NC_000023.11:100406957:GC:AA
NM_001184880.2(PCDH19):c.853_854dup (p.Glu287fs)	PCDH19	E287fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000976324	X	99662741 - 99662742	X	100407743 - 100407744	976324	964563		NC_000023.11:100407743:GTG:GTGTG
NM_001184880.2(PCDH19):c.3057dup (p.Lys1020fs)	PCDH19	K1020fs, K972fs, K973fs	Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000976214	X	99551664 - 99551665	X	100296666 - 100296667	976214	964559		NC_000023.11:100296666:CCC:CCCC
NM_001184880.2(PCDH19):c.1640delinsTA (p.Ala547fs)	PCDH19	A547fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000971886	X	99661956	X	100406958	971886	959143		NC_000023.11:100406957:G:TA
NM_001184880.2(PCDH19):c.244dup (p.Val82fs)	PCDH19	V82fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000961005	X	99663351 - 99663352	X	100408353 - 100408354	961005	951556		NC_000023.11:100408353:CC:CCC
NM_001184880.2(PCDH19):c.1172dup (p.Asn391fs)	PCDH19	N391fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000958756	X	99662423 - 99662424	X	100407425 - 100407426	958756	951548		NC_000023.11:100407425:TT:TTT
NM_001184880.2(PCDH19):c.3431_3436dup (p.Lys1144_Asp1145dup)	PCDH19		Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000955455	X	99551285 - 99551286	X	100296287 - 100296288	955455	951539		NC_000023.11:100296287:TATCCTT:TATCCTTATCCTT
NM_001184880.2(PCDH19):c.1713_1719dup (p.Glu574fs)	PCDH19	E574fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000870186	X	99661876 - 99661877	X	100406878 - 100406879	870186	858362		NC_000023.11:100406878:GGCAGTG:GGCAGTGGGCAGTG
NM_001184880.2(PCDH19):c.2567dup (p.Pro858fs)	PCDH19	P811fs, P858fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000870185	X	99657570 - 99657571	X	100402572 - 100402573	870185	858359		NC_000023.11:100402572:T:TT
NM_001184880.2(PCDH19):c.1973delinsGTA (p.Val658fs)	PCDH19	V658fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000870166	X	99661623	X	100406625	870166	858361		NC_000023.11:100406624:A:TAC
NM_001184880.2(PCDH19):c.2470_2474dup (p.Cys825fs)	PCDH19	C778fs, C825fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000862065	X	99657663 - 99657664	X	100402665 - 100402666	862065	849479		NC_000023.11:100402665:CAGCCCAG:CAGCCCAGCCCAG
NM_001184880.2(PCDH19):c.1645dup (p.Val549fs)	PCDH19	V549fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Mar 3, 2019)	criteria provided, single submitter	VCV000850651	X	99661950 - 99661951	X	100406952 - 100406953	850651	849486		NC_000023.11:100406952:CC:CCC
NM_001184880.2(PCDH19):c.1901_1902insG (p.Lys635fs)	PCDH19	K635fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000849772	X	99661694 - 99661695	X	100406696 - 100406697	849772	849484		NC_000023.11:100406696::C
NM_001184880.2(PCDH19):c.471dup (p.Ser158fs)	PCDH19	S158fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000839360	X	99663124 - 99663125	X	100408126 - 100408127	839360	849502		NC_000023.11:100408126:G:GG
NC_000023.11:g.(?_100296257)_(100408617_?)dup	PCDH19		Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000831023	X	99551255 - 99663615			831023	821536		
NM_001184880.2(PCDH19):c.2341dup (p.Ile781fs)	PCDH19	I781fs, I734fs	Early infantile epileptic encephalopathy 9|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000804051	X	99657796 - 99657797	X	100402798 - 100402799	804051	792088	rs1060502175	NC_000023.11:100402798:TTTTTTT:TTTTTTTT
NM_001184880.2(PCDH19):c.2697dup (p.Glu900fs)	PCDH19	E852fs, E853fs, E900fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804049	X	99597051 - 99597052	X	100342053 - 100342054	804049	792086	rs1602595101	NC_000023.11:100342053:T:TT
NM_001184880.2(PCDH19):c.1853_1857delinsCGAAGTCAGAA (p.Asp618_Gln619delinsAlaLysSerGlu)	PCDH19		Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000570838	X	99661739 - 99661743	X	100406741 - 100406745	570838	573497	rs1569314297	NC_000023.11:100406740:CTGGT:TTCTGACTTCG
NM_001184880.2(PCDH19):c.489_490delinsAT (p.Gln164Ter)	PCDH19	Q164*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000548139	X	99663106 - 99663107	X	100408108 - 100408109	548139	538624	rs1555985639	NC_000023.11:100408107:GC:AT
NM_001184880.2(PCDH19):c.2263_2288+1dup	PCDH19		Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV000533850	X	99658520 - 99658521	X	100403522 - 100403523	533850	534444	rs779136255	NC_000023.11:100403522:CCTCTTTCCCCTTAGGCTCACTTTCTCC:CCTCTTTCCCCTTAGGCTCACTTTCTCCCTCTTTCCCCTTAGGCTCACTTTCTCC
NM_001184880.2(PCDH19):c.1521dup (p.Ile508fs)	PCDH19	I508fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000533849	X	99662074 - 99662075	X	100407076 - 100407077	533849	534422	rs1131691646	NC_000023.11:100407076:GG:GGG
NM_001184880.2(PCDH19):c.875_879dup (p.His294fs)	PCDH19	H294fs	Early infantile epileptic encephalopathy 9|not provided	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000504290	X	99662716 - 99662717	X	100407718 - 100407719	504290	495779	rs1555985416	NC_000023.11:100407718:CGGGTCG:CGGGTCGGGTCG
NM_001184880.2(PCDH19):c.138_139delinsTT (p.Arg47Ter)	PCDH19	R47*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000446433	X	99663457 - 99663458	X	100408459 - 100408460	446433	439889	rs1555985820	NC_000023.11:100408458:GC:AA
NM_001184880.2(PCDH19):c.457_458delinsAT (p.Ala153Ile)	PCDH19	A153I	Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Aug 12, 2014)	criteria provided, single submitter	VCV000216981	X	99663138 - 99663139	X	100408140 - 100408141	216981	213663	rs863224907	NC_000023.11:100408139:GC:AT
NM_001184880.2(PCDH19):c.966dup (p.Pro323fs)	PCDH19	P323fs	not provided	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000206368	X	99662629 - 99662630	X	100407631 - 100407632	206368	203927	rs796052842	NC_000023.11:100407631:CCCC:CCCCC
NM_001184880.2(PCDH19):c.218_219insG (p.Asp73fs)	PCDH19	D73fs	not provided	Pathogenic(Last reviewed: Aug 12, 2014)	criteria provided, single submitter	VCV000206367	X	99663377 - 99663378	X	100408379 - 100408380	206367	203951	rs796052841	NC_000023.11:100408379::C
NM_001184880.2(PCDH19):c.1091dup (p.Tyr366fs)	PCDH19	Y366fs	not provided|Early infantile epileptic encephalopathy 9|Generalized tonic-clonic seizures|Prominent fingertip pads|Hand tremor|Temporal cortical atrophy|Generalized seizures|Frontal cortical atrophy|Absence seizures|Global developmental delay|Strabismus|Long palpebral fissure|Delayed speech and language development	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000206353	X	99662504 - 99662505	X	100407506 - 100407507	206353	203922	rs758946412	NC_000023.11:100407506:GGGGGGG:GGGGGGGG
PCDH19, 5-BP DUP, NT1036	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 7, 2020)	no assertion criteria provided	VCV000011021					11021	26060		
NM_001184880.2(PCDH19):c.2030dup (p.Leu677fs)	PCDH19	L677fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000011019	X	99661565 - 99661566	X	100406567 - 100406568	11019	26058	rs1569314152	NC_000023.11:100406567:AA:AAA
NM_000284.4(PDHA1):c.1142_1145dup (p.Trp383fs)	PDHA1	W390fs, W352fs, W383fs, W421fs	not provided|Pyruvate dehydrogenase complex deficiency|Inborn genetic diseases|Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: May 6, 2021)	reviewed by expert panel	VCV000010880	X	19377737 - 19377738	X	19359619 - 19359620	10880	25919	rs606231189	NC_000023.11:19359619:CAATCA:CAATCAATCA
NM_001351132.2(PEX5):c.677dup (p.Val227fs)	PEX5	V242fs, V227fs	Rhizomelic chondrodysplasia punctata type 5|Rhizomelic chondrodysplasia punctata	Pathogenic(Last reviewed: May 15, 2015)	criteria provided, single submitter	VCV000190410	12	7354870 - 7354871	12	7202274 - 7202275	190410	188236	rs796051881	NC_000012.12:7202274:A:AA
NM_001015877.2(PHF6):c.29_30dup (p.Pro11fs)	PHF6	P11fs	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000488575	X	133511674 - 133511675	X	134377644 - 134377645	488575	481443	rs1556013203	NC_000023.11:134377644:GGG:GGGGG
NM_001015877.2(PHF6):c.27dup (p.Gly10fs)	PHF6	G10fs	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000011072	X	133511668 - 133511669	X	134377638 - 134377639	11072	26111	rs758791658	NC_000023.11:134377638:AAAAAA:AAAAAAA
NM_032634.4(PIGO):c.2736dup (p.Pro913fs)	PIGO	P913fs, P496fs	Hyperphosphatasia-intellectual disability syndrome	Likely pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000666981	9	35090580 - 35090581	9	35090583 - 35090584	666981	654540	rs1587159769	NC_000009.12:35090583:AAA:AAAA
NM_032634.4(PIGO):c.1810dup (p.Arg604fs)	PIGO	R604fs	not provided|Hyperphosphatasia with mental retardation syndrome 2|Hyperphosphatasia-intellectual disability syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000286126	9	35092073 - 35092074	9	35092076 - 35092077	286126	270363	rs774508288	NC_000009.12:35092076:GGGG:GGGGG
NM_004204.5(PIGQ):c.638_639delinsTT (p.Cys213Phe)	PIGQ	C213F	Epilepsy	Uncertain significance(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000956711	16	624712 - 624713	16	574712 - 574713	956711	949447		NC_000016.10:574711:GC:TT
NM_004204.5(PIGQ):c.1631dup (p.Tyr544Ter)	PIGQ	Y544*, P524fs	Epilepsy	Uncertain significance(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000576638	16	632919 - 632920	16	582919 - 582920	576638	574097	rs760045515	NC_000016.10:582919:A:AA
NM_004204.5(PIGQ):c.39_40delinsAG (p.Thr14Ala)	PIGQ	T14A	Epilepsy	Uncertain significance(Last reviewed: Feb 22, 2020)	criteria provided, single submitter	VCV000526275	16	624113 - 624114	16	574113 - 574114	526275	530366	rs1555451582	NC_000016.10:574112:GA:AG
NM_017837.4(PIGV):c.*518dup	PIGV		Hyperphosphatasia-intellectual disability syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000297132	1	27124852 - 27124853	1	26798361 - 26798362	297132	282089	rs780242432	NC_000001.11:26798361:A:AA
NM_005027.4(PIK3R2):c.1809-3_1809-2insCCCCCCG	PIK3R2		Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	Uncertain significance(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000931214	19	18279533 - 18279534	19	18168723 - 18168724	931214	920404		NC_000019.10:18168723::CCCCCCG
NM_005027.4(PIK3R2):c.64_88dup (p.Val30fs)	PIK3R2	V30fs	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	Uncertain significance(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV000930706	19	18266751 - 18266752	19	18155941 - 18155942	930706	919843		NC_000019.10:18155941:GGACCTGGAGCTGCTGCCCGGCGACG:GGACCTGGAGCTGCTGCCCGGCGACGGACCTGGAGCTGCTGCCCGGCGACG
NC_000019.10:g.(?_18167110)_(18169314_?)dup	PIK3R2		Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	Uncertain significance(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000831457	19	18277920 - 18280124			831457	821245		
NM_014889.4(PITRM1):c.2236-1dup	PITRM1|PITRM1-AS1		Infantile onset spinocerebellar ataxia	Pathogenic(Last reviewed: May 27, 2018)	no assertion criteria provided	VCV001120050	10	3189441 - 3189442	10	3147249 - 3147250	1120050	1108851		NC_000010.11:3147249:CC:CCC
NM_007254.4(PNKP):c.1317_1321dup (p.Ala441fs)	PNKP	A441fs	Early infantile epileptic encephalopathy 12|not provided	Pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000206429	19	50364929 - 50364930	19	49861672 - 49861673	206429	203579	rs796052862	NC_000019.10:49861672:CGGCTCGG:CGGCTCGGCTCGG
NM_007254.4(PNKP):c.1126+3_1126+4dup	PNKP		not provided	Likely pathogenic(Last reviewed: Sep 6, 2013)	criteria provided, single submitter	VCV000206425	19	50365437 - 50365438	19	49862180 - 49862181	206425	203591	rs750550558	NC_000019.10:49862180:TT:TTTT
NM_018129.4(PNPO):c.205delinsTTTCCCCT (p.Ala69fs)	PNPO	A69fs	Pyridoxal phosphate-responsive seizures	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000967984	17	46020738	17	47943372	967984	958152		NC_000017.11:47943371:G:TTTCCCCT
NM_018129.4(PNPO):c.539_541dup (p.Arg181_Glu182insHis)	PNPO		not provided|Pyridoxal phosphate-responsive seizures	Uncertain significance(Last reviewed: May 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000430237	17	46023347 - 46023348	17	47945981 - 47945982	430237	422178	rs1131691848	NC_000017.11:47945981:ATC:ATCATC
NM_018129.4(PNPO):c.*764dup	PNPO		Pyridoxal phosphate-responsive seizures	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000323923	17	46024900 - 46024901	17	47947534 - 47947535	323923	339053	rs199634607	NC_000017.11:47947534:TTTTTTTTTTTT:TTTTTTTTTTTTT
NM_018129.4(PNPO):c.*656_*657dup	PNPO		Pyridoxal phosphate-responsive seizures	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000323920	17	46024791 - 46024792	17	47947425 - 47947426	323920	339045	rs35312568	NC_000017.11:47947425:TTTTTTTTTTTTTT:TTTTTTTTTTTTTTTT
NM_018129.4(PNPO):c.*282_*283insAG	PNPO		Pyridoxal phosphate-responsive seizures	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000323915	17	46024429 - 46024430	17	47947063 - 47947064	323915	346382	rs886053102	NC_000017.11:47947063:G:GAG
NM_002693.3(POLG):c.1237_1250dup (p.Arg417fs)	POLG	R417fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV001075687	15	89871686 - 89871687	15	89328455 - 89328456	1075687	1063438		NC_000015.10:89328455:CTCTCCAAGAAGAGC:CTCTCCAAGAAGAGCTCTCCAAGAAGAGC
NM_002693.3(POLG):c.152_153insACA (p.Gln55dup)	POLG		Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001056216	15	89876833 - 89876834	15	89333602 - 89333603	1056216	1049156		NC_000015.10:89333602:TG:TGTTG
NM_002693.3(POLG):c.127_128insGGCAGC (p.Gln43_Gln44insArgGln)	POLG		Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001047240	15	89876858 - 89876859	15	89333627 - 89333628	1047240	1032205		NC_000015.10:89333627:GC:GCTGCCGC
NM_002693.3(POLG):c.149_166dup (p.Gln50_Gln55dup)	POLG		Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV001045880	15	89876819 - 89876820	15	89333588 - 89333589	1045880	1032203		NC_000015.10:89333588:GCTGCTGTTGCTGCTGCTGCTGCTG:GCTGCTGTTGCTGCTGCTGCTGCTGTTGCTGCTGCTGCTGCTG
NM_002693.3(POLG):c.3559_3560insCACC (p.Arg1187fs)	POLG	R1187fs	Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV001017904	15	89860690 - 89860691	15	89317459 - 89317460	1017904	1011669		NC_000015.10:89317459:GGT:GGTGGGT
NM_002693.3(POLG):c.143_144insCCAGCA (p.Gln48_Gln49insHisGln)	POLG		not provided|Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV001008478	15	89876842 - 89876843	15	89333611 - 89333612	1008478	996456		NC_000015.10:89333611:TGCTG:TGCTGGTGCTG
NM_002693.3(POLG):c.158_159insGCAACA (p.Gln54_Gln55dup)	POLG		Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001000305	15	89876827 - 89876828	15	89333596 - 89333597	1000305	996455		NC_000015.10:89333596:TG:TGTTGCTG
NM_002693.3(POLG):c.1022_1023delinsAT (p.Ala341Asp)	POLG	A341D	Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV000946586	15	89872174 - 89872175	15	89328943 - 89328944	946586	927448		NC_000015.10:89328942:CG:AT
NM_002693.3(POLG):c.3701_3702insT (p.Ser1235fs)	POLG|FANCI	S1235fs	Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000945006	15	89860000 - 89860001	15	89316769 - 89316770	945006	927446		NC_000015.10:89316769::A
NM_002693.3(POLG):c.168_176dup (p.55QPQ[3])	POLG		Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000942573	15	89876809 - 89876810	15	89333578 - 89333579	942573	937113		NC_000015.10:89333578:GGCTGCTGAGGCTGCTG:GGCTGCTGAGGCTGCTGAGGCTGCTG
NM_002693.3(POLG):c.2884dup (p.Ala962fs)	POLG	A962fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000845148	15	89864093 - 89864094	15	89320862 - 89320863	845148	842779		NC_000015.10:89320862:C:CC
NM_002693.3(POLG):c.158_159insGCAACAGCA (p.Gln53_Gln55dup)	POLG		Progressive sclerosing poliodystrophy|not provided	Likely benign(Last reviewed: Jul 8, 2018)	criteria provided, single submitter	VCV000762188	15	89876827 - 89876828	15	89333596 - 89333597	762188	770403	rs1555454334	NC_000015.10:89333596:TGCTG:TGCTGTTGCTGCTG
NM_002693.3(POLG):c.159_167dup (p.55QPQ[3])	POLG		Progressive sclerosing poliodystrophy	Likely benign(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000753869	15	89876818 - 89876819	15	89333587 - 89333588	753869	770402	rs776709929	NC_000015.10:89333587:GGCTGCTGT:GGCTGCTGTGGCTGCTGT
NM_002693.3(POLG):c.951_961dup (p.Lys321fs)	POLG	K321fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000694426	15	89872235 - 89872236	15	89329004 - 89329005	694426	682362	rs1596359629	NC_000015.10:89329004:TGTGTTTGCCCTG:TGTGTTTGCCCTGTGTTTGCCCTG
NM_002693.3(POLG):c.159delinsGCAACAGCAGCCT (p.Pro56_Gln57insGlnProGlnGln)	POLG		Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000648340	15	89876827	15	89333596	648340	643619	rs1596362608	NC_000015.10:89333595:T:AGGCTGCTGTTGC
NM_002693.3(POLG):c.3255dup (p.Ser1086fs)	POLG	S1086fs	Progressive sclerosing poliodystrophy|Myoclonic epilepsy myopathy sensory ataxia|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Mitochondrial DNA depletion syndrome 4B, MNGIE type|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions|Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000640935	15	89862179 - 89862180	15	89318948 - 89318949	640935	643599	rs1596350386	NC_000015.10:89318948:GGG:GGGG
NM_002693.3(POLG):c.2157+5_2157+6delinsAG	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619500	15	89867040 - 89867041	15	89323809 - 89323810	619500	610897	rs1596354607	NC_000015.10:89323808:GC:CT
NM_002693.3(POLG):c.133_134insGGC (p.Gln45_Gln46insArg)	POLG		Progressive sclerosing poliodystrophy	Likely benign(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619409	15	89876852 - 89876853	15	89333621 - 89333622	619409	610805	rs1567194472	NC_000015.10:89333621:GC:GCCGC
NM_002693.3(POLG):c.698dup (p.Tyr233Ter)	POLG	Y233*	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619403	15	89873468 - 89873469	15	89330237 - 89330238	619403	610791	rs1567192884	NC_000015.10:89330237:T:TT
NM_002693.3(POLG):c.3490_3493dup (p.Ala1165fs)	POLG	A1165fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619402	15	89860756 - 89860757	15	89317525 - 89317526	619402	610707	rs778115255	NC_000015.10:89317525:CAAACA:CAAACAAACA
NM_002693.3(POLG):c.2543_2544dup (p.Thr849fs)	POLG	T849fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619401	15	89865020 - 89865021	15	89321789 - 89321790	619401	610752	rs1567187103	NC_000015.10:89321789:GC:GCGC
NM_002693.3(POLG):c.2734+39_2734+40insAGGT	POLG		Progressive sclerosing poliodystrophy|not provided	Benign(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000619386	15	89864316 - 89864317	15	89321085 - 89321086	619386	610835	rs2307433	NC_000015.10:89321085:CT:CTACCT
NM_002693.3(POLG):c.3447dup (p.Ala1150fs)	POLG	A1150fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619312	15	89861806 - 89861807	15	89318575 - 89318576	619312	610710	rs1567185026	NC_000015.10:89318575:A:AA
NM_002693.3(POLG):c.3430_3433dup (p.Asp1145fs)	POLG	D1145fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619311	15	89861820 - 89861821	15	89318589 - 89318590	619311	610711	rs1567185048	NC_000015.10:89318589:CCTCC:CCTCCCTCC
NM_002693.3(POLG):c.2674dup (p.Asp892fs)	POLG	D892fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619306	15	89864415 - 89864416	15	89321184 - 89321185	619306	610741	rs1283198587	NC_000015.10:89321184:CC:CCC
NM_002693.3(POLG):c.134_137delinsG (p.Gln45_Gln46delinsArg)	POLG		Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000580549	15	89876849 - 89876852	15	89333618 - 89333621	580549	567336	rs1567194455	NC_000015.10:89333617:TGCT:C
NM_002693.3(POLG):c.2217_2230dup (p.Ile744fs)	POLG	I744fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000577990	15	89866669 - 89866670	15	89323438 - 89323439	577990	569207	rs1282521429	NC_000015.10:89323438:TGTCCACGTCGTTGT:TGTCCACGTCGTTGTGTCCACGTCGTTGT
NC_000015.9:g.(?_89868661)_(89873527_?)dup	POLG|MIR6766		Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000528392	15	89868661 - 89873527	15	89325430 - 89330296	528392	528579		
NM_002693.3(POLG):c.143_166dup (p.Gln48_Gln55dup)	POLG		Progressive sclerosing poliodystrophy	Likely benign(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000528387	15	89876819 - 89876820	15	89333588 - 89333589	528387	529127	rs1555454325	NC_000015.10:89333588:GCTGCTGTTGCTGCTGCTGCTGCTGCTGCTG:GCTGCTGTTGCTGCTGCTGCTGCTGCTGCTGTTGCTGCTGCTGCTGCTGCTGCTG
NM_002693.3(POLG):c.158_166dup (p.Gln53_Gln55dup)	POLG		not provided|Progressive sclerosing poliodystrophy	Likely benign(Last reviewed: Jan 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000528385	15	89876819 - 89876820	15	89333588 - 89333589	528385	529124	rs769735492	NC_000015.10:89333588:GCTGCTGTTGCTGCTG:GCTGCTGTTGCTGCTGTTGCTGCTG
NM_002693.3(POLG):c.3155dup (p.Thr1053fs)	POLG	T1053fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Mar 4, 2017)	criteria provided, single submitter	VCV000458711	15	89862279 - 89862280	15	89319048 - 89319049	458711	465354	rs1447799185	NC_000015.10:89319048:CCCCCC:CCCCCCC
NM_002693.3(POLG):c.3409dup (p.Val1137fs)	POLG	V1137fs	Progressive sclerosing poliodystrophy|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423899	15	89861844 - 89861845	15	89318613 - 89318614	423899	409368	rs1555452461	NC_000015.10:89318613:CC:CCC
NM_002693.3(POLG):c.158_159delinsCT (p.Gln53Pro)	POLG	Q53P	not provided|Progressive sclerosing poliodystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 9, 2021)	criteria provided, conflicting interpretations	VCV000422763	15	89876827 - 89876828	15	89333596 - 89333597	422763	409384	rs1064795981	NC_000015.10:89333595:TT:AG
NM_002693.3(POLG):c.3424dup (p.Arg1142fs)	POLG	R1142fs	not provided|Progressive sclerosing poliodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000422438	15	89861829 - 89861830	15	89318598 - 89318599	422438	409367	rs1555452453	NC_000015.10:89318598:G:GG
NM_002693.2(POLG):c.125_139dup	POLG		Progressive sclerosing poliodystrophy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2018)	criteria provided, conflicting interpretations	VCV000421770	15	89876846 - 89876847	15	89333615 - 89333616	421770	409387	rs780010436	NC_000015.10:89333615:GCTGCTGCTGCTGCCGC:GCTGCTGCTGCTGCCGCTGCTGCTGCTGCCGC
NM_002693.3(POLG):c.3240_3242dup (p.Arg1081dup)	POLG		Inborn genetic diseases|not provided|Progressive sclerosing poliodystrophy	Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419974	15	89862192 - 89862193	15	89318961 - 89318962	419974	409370	rs1064794213	NC_000015.10:89318961:CGGC:CGGCGGC
NM_002693.3(POLG):c.159_164dup (p.Gln54_Gln55dup)	POLG		not provided|Progressive sclerosing poliodystrophy	Likely benign(Last reviewed: Apr 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000419760	15	89876821 - 89876822	15	89333590 - 89333591	419760	409383	rs760135553	NC_000015.10:89333590:TGCTGTTGCTG:TGCTGTTGCTGTTGCTG
NM_002693.3(POLG):c.3358_3361dup (p.Glu1121delinsValTer)	POLG		Progressive sclerosing poliodystrophy|not provided	Pathogenic(Last reviewed: Sep 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000419336	15	89861892 - 89861893	15	89318661 - 89318662	419336	409369	rs1064793800	NC_000015.10:89318661:CAAACA:CAAACAAACA
NM_002693.3(POLG):c.1612_1613delinsTT (p.Glu538Leu)	POLG	E538L	not specified|Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000206634	15	89869942 - 89869943	15	89326711 - 89326712	206634	203004	rs796052921	NC_000015.10:89326710:TC:AA
NM_002693.3(POLG):c.-186_-185delinsCC	POLG		not specified	Likely benign(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	VCV000206495	15	89877929 - 89877930	15	89334698 - 89334699	206495	203071	rs796052879	NC_000015.10:89334697:CT:GG
NM_002693.3(POLG):c.159_161dup (p.Gln55dup)	POLG		not specified|not provided|Progressive sclerosing poliodystrophy	Likely benign(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206483	15	89876824 - 89876825	15	89333593 - 89333594	206483	203055	rs768088414	NC_000015.10:89333593:TGTTG:TGTTGTTG
NM_001035256.2(POMC):c.20_21ins25	POMC		Inborn genetic diseases	Pathogenic	criteria provided, single submitter	VCV000208711	2	25387621 - 25387622	2	25164752 - 25164753	208711	205232		
NM_000944.5(PPP3CA):c.1308_1311dup (p.Ser438fs)	PPP3CA	S438fs, S396fs	Developmental and epileptic encephalopathy 91	Pathogenic(Last reviewed: Nov 26, 2017)	criteria provided, single submitter	VCV000522802	4	101953451 - 101953452	4	101032294 - 101032295	522802	513416	rs1553920379	NC_000004.12:101032294:AAGTA:AAGTAAGTA
NM_000310.4(PPT1):c.169dup (p.Met57fs)	PPT1	M57fs	not provided|Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056182	1	40558134 - 40558135	1	40092462 - 40092463	56182	70821	rs386833634	NC_000001.11:40092462:TTTTTTT:TTTTTTTT
NM_001099403.2(PRDM8):c.1779_1784dup (p.Ala597_Ala598dup)	PRDM8		Epilepsy, progressive myoclonic, 10	Uncertain significance(Last reviewed: Feb 22, 2020)	criteria provided, single submitter	VCV000934075	4	81124389 - 81124390	4	80203235 - 80203236	934075	932454		NC_000004.12:80203235:GCGGCTGCGGC:GCGGCTGCGGCTGCGGC
NM_001099403.2(PRDM8):c.1951_1952delinsAT (p.Glu651Met)	PRDM8	E651M	Epilepsy, progressive myoclonic, 10	Uncertain significance(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000662898	4	81124567 - 81124568	4	80203413 - 80203414	662898	632472	rs1578268165	NC_000004.12:80203412:GA:AT
NM_001099403.2(PRDM8):c.1767_1775dup (p.Ala596_Ala598dup)	PRDM8		Epilepsy, progressive myoclonic, 10	Uncertain significance(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000639513	4	81124377 - 81124378	4	80203223 - 80203224	639513	632469	rs1480528424	NC_000004.12:80203223:GCCGCTGCAGCCGC:GCCGCTGCAGCCGCTGCAGCCGC
NM_153026.3(PRICKLE1):c.949dup (p.Ser317fs)	PRICKLE1	S317fs	Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001006994	12	42858886 - 42858887	12	42465084 - 42465085	1006994	995202		NC_000012.12:42465084:AA:AAA
NM_153026.3(PRICKLE1):c.1985_1996delinsG (p.Asn662fs)	PRICKLE1	N662fs	Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000970481	12	42854111 - 42854122	12	42460309 - 42460320	970481	956869		NC_000012.12:42460308:TCTCTTCAAAAT:C
NM_153026.3(PRICKLE1):c.379_380insT (p.Glu127fs)	PRICKLE1	E127fs	Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV000956098	12	42863256 - 42863257	12	42469454 - 42469455	956098	948018		NC_000012.12:42469454::A
NM_153026.3(PRICKLE1):c.1571_1573dup (p.Leu524dup)	PRICKLE1		Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Oct 16, 2019)	criteria provided, single submitter	VCV000954561	12	42858262 - 42858263	12	42464460 - 42464461	954561	948014		NC_000012.12:42464460:ACA:ACAACA
NM_153026.3(PRICKLE1):c.2141_2142delinsTT (p.Gln714Leu)	PRICKLE1	Q714L	Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000940233	12	42853965 - 42853966	12	42460163 - 42460164	940233	936116		NC_000012.12:42460162:CT:AA
NM_153026.3(PRICKLE1):c.1088_1089delinsAT (p.Leu363His)	PRICKLE1	L363H	Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000856256	12	42858747 - 42858748	12	42464945 - 42464946	856256	839916		NC_000012.12:42464944:GA:AT
NC_000012.11:g.(?_42853591)_(42866338_?)dup	PRICKLE1		Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000584101	12	42853591 - 42866338	12	42459789 - 42472536	584101	566287		
NM_153026.3(PRICKLE1):c.1413_1414delinsTC (p.Met471_Tyr472delinsIleHis)	PRICKLE1		Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Oct 15, 2016)	criteria provided, single submitter	VCV000410635	12	42858422 - 42858423	12	42464620 - 42464621	410635	399457	rs1060502985	NC_000012.12:42464619:AC:GA
NM_153026.3(PRICKLE1):c.-279_-277dup	PRICKLE1		Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308719	12	42983494 - 42983495	12	42589692 - 42589693	308719	317084	rs886049380	NC_000012.12:42589692:GGG:GGGGGG
NM_198859.4(PRICKLE2):c.*581dup	PRICKLE2|PRICKLE2-AS1		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346466	3	64084145 - 64084146	3	64098469 - 64098470	346466	292651	rs886058797	NC_000003.12:64098469:A:AA
NM_198859.4(PRICKLE2):c.*792dup	PRICKLE2|PRICKLE2-AS1		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346461	3	64083934 - 64083935	3	64098258 - 64098259	346461	292630	rs535354956	NC_000003.12:64098258:AAAAA:AAAAAA
NM_198859.4(PRICKLE2):c.*2288_*2296delinsT	PRICKLE2|PRICKLE2-AS1		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346442	3	64082431 - 64082439	3	64096755 - 64096763	346442	295956	rs386661734	NC_000003.12:64096754:TGAGAAAGG:A
NM_198859.4(PRICKLE2):c.*2980_*2981dup	PRICKLE2|PRICKLE2-AS1		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346432	3	64081745 - 64081746	3	64096069 - 64096070	346432	291399	rs759645403	NC_000003.12:64096069:TGT:TGTGT
NM_198859.4(PRICKLE2):c.*4861dup	PRICKLE2|PRICKLE2-AS1		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346414	3	64079865 - 64079866	3	64094189 - 64094190	346414	291386	rs571451772	NC_000003.12:64094189:AAAAAAAAA:AAAAAAAAAA
NM_178013.4(PRIMA1):c.186_194dup (p.Pro68_Pro70dup)	PRIMA1		Nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001055237	14	94245556 - 94245557	14	93779210 - 93779211	1055237	1048740		NC_000014.9:93779210:GGGGGCGGCGGGGGC:GGGGGCGGCGGGGGCGGCGGGGGC
NM_145239.3(PRRT2):c.971dup (p.Val325fs)	PRRT2	V325fs	not provided|Paroxysmal kinesigenic dyskinesia|Seizures, benign familial infantile, 2	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000871891	16	29825739 - 29825740	16	29814418 - 29814419	871891	860254		NC_000016.10:29814418:GGGGGG:GGGGGGG
NC_000016.9:g.(?_29824311)_(29827202_?)dup	PRRT2		Episodic kinesigenic dyskinesia 1	Uncertain significance(Last reviewed: Jul 19, 2016)	criteria provided, single submitter	VCV000417331	16	29824311 - 29827202	16	29812990 - 29815881	417331	401080		
NM_145239.3(PRRT2):c.649dup (p.Arg217fs)	PRRT2	R217fs	Infantile convulsions and choreoathetosis|Seizures, benign familial infantile, 2|Paroxysmal kinesigenic dyskinesia|Seizures|PRRT2 insufficiency|Episodic kinesigenic dyskinesia 1|PRRT2-Associated Paroxysmal Movement Disorders|not provided|Paroxysmal nonkinesigenic dyskinesia 1|History of neurodevelopmental disorder|Seizures, benign familial infantile, 2|Episodic kinesigenic dyskinesia 1|Infantile convulsions and choreoathetosis	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000065758	16	29825015 - 29825016	16	29813694 - 29813695	65758	76666		NC_000016.10:29813694:CCCCCCCCC:CCCCCCCCCC
NM_145239.3(PRRT2):c.510dup (p.Leu171fs)	PRRT2	L171fs	Episodic kinesigenic dyskinesia 1	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000065756	16	29824883 - 29824884	16	29813562 - 29813563	65756	76664	rs397515576	NC_000016.10:29813562:TT:TTT
NM_145239.3(PRRT2):c.516dup (p.Glu173Ter)	PRRT2	E173*	Infantile convulsions and choreoathetosis|Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV000031175	16	29824890 - 29824891	16	29813569 - 29813570	31175	40132	rs730882068	NC_000016.10:29813569:T:TT
NM_145239.3(PRRT2):c.629dup (p.Ala211fs)	PRRT2	A211fs	Infantile convulsions and choreoathetosis|Episodic kinesigenic dyskinesia 1|not provided	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031171	16	29824997 - 29824998	16	29813676 - 29813677	31171	40128	rs730882067	NC_000016.10:29813676:CCCCCCC:CCCCCCCC
NC_000001.10:g.(?_151122490)_(151585008_?)dup	PSMB4|PIP5K1A|SCNM1|RFX5|PSMD4|TNFAIP8L2|ZNF687|LYSMD1|TUFT1|VPS72|POGZ|SELENBP1|PI4KB|TMOD4|SNX27|CGN		Severe myoclonic epilepsy in infancy	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001023952	1	151122490 - 151585008			1023952	1001344		
NM_000314.8(PTEN):c.1110_1111dup (p.Asp371fs)	PTEN	D174fs, D371fs, D544fs	Hemimegalencephaly	Pathogenic(Last reviewed: Mar 23, 2021)	criteria provided, single submitter	VCV001048544	10	89725125 - 89725126	10	87965368 - 87965369	1048544	1036491		NC_000010.11:87965368:GTG:GTGTG
NM_000314.8(PTEN):c.255_262delinsC (p.Ala86fs)	PTEN	A259fs, A86fs	Hemimegalencephaly	Pathogenic(Last reviewed: Mar 23, 2021)	criteria provided, single submitter	VCV001048543	10	89692771 - 89692778	10	87933014 - 87933021	1048543	1036490		NC_000010.11:87933013:TGCACAAT:C
Single allele	PWAR4|LOC645202|SNORD115-1|GOLGA8S|APBA2|GABRA5|PWAR5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|SNURF|CYFIP1|FAM189A1|NPAP1|LINC02249|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-6|SNORD115-7|MAGEL2|NSMCE3|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|GOLGA6L1|GOLGA8J|GOLGA8T|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|LOC112272579|LOC112272580|GOLGA8G|SNORD108|LOC112272581|GOLGA6L7|SNORD116-20|SNORD116-21|SNORD115-17|SNORD115-18|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|ATP10A-DT|LOC112272575|LOC112272578|CHRFAM7A|HERC2|SNORD107|LOC100132202|LOC102723623|SNHG14|SNORD115-3|SNORD115-4|SNORD115-5|SNORD109B|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-24|SNORD116-25|MIR4508|MIR4509-3|MIR4509-2|MIR4715|SNORD116-30|SNORD115-46|GOLGA8F|TRE-TTC2-2|PWRN4|SNORD115-19|SNORD115-20|SNORD115-41|SNORD115-42|SNORD115-43|PWAR6|SNORD116-7|SNORD115-44|SNORD116-28|PWRN3|GABRG3-AS1|MIR4509-1|SNORD109A|LINC02250|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100130111|PWRN1|PWRN2|SNORD115-21|SNORD115-22|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-23|SNORD115-25|SNORD115-26|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD115-34|SNORD115-35|SNORD116-22|SNORD116-23|SNORD64|PWARSN|LINC00929		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Jun 5, 2020)	criteria provided, single submitter	VCV001098669			15	22804175 - 30375696	1098669	1087289		
NM_012233.3(RAB3GAP1):c.2187_2188delinsCT (p.Met729_Lys730delinsIleTer)	RAB3GAP1		Warburg micro syndrome 1	Pathogenic(Last reviewed: Jul 7, 2021)	no assertion criteria provided	VCV001177056	2	135911344 - 135911345	2	135153774 - 135153775	1177056	1166548		NC_000002.12:135153773:GA:CT
NM_012233.3(RAB3GAP1):c.2865_2866insTTCT (p.Pro956fs)	RAB3GAP1	P963fs, P956fs	Warburg micro syndrome 1	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000545411	2	135926270 - 135926271	2	135168700 - 135168701	545411	535676	rs1553450718	NC_000002.12:135168700::TTCT
NM_012233.3(RAB3GAP1):c.429dup (p.Lys144Ter)	RAB3GAP1	K144*	Warburg micro syndrome 1	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522788	2	135870786 - 135870787	2	135113216 - 135113217	522788	513246	rs1553444644	NC_000002.12:135113216:T:TT
NM_012233.3(RAB3GAP1):c.630_631insC (p.Ile211fs)	RAB3GAP1	I211fs	Warburg micro syndrome 1|not provided	Pathogenic(Last reviewed: Feb 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000420527	2	135872933 - 135872934	2	135115363 - 135115364	420527	405294	rs1064794536	NC_000002.12:135115363::C
NM_012233.3(RAB3GAP1):c.2037_2055dup (p.Phe686fs)	RAB3GAP1	F686fs	Warburg micro syndrome 1	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000100770	2	135908047 - 135908048	2	135150477 - 135150478	100770	106636	rs587777153	NC_000002.12:135150477:GTCTGCTCTCAGATATGGAGTCT:GTCTGCTCTCAGATATGGAGTCTGCTCTCAGATATGGAGTCT
NM_012233.3(RAB3GAP1):c.264_270delinsTTATTA (p.Lys89fs)	RAB3GAP1	K89fs	Warburg micro syndrome 1	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000007062	2	135848681 - 135848687	2	135091111 - 135091117	7062	22101	rs730882184	NC_000002.12:135091110:AAAGGAT:TTATTA
NM_012414.4(RAB3GAP2):c.2366_2370delinsGACTGTGG (p.Gln789_Ser790delinsArgLeuTrp)	RAB3GAP2		Cataract-intellectual disability-hypogonadism syndrome	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV001030256	1	220346025 - 220346029	1	220172683 - 220172687	1030256	1015658		NC_000001.11:220172682:TGACT:CCACAGTC
NM_012414.4(RAB3GAP2):c.2207dup (p.Leu737fs)	RAB3GAP2	L737fs	Warburg micro syndrome 2	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000436479	1	220356064 - 220356065	1	220182722 - 220182723	436479	427709	rs1553275687	NC_000001.11:220182722:G:GG
NM_012414.4(RAB3GAP2):c.613-24dup	RAB3GAP2		not provided|Warburg micro syndrome|Cataract-intellectual disability-hypogonadism syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 10, 2019)	criteria provided, conflicting interpretations	VCV000295667	1	220379361 - 220379362	1	220206019 - 220206020	295667	279535	rs572027376	NC_000001.11:220206019:AAAAAAAAAAA:AAAAAAAAAAAA
NM_012414.4(RAB3GAP2):c.*798_*799dup	RAB3GAP2		Cataract-intellectual disability-hypogonadism syndrome|Warburg micro syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295632	1	220323793 - 220323794	1	220150451 - 220150452	295632	279301	rs35147354	NC_000001.11:220150451:TTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTT
NM_012414.4(RAB3GAP2):c.*799dup	RAB3GAP2		Cataract-intellectual disability-hypogonadism syndrome|Warburg micro syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295631	1	220323793 - 220323794	1	220150451 - 220150452	295631	280813	rs35147354	NC_000001.11:220150451:TTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTT
NM_012414.4(RAB3GAP2):c.*1694_*1695insACA	RAB3GAP2		Cataract-intellectual disability-hypogonadism syndrome|Warburg micro syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295620	1	220322898 - 220322899	1	220149556 - 220149557	295620	280860	rs143194915	NC_000001.11:220149556:T:TGTT
NM_012414.4(RAB3GAP2):c.*2392_*2395dup	RAB3GAP2		Cataract-intellectual disability-hypogonadism syndrome|Warburg micro syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295612	1	220322197 - 220322198	1	220148855 - 220148856	295612	280804	rs552063647	NC_000001.11:220148855:AGTTA:AGTTAGTTA
NM_012414.4(RAB3GAP2):c.*2512dup	RAB3GAP2		Warburg micro syndrome|Cataract-intellectual disability-hypogonadism syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295608	1	220322080 - 220322081	1	220148738 - 220148739	295608	280799	rs143756119	NC_000001.11:220148738:TTTTTTTTT:TTTTTTTTTT
NM_012414.3(RAB3GAP2):c.*2971_*2974dupAACA	RAB3GAP2		Warburg micro syndrome|Cataract-intellectual disability-hypogonadism syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295601	1	220321618 - 220321619	1	220148276 - 220148277	295601	280795	rs529035209	NC_000001.11:220148276:TGTTT:TGTTTGTTT
RAPGEF2, 5-BP INS, TTTCA(n)	RAPGEF2		Epilepsy, familial adult myoclonic, 7	Pathogenic(Last reviewed: Aug 3, 2018)	no assertion criteria provided	VCV000559389					559389	550117		
NC_000016.9:g.(?_7382983)_(7647453_?)dup	RBFOX1		Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001036883	16	7382983 - 7647453			1036883	1022368		
NC_000016.9:g.(?_7102053)_(7760767_?)dup	RBFOX1		Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV001025478	16	7102053 - 7760767			1025478	1001792		
NC_000016.9:g.(?_7102053)_(7760767_?)dup	RBFOX1		Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000831383	16	7102053 - 7760767			831383	820976		
NC_000016.9:g.(?_7560981)_(7680705_?)dup	RBFOX1		Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000654098	16	7560981 - 7680705	16	7510979 - 7630703	654098	652866		
NM_018723.4(RBFOX1):c.758-5_758-4delinsTT	RBFOX1		Idiopathic generalized epilepsy	Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, single submitter	VCV000415954	16	7703812 - 7703813	16	7653810 - 7653811	415954	401350	rs1060504699	NC_000016.10:7653809:CG:TT
NM_001350451.2(RBFOX3):c.622+3dup	RBFOX3		Idiopathic generalized epilepsy	Benign(Last reviewed: Sep 14, 2020)	criteria provided, single submitter	VCV001164626	17	77093767 - 77093768	17	79097685 - 79097686	1164626	1158162		NC_000017.11:79097685:TTTT:TTTTT
NM_005045.4(RELN):c.4937-14_4937-12dup	RELN		Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome	Likely benign(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001157518	7	103206001 - 103206002	7	103565554 - 103565555	1157518	1138243		NC_000007.14:103565554:AAAAAAAAAAA:AAAAAAAAAAAAAA
NM_005045.4(RELN):c.1290-11_1290-9dup	RELN		Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001155534	7	103301976 - 103301977	7	103661529 - 103661530	1155534	1138254		NC_000007.14:103661529:AAAAAAAAA:AAAAAAAAAAAA
NM_005045.4(RELN):c.2466-6dup	RELN		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Likely benign(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV001101122	7	103270628 - 103270629	7	103630181 - 103630182	1101122	1095780		NC_000007.14:103630181:G:GG
NM_005045.4(RELN):c.1763+5_1763+6delinsTT	RELN		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001063822	7	103292992 - 103292993	7	103652545 - 103652546	1063822	1044507		NC_000007.14:103652544:TC:AA
NM_005045.4(RELN):c.3552_3553delinsTA (p.Glu1185Lys)	RELN	E1185K	Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001016544	7	103234926 - 103234927	7	103594479 - 103594480	1016544	1007038		NC_000007.14:103594478:CC:TA
NM_005045.4(RELN):c.1289+4dup	RELN		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Uncertain significance(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000948859	7	103322558 - 103322559	7	103682111 - 103682112	948859	940865		NC_000007.14:103682111:TT:TTT
NM_005045.4(RELN):c.3955_3957dup (p.Val1319dup)	RELN		Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome	Uncertain significance(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000940903	7	103230230 - 103230231	7	103589783 - 103589784	940903	933566		NC_000007.14:103589783:AAC:AACAAC
NM_005045.4(RELN):c.52_63dup (p.Gly18_Leu21dup)	RELN		Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome	Uncertain significance(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV000935682	7	103629740 - 103629741	7	103989293 - 103989294	935682	933578		NC_000007.14:103989293:CAGCGTCGCCCCCAGC:CAGCGTCGCCCCCAGCGTCGCCCCCAGC
NM_005045.4(RELN):c.3463dup (p.Leu1155fs)	RELN	L1155fs	Epilepsy, familial temporal lobe, 7	Likely pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000930436	7	103236978 - 103236979	7	103596531 - 103596532	930436	919067		NC_000007.14:103596531:GG:GGG
NM_005045.4(RELN):c.2086dup (p.Ser696fs)	RELN	S696fs	Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome	Pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV000859187	7	103276898 - 103276899	7	103636451 - 103636452	859187	832713		NC_000007.14:103636451:AAAA:AAAAA
NM_005045.4(RELN):c.3485dup (p.Ile1163fs)	RELN	I1163fs	Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome	Pathogenic(Last reviewed: Feb 10, 2020)	criteria provided, single submitter	VCV000840300	7	103236956 - 103236957	7	103596509 - 103596510	840300	832697		NC_000007.14:103596509:CCCCC:CCCCCC
NC_000007.14:g.(?_103589576)_(103610827_?)dup	RELN		Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome	Likely pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000831042	7	103230023 - 103251274			831042	819771		
NM_005045.4(RELN):c.3913-6dup	RELN		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Likely benign(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV000766936	7	103230280 - 103230281	7	103589833 - 103589834	766936	777600	rs781655960	NC_000007.14:103589833:AAAA:AAAAA
NM_005045.4(RELN):c.7668+8_7668+9delinsAG	RELN		Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome|not provided	Likely benign(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000763139	7	103162460 - 103162461	7	103522013 - 103522014	763139	775266	rs1584261648	NC_000007.14:103522012:AA:CT
NM_005045.4(RELN):c.7350-6dup	RELN		not provided|Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Likely benign(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000755043	7	103163983 - 103163984	7	103523536 - 103523537	755043	775311	rs1325259154	NC_000007.14:103523536:AA:AAA
NM_005045.4(RELN):c.4937-9_4937-8insG	RELN		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Likely benign(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000743874	7	103206006 - 103206007	7	103565559 - 103565560	743874	759617	rs1584300778	NC_000007.14:103565559::C
NM_005045.4(RELN):c.8951-11_8951-8dup	RELN|SLC26A5-AS1		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Likely benign(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000542602	7	103137222 - 103137223	7	103496775 - 103496776	542602	522677	rs1554364085	NC_000007.14:103496775:AACAAA:AACAAACAAA
NM_005045.4(RELN):c.656+7dup	RELN		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7|not provided	Likely benign(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000542597	7	103389865 - 103389866	7	103749418 - 103749419	542597	522351	rs768445353	NC_000007.14:103749418:AA:AAA
NM_005045.4(RELN):c.4937-5_4937-4dup	RELN		not provided|Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7|not specified	Benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000475969	7	103206001 - 103206002	7	103565554 - 103565555	475969	456209	rs35268159	NC_000007.14:103565554:AAAAAAAAAAA:AAAAAAAAAAAAA
NM_005045.4(RELN):c.4937-4dup	RELN		Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome|Lissencephaly, Recessive|not specified	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000358398	7	103206001 - 103206002	7	103565554 - 103565555	358398	309305	rs35268159	NC_000007.14:103565554:AAAAAAAAAAA:AAAAAAAAAAAA
NM_005045.4(RELN):c.329dup (p.Gly111fs)	RELN	G111fs	Norman-Roberts syndrome	Pathogenic(Last reviewed: Sep 4, 2014)	criteria provided, single submitter	VCV000212035	7	103557529 - 103557530	7	103917082 - 103917083	212035	207457	rs797045912	NC_000007.14:103917082:AAA:AAAA
NM_005045.4(RELN):c.2466-7dup	RELN		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7|not specified	Benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000195496	7	103270629 - 103270630	7	103630182 - 103630183	195496	192657	rs571882672	NC_000007.14:103630182:AAAAAAAAAAA:AAAAAAAAAAAA
NM_005045.4(RELN):c.5195_5208dup (p.Ile1737fs)	RELN	I1737fs	Norman-Roberts syndrome	Pathogenic(Last reviewed: Jun 12, 2013)	criteria provided, single submitter	VCV000130111	7	103205726 - 103205727	7	103565279 - 103565280	130111	135557	rs587780436	NC_000007.14:103565279:GGTGGAGAGTGGAAGGT:GGTGGAGAGTGGAAGGTGGAGAGTGGAAGGT
NM_005045.4(RELN):c.1290-3dup	RELN		Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome|Lissencephaly, Recessive|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095210	7	103301976 - 103301977	7	103661529 - 103661530	95210	101110	rs146986040	NC_000007.14:103661529:AAAAAAAAA:AAAAAAAAAA
NC_000016.9:g.(?_624055)_(2153916_?)dup	RHOT2|CLCN7|TPSG1|C1QTNF8|CHTF18|TPSB2|TMEM204|WFIKKN1|HS3ST6|FAHD1|TELO2|ZNF598|CCDC154|NTHL1|GFER|MSLN|ANTKMT|BAIAP3|RNF151|EME2|GNG13|RPUSD1|GNPTG|SOX8|TPSD1|SSTR5|MAPK8IP3|NPW|JMJD8|PRR25|SPSB3|TPSAB1|RPL3L|MSRB1|PTX4|MEIOB|MCRIP2|UBE2I|CIAO3|CCDC78|TSC2|METTL26|WDR90|RAB40C|STUB1|LMF1|IFT140|HAGHL|IGFALS|RHBDL1|PIGQ|MIR1225|SNHG9|MRPS34|NDUFB10|SLC9A3R2|NUBP2|NOXO1|PKD1|HAGH|UNKL|TBL3|C16orf91|RPS2|NME3|CACNA1H|JPT2|CRAMP1|WDR24|SYNGR3|TSR3|METRN|FBXL16		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV|Epilepsy	Uncertain significance(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV001017417	16	624055 - 2153916			1017417	1001786		
NC_000006.12:g.(?_33173681)_(33451926_?)dup	RING1|RPS18|RXRB|VPS52|TAPBP|SLC39A7|HSD17B8|B3GALT4|SYNGAP1|WDR46|ZBTB22|PFDN6|CUTA|MIR219A1|COL11A2|DAXX|KIFC1|PHF1|RGL2		Mental retardation, autosomal dominant 5	Uncertain significance(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000831717	6	33141458 - 33419703			831717	819682		
NM_024589.3(ROGDI):c.652dup (p.Arg218fs)	ROGDI	R218fs	Amelocerebrohypohidrotic syndrome	Pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001072900	16	4847981 - 4847982	16	4797980 - 4797981	1072900	1063647		NC_000016.10:4797980:GG:GGG
NM_024589.3(ROGDI):c.117+6_117+7delinsAT	ROGDI		Amelocerebrohypohidrotic syndrome	Uncertain significance(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV000958701	16	4852376 - 4852377	16	4802375 - 4802376	958701	960161		NC_000016.10:4802374:TC:AT
NM_024589.3(ROGDI):c.775_795dup (p.Val259_Leu265dup)	ROGDI		Amelocerebrohypohidrotic syndrome	Uncertain significance(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV000934929	16	4847741 - 4847742	16	4797740 - 4797741	934929	937456		NC_000016.10:4797740:CAGGGAGACGGTGAAGTAGACCAGGG:CAGGGAGACGGTGAAGTAGACCAGGGAGACGGTGAAGTAGACCAGGG
NM_024589.3(ROGDI):c.432+1dup	ROGDI		Amelocerebrohypohidrotic syndrome	Likely pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000930998	16	4849685 - 4849686	16	4799684 - 4799685	930998	920362		NC_000016.10:4799684:CC:CCC
NC_000016.9:g.(?_4847441)_(4852592_?)dup	ROGDI		Amelocerebrohypohidrotic syndrome	Uncertain significance(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000656288	16	4847441 - 4852592	16	4797440 - 4802591	656288	652856		
NM_024589.3(ROGDI):c.302_308dup (p.Glu104fs)	ROGDI	E104fs	Amelocerebrohypohidrotic syndrome	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000654553	16	4850526 - 4850527	16	4800525 - 4800526	654553	644705	rs1596277148	NC_000016.10:4800525:CGGAAGGCG:CGGAAGGCGGAAGGCG
NM_024589.3(ROGDI):c.665dup (p.Ala223fs)	ROGDI	A223fs	Amelocerebrohypohidrotic syndrome	Pathogenic(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000530797	16	4847968 - 4847969	16	4797967 - 4797968	530797	530316	rs1039568775	NC_000016.10:4797967:CCCCC:CCCCCC
NM_024589.3(ROGDI):c.506_507dup (p.Glu170fs)	ROGDI	E170fs	Amelocerebrohypohidrotic syndrome	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000453294	16	4848593 - 4848594	16	4798592 - 4798593	453294	446891	rs786205124	NC_000016.10:4798592:GGGG:GGGGGG
NM_134261.3(RORA):c.867_876dup (p.Glu293fs)	RORA|RORA-AS1	E293fs, E238fs, E318fs, E326fs	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000807672	15	60797772 - 60797773	15	60505573 - 60505574	807672	798688	rs1595874842	NC_000015.10:60505573:TCTCAAGTATT:TCTCAAGTATTCTCAAGTATT
NM_134261.3(RORA):c.821-17_827delinsGCTTTCGTGTTTG	RORA|RORA-AS1		Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	Likely pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000636257	15	60797822 - 60797845	15	60505623 - 60505646	636257	624068	rs1595874995	NC_000015.10:60505622:AGGTGTTCTAAGGAGAAAACGGGA:CAAACACGAAAGC
NM_006914.4(RORB):c.357dup (p.Arg120fs)	RORB	R120fs, R131fs	Epilepsy, idiopathic generalized, susceptibility to, 15	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000807673	9	77257449 - 77257450	9	74642533 - 74642534	807673	798621	rs1587401875	NC_000009.12:74642533:CC:CCC
SAMD12, 5-BP INS, TTTCA(n), IVS4	SAMD12		Epilepsy, familial adult myoclonic, 1	Pathogenic(Last reviewed: Oct 31, 2019)	no assertion criteria provided	VCV000560216					560216	551266		
NC_000002.11:g.(?_200136934)_(200320760_?)dup	SATB2		Chromosome 2q32-q33 deletion syndrome	Likely benign(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV001139590	2	200136934 - 200320760			1139590	1109167		
NC_000002.11:g.(?_200213424)_(200246543_?)dup	SATB2		Chromosome 2q32-q33 deletion syndrome	Likely pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV001066450	2	200213424 - 200246543			1066450	1054287		
NC_000002.11:g.(?_200320572)_(200320780_?)dup	SATB2		Chromosome 2q32-q33 deletion syndrome	Likely pathogenic(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV001066449	2	200320572 - 200320780			1066449	1054288		
NC_000002.11:g.(?_200136914)_(200298257_?)dup	SATB2		Chromosome 2q32-q33 deletion syndrome	Uncertain significance(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV001023605	2	200136914 - 200298257			1023605	1001405		
NM_001172509.2(SATB2):c.1329_1347dup (p.Ser450fs)	SATB2	S450fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000958421	2	200193459 - 200193460	2	199328736 - 199328737	958421	942543		NC_000002.12:199328736:GGAGACCATGCTCACATTGGGA:GGAGACCATGCTCACATTGGGAGACCATGCTCACATTGGGA
NC_000002.12:g.(?_199380344)_(199433534_?)dup	SATB2		Chromosome 2q32-q33 deletion syndrome	Likely pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000832126	2	200245067 - 200298257			832126	819095		
NM_001172509.2(SATB2):c.553_554insT (p.Glu185fs)	SATB2	E185fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000807483	2	200245130 - 200245131	2	199380407 - 199380408	807483	798493	rs1574566833	NC_000002.12:199380407::A
NM_001172509.2(SATB2):c.2018dup (p.His673fs)	SATB2	H673fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	no assertion criteria provided	VCV000584425	2	200137117 - 200137118	2	199272394 - 199272395	584425	575477	rs1559136015	NC_000002.12:199272394:T:TT
NM_001172509.2(SATB2):c.1945dup (p.Ser649fs)	SATB2	S649fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	no assertion criteria provided	VCV000584424	2	200137190 - 200137191	2	199272467 - 199272468	584424	575478	rs1559136052	NC_000002.12:199272467:AAA:AAAA
NM_001172509.2(SATB2):c.598-13dup	SATB2		Chromosome 2q32-q33 deletion syndrome	Benign(Last reviewed: Nov 7, 2020)	criteria provided, single submitter	VCV000469562	2	200233433 - 200233434	2	199368710 - 199368711	469562	450206	rs199978702	NC_000002.12:199368710:AAAAAAAAAA:AAAAAAAAAAA
NM_001172509.2(SATB2):c.1592dup (p.Asn531fs)	SATB2	N531fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000469544	2	200173630 - 200173631	2	199308907 - 199308908	469544	450196	rs1553544158	NC_000002.12:199308907:TTTT:TTTTT
NC_000002.11:g.(?_200173463)_(200320780_?)dup	SATB2		Chromosome 2q32-q33 deletion syndrome	Uncertain significance(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000469539	2	200173463 - 200320780	2	199308740 - 199456057	469539	448529		
NM_001172509.1(SATB2):c.170_346dup	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000218098	2	200298061 - 200298237	2	199391823 - 199446462	218098	214752		
NC_000002.12:g.(199364049_199364051)_(199399060_199399062)dup	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000217315	2	200228772 - 200263785	2	199364049 - 199399062	217315	213969		
NC_000004.11:g.(?_77116850)_(77134696_?)dup	SCARB2		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001064197	4	77116850 - 77134696			1064197	1039065		
NC_000004.11:g.(?_77082846)_(77102274_?)dup	SCARB2		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001011186	4	77082846 - 77102274			1011186	986271		
NM_005506.4(SCARB2):c.108dup (p.Ile37fs)	SCARB2	I37fs	Epilepsy, progressive myoclonic 4, with or without renal failure	Likely pathogenic(Last reviewed: Jun 7, 2020)	no assertion criteria provided	VCV000993025	4	77134588 - 77134589	4	76213435 - 76213436	993025	980915		NC_000004.12:76213435:A:AA
NM_005506.4(SCARB2):c.1002dup (p.Ile335fs)	SCARB2	I192fs, I335fs	Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, single submitter	VCV000938927	4	77091130 - 77091131	4	76169977 - 76169978	938927	932441		NC_000004.12:76169977:GGG:GGGG
NC_000004.11:g.(?_77082846)_(77102274_?)dup	SCARB2		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000583450	4	77082846 - 77102274	4	76161693 - 76181121	583450	559704		
NC_000004.11:g.(?_77116840)_(77134716_?)dup	SCARB2		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000531812	4	77116840 - 77134716	4	76195687 - 76213563	531812	519942		
NM_005506.4(SCARB2):c.367dup (p.Gln123fs)	SCARB2	Q123fs	Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 21, 2016)	no assertion criteria provided	VCV000453288	4	77102162 - 77102163	4	76181009 - 76181010	453288	446885	rs1553948516	NC_000004.12:76181009:GG:GGG
NM_005506.4(SCARB2):c.1385_1390delinsATGCATGCACC (p.Gly462fs)	SCARB2	G462fs, G319fs	Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268147	4	77084386 - 77084391	4	76163233 - 76163238	268147	263763	rs886041079	NC_000004.12:76163232:TGGATC:GGTGCATGCAT
NM_005506.4(SCARB2):c.1016dup (p.His341fs)	SCARB2	H198fs, H341fs	Epilepsy, progressive myoclonic 4, with or without renal failure|not provided	Pathogenic(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV000268142	4	77091116 - 77091117	4	76169963 - 76169964	268142	263766	rs886041077	NC_000004.12:76169963:AAA:AAAA
NM_005506.4(SCARB2):c.1187+2dup	SCARB2		Epilepsy, progressive myoclonic 4, with or without renal failure|Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000030259	4	77089553 - 77089554	4	76168400 - 76168401	30259	39215	rs727502783	NC_000004.12:76168400:A:AA
NM_001165963.4(SCN1A):c.1423_1424delinsCT (p.Ala475Leu)	SCN1A	A474L, A475L	Generalized epilepsy with febrile seizures plus, type 2|Severe myoclonic epilepsy in infancy	Conflicting interpretations of pathogenicity	criteria provided, conflicting interpretations	VCV001164075	2	166901791 - 166901792	2	166045281 - 166045282	1164075	1153075		NC_000002.12:166045280:GC:AG
NM_001165963.4(SCN1A):c.2680dup (p.Thr894fs)	SCN1A	T80fs, T865fs, T866fs, T882fs, T883fs, T894fs	Severe myoclonic epilepsy in infancy	Pathogenic	criteria provided, single submitter	VCV000981239	2	166894551 - 166894552	2	166038041 - 166038042	981239	969323		NC_000002.12:166038041:TT:TTT
NM_001165963.4(SCN1A):c.1164delinsGG (p.Tyr388Ter)	SCN1A	Y388*	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000870157	2	166904143	2	166047633	870157	858339		NC_000002.12:166047632:A:CC
NM_001165963.4(SCN1A):c.689_690insG (p.Ile230fs)	SCN1A	I230fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000870156	2	166909366 - 166909367	2	166052856 - 166052857	870156	858340		NC_000002.12:166052856::C
NM_001165963.4(SCN1A):c.126dup (p.Asp43fs)	SCN1A	D43fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801826	2	166930005 - 166930006	2	166073495 - 166073496	801826	790123	rs1553560831	NC_000002.12:166073495:TTTTTT:TTTTTTT
NM_001165963.4(SCN1A):c.1810dup (p.Arg604fs)	SCN1A	R604fs, R603fs	Severe myoclonic epilepsy in infancy	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801811	2	166900411 - 166900412	2	166043901 - 166043902	801811	790108	rs1574217232	NC_000002.12:166043901:GG:GGG
NC_000002.11:g.(?_166929868)_(167056374_?)dup	SCN1A|SCN1A-AS1|SCN9A		Early infantile epileptic encephalopathy with suppression bursts|Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000584051	2	166929868 - 167056374	2	166073358 - 166199864	584051	557473		
NM_001165963.4(SCN1A):c.3971dup (p.Arg1325fs)	SCN1A|LOC102724058	R1313fs, R1325fs, R511fs, R1297fs, R1296fs, R1314fs	Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000569941	2	166866259 - 166866260	2	166009749 - 166009750	569941	557616	rs1559140306	NC_000002.12:166009749:A:AA
NM_001165963.4(SCN1A):c.3690dup (p.Ser1231Ter)	SCN1A|LOC102724058	S1203*, S1231*, S1202*, S1219*, S1220*, S417*	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000375516	2	166870268 - 166870269	2	166013758 - 166013759	375516	362324	rs1057519534	NC_000002.12:166013758:AA:AAA
NM_001165963.4(SCN1A):c.2177-11dup	SCN1A		Epilepsy|not provided|Familial hemiplegic migraine|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000331890	2	166897989 - 166897990	2	166041479 - 166041480	331890	282540	rs11394960	NC_000002.12:166041479:AAAAAAAAAAAAAA:AAAAAAAAAAAAAAA
NM_001165963.4(SCN1A):c.2177-8dup	SCN1A		not provided|Epilepsy|Familial hemiplegic migraine	Likely benign(Last reviewed: Jul 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000331889	2	166897986 - 166897987	2	166041476 - 166041477	331889	284808	rs747086735	NC_000002.12:166041476:AA:AAA
NM_001165963.4(SCN1A):c.602+6_602+7dup	SCN1A		Early infantile epileptic encephalopathy with suppression bursts|not specified	Benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257623	2	166911140 - 166911141	2	166054630 - 166054631	257623	250344	rs577627288	NC_000002.12:166054630:CAC:CACAC
NM_001165963.4(SCN1A):c.992dup (p.Leu331fs)	SCN1A	L331fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jul 13, 2015)	criteria provided, single submitter	VCV000217249	2	166905431 - 166905432	2	166048921 - 166048922	217249	213803	rs863225038	NC_000002.12:166048921:AAAAAA:AAAAAAA
NM_001165963.4(SCN1A):c.1053dup (p.Val352fs)	SCN1A	V352fs	not provided	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	VCV000206951	2	166904253 - 166904254	2	166047743 - 166047744	206951	201596	rs796053106	NC_000002.12:166047743:A:AA
NM_001165963.4(SCN1A):c.5708_5711dup (p.Pro1905fs)	SCN1A|LOC102724058	P1894fs, P1905fs, P1876fs, P1893fs, P1877fs, P1091fs	Early infantile epileptic encephalopathy with suppression bursts|not provided	Pathogenic(Last reviewed: Apr 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000206924	2	166848073 - 166848074	2	165991563 - 165991564	206924	201428	rs796053086	NC_000002.12:165991563:TGAT:TGATTGAT
NM_001165963.4(SCN1A):c.4896dup (p.Thr1633fs)	SCN1A|LOC102724058	T1604fs, T1621fs, T1622fs, T1633fs, T819fs, T1605fs	not provided	Pathogenic(Last reviewed: Feb 4, 2014)	criteria provided, single submitter	VCV000206922	2	166848888 - 166848889	2	165992378 - 165992379	206922	201462	rs796053084	NC_000002.12:165992378:A:AA
NM_001165963.4(SCN1A):c.3853dup (p.Cys1285fs)	SCN1A|LOC102724058	C1273fs, C1274fs, C1256fs, C1257fs, C471fs, C1285fs	not provided	Pathogenic(Last reviewed: May 22, 2014)	criteria provided, single submitter	VCV000206912	2	166868644 - 166868645	2	166012134 - 166012135	206912	201512	rs796053074	NC_000002.12:166012134:A:AA
NM_001165963.4(SCN1A):c.3776dup (p.Thr1260fs)	SCN1A|LOC102724058	T1232fs, T1249fs, T446fs, T1260fs, T1248fs, T1231fs	not provided	Pathogenic(Last reviewed: Jun 26, 2014)	criteria provided, single submitter	VCV000206911	2	166868721 - 166868722	2	166012211 - 166012212	206911	201515	rs796053073	NC_000002.12:166012211:AAAA:AAAAA
NM_001165963.4(SCN1A):c.3268dup (p.Ser1090fs)	SCN1A|LOC102724058	S1061fs, S1062fs, S276fs, S1078fs, S1079fs, S1090fs	not provided	Pathogenic(Last reviewed: Dec 26, 2014)	criteria provided, single submitter	VCV000206908	2	166892718 - 166892719	2	166036208 - 166036209	206908	201530	rs796053070	NC_000002.12:166036208:T:TT
NM_001165963.4(SCN1A):c.1850_1851delinsAT (p.Arg617Asn)	SCN1A	R616N, R617N	not specified	Uncertain significance(Last reviewed: Sep 9, 2014)	criteria provided, single submitter	VCV000206901	2	166900371 - 166900372	2	166043861 - 166043862	206901	201562	rs796053063	NC_000002.12:166043860:TC:AT
NM_001165963.4(SCN1A):c.1537dup (p.Glu513fs)	SCN1A	E513fs, E512fs	not provided	Pathogenic(Last reviewed: Aug 28, 2014)	criteria provided, single submitter	VCV000206897	2	166901677 - 166901678	2	166045167 - 166045168	206897	201574	rs796053059	NC_000002.12:166045167:CCCC:CCCCC
NM_001165963.4(SCN1A):c.1247_1248insGTAGA (p.Asn416delinsLysTer)	SCN1A		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000206894	2	166903409 - 166903410	2	166046899 - 166046900	206894	201584	rs796053056	NC_000002.12:166046899:T:TCTACT
NM_001165963.4(SCN1A):c.602+2dup	SCN1A		not provided|Early infantile epileptic encephalopathy with suppression bursts	Conflicting interpretations of pathogenicity(Last reviewed: Oct 18, 2016)	criteria provided, conflicting interpretations	VCV000206892	2	166911145 - 166911146	2	166054635 - 166054636	206892	201619	rs796053054	NC_000002.12:166054635:A:AA
NM_001165963.4(SCN1A):c.305dup (p.Ser103fs)	SCN1A	S103fs	not provided	Pathogenic(Last reviewed: Oct 14, 2013)	criteria provided, single submitter	VCV000206889	2	166915157 - 166915158	2	166058647 - 166058648	206889	201630	rs796053051	NC_000002.12:166058647:AA:AAA
NM_001165963.4(SCN1A):c.384_1662dup	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190027					190027	187889		
NM_001165963.4(SCN1A):c.930_931dup (p.Glu311fs)	SCN1A	E311fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190020	2	166908261 - 166908262	2	166051751 - 166051752	190020	187856	rs794726846	NC_000002.12:166051751:CA:CACA
NM_001165963.4(SCN1A):c.2318_2319insT (p.Ile774fs)	SCN1A	I745fs, I774fs, I746fs, I762fs, I763fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189989	2	166897837 - 166897838	2	166041327 - 166041328	189989	187810	rs794726820	NC_000002.12:166041327::A
NM_001165963.4(SCN1A):c.825_826insGTATA (p.Lys276delinsValTer)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189979	2	166908367 - 166908368	2	166051857 - 166051858	189979	187859	rs794726812	NC_000002.12:166051857::TATAC
NM_001165963.4(SCN1A):c.1182_1183insA (p.Ala395fs)	SCN1A	A395fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189940	2	166903474 - 166903475	2	166046964 - 166046965	189940	187838	rs794726777	NC_000002.12:166046964::T
NM_001165963.4(SCN1A):c.2299_2302dup (p.Pro768fs)	SCN1A	P739fs, P757fs, P768fs, P740fs, P756fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189909	2	166897853 - 166897854	2	166041343 - 166041344	189909	187812	rs794726750	NC_000002.12:166041343:GGTC:GGTCGGTC
NM_001165963.4(SCN1A):c.1660dup (p.Gln554fs)	SCN1A	Q554fs, Q553fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189868	2	166901554 - 166901555	2	166045044 - 166045045	189868	187827	rs794726717	NC_000002.12:166045044:GG:GGG
NM_001365536.1(SCN9A):c.2984_2985insC (p.Ile995_Lys996insTer)	SCN1A-AS1|SCN9A		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV001070653	2	167129275 - 167129276	2	166272765 - 166272766	1070653	1059079		NC_000002.12:166272765::G
NM_001365536.1(SCN9A):c.4775-47_4803dup	SCN1A-AS1|SCN9A		Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA	Uncertain significance(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV001019410	2	167056345 - 167056346	2	166199835 - 166199836	1019410	1003394		
NM_001365536.1(SCN9A):c.4629_4631delinsAGA (p.Met1543_Thr1544delinsIleAsp)	SCN1A-AS1|SCN9A		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000968165	2	167060608 - 167060610	2	166204098 - 166204100	968165	952769		NC_000002.12:166204097:GTC:TCT
NM_001365536.1(SCN9A):c.1320_1325dup (p.Ala444_Ala445dup)	SCN1A-AS1|SCN9A		Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA	Uncertain significance(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000847025	2	167143122 - 167143123	2	166286612 - 166286613	847025	825170		NC_000002.12:166286612:GCTGCA:GCTGCAGCTGCA
NM_001365536.1(SCN9A):c.4503+3dup	SCN1A-AS1|SCN9A		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Likely benign(Last reviewed: Sep 25, 2020)	criteria provided, single submitter	VCV000699431	2	167060860 - 167060861	2	166204350 - 166204351	699431	689676	rs759871579	NC_000002.12:166204350:TTTTTTT:TTTTTTTT
NM_001365536.1(SCN9A):c.1975-12_1975-11dup	SCN1A-AS1|SCN9A		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Likely benign(Last reviewed: Nov 12, 2020)	criteria provided, single submitter	VCV000696802	2	167138320 - 167138321	2	166281810 - 166281811	696802	685116	rs35888674	NC_000002.12:166281810:AAAAAAAAAA:AAAAAAAAAAAA
NM_001365536.1(SCN9A):c.2984delinsCC (p.Ile995fs)	SCN1A-AS1|SCN9A	I984fs, I995fs	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000663011	2	167129276	2	166272766	663011	628923	rs1574844397	NC_000002.12:166272765:A:GG
NM_001365536.1(SCN9A):c.5904_5906dup (p.Tyr1969Ter)	SCN1A-AS1|SCN9A	Y1969*, Y1958*	Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA	Uncertain significance(Last reviewed: Jul 28, 2019)	criteria provided, single submitter	VCV000642763	2	167055242 - 167055243	2	166198732 - 166198733	642763	628889	rs1574690079	NC_000002.12:166198732:TATT:TATTATT
NM_001365536.1(SCN9A):c.2875-6_2875-5delinsG	SCN1A-AS1|SCN9A		Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA	Uncertain significance(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000577786	2	167129390 - 167129391	2	166272880 - 166272881	577786	557672	rs1558999342	NC_000002.12:166272879:AT:C
NM_001365536.1(SCN9A):c.4869_4870delinsGA (p.Val1624Ile)	SCN1A-AS1|SCN9A	V1613I, V1624I	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV000538449	2	167056279 - 167056280	2	166199769 - 166199770	538449	516693	rs1553473301	NC_000002.12:166199768:CT:TC
NM_001365536.1(SCN9A):c.3400_3405dup (p.Leu1134_Pro1135dup)	SCN1A-AS1|SCN9A		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV000471111	2	167108341 - 167108342	2	166251831 - 166251832	471111	449089	rs749806397	NC_000002.12:166251831:AGGCAAAGG:AGGCAAAGGCAAAGG
NM_001365536.1(SCN9A):c.2109dup (p.Glu704Ter)	SCN1A-AS1|SCN9A	E704*, E693*	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV000471093	2	167137100 - 167137101	2	166280590 - 166280591	471093	449181	rs779327684	NC_000002.12:166280590:AA:AAA
NM_001365536.1(SCN9A):c.5897_5900dup (p.Lys1968fs)	SCN1A-AS1|SCN9A	K1968fs, K1957fs	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000408579	2	167055248 - 167055249	2	166198738 - 166198739	408579	391614	rs1060502049	NC_000002.12:166198738:TCTTT:TCTTTCTTT
NM_001365536.1(SCN9A):c.4503+8_4503+9insT	SCN1A-AS1|SCN9A		Congenital Indifference to Pain|Familial febrile seizures|Inherited Erythromelalgia|Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|Paroxysmal extreme pain disorder|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|Severe myoclonic epilepsy in infancy	Conflicting interpretations of pathogenicity(Last reviewed: Jul 24, 2020)	criteria provided, conflicting interpretations	VCV000331962	2	167060861 - 167060862	2	166204351 - 166204352	331962	285355	rs767624579	NC_000002.12:166204351::A
NM_001365536.1(SCN9A):c.*165_*167dup	SCN1A-AS1|SCN9A		Congenital Indifference to Pain|Severe myoclonic epilepsy in infancy|Paroxysmal extreme pain disorder|Small fiber neuropathy|Familial febrile seizures|Inherited Erythromelalgia|Generalized epilepsy with febrile seizures plus	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331956	2	167055014 - 167055015	2	166198504 - 166198505	331956	283293	rs886055049	NC_000002.12:166198504:CATC:CATCATC
NM_001365536.1(SCN9A):c.*798dup	SCN1A-AS1|SCN9A		Severe myoclonic epilepsy in infancy|Paroxysmal extreme pain disorder|Familial febrile seizures|Congenital Indifference to Pain|Inherited Erythromelalgia|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331942	2	167054383 - 167054384	2	166197873 - 166197874	331942	283258	rs564394161	NC_000002.12:166197873:TTTTTTTT:TTTTTTTTT
NM_001365536.1(SCN9A):c.*1960_*1962dup	SCN1A-AS1|SCN9A		Small fiber neuropathy|Familial febrile seizures|Severe myoclonic epilepsy in infancy|Congenital Indifference to Pain|Inherited Erythromelalgia|Paroxysmal extreme pain disorder|Generalized epilepsy with febrile seizures plus	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331924	2	167053219 - 167053220	2	166196709 - 166196710	331924	283206	rs202073550	NC_000002.12:166196709:CAACA:CAACAACA
NM_001365536.1(SCN9A):c.1975-12dup	SCN1A-AS1|SCN9A		Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|Severe myoclonic epilepsy in infancy|Paroxysmal extreme pain disorder|not provided|Severe myoclonic epilepsy in infancy|Primary erythromelalgia|Generalized epilepsy with febrile seizures plus, type 7|not specified|Hereditary sensory and autonomic neuropathy type IIA|Inherited Erythromelalgia|Congenital Indifference to Pain|Familial febrile seizures	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000167661	2	167138320 - 167138321	2	166281810 - 166281811	167661	178058	rs35888674	NC_000002.12:166281810:AAAAAAAAAA:AAAAAAAAAAA
NM_001040142.2(SCN2A):c.3400-4dup	SCN2A		Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001127623	2	166221645 - 166221646	2	165365135 - 165365136	1127623	1111444		NC_000002.12:165365135:TTTT:TTTTT
NM_001040142.2(SCN2A):c.4533dup (p.Pro1512fs)	SCN2A	P1512fs	Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV001073234	2	166237684 - 166237685	2	165381174 - 165381175	1073234	1059011		NC_000002.12:165381174:AAAAA:AAAAAA
NM_001040142.2(SCN2A):c.1970_1971insGTGCAATGTGTGAGGG (p.Gly658_Gly659insCysAsnValTer)	SCN2A		Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Aug 30, 2020)	criteria provided, single submitter	VCV001069977	2	166179964 - 166179965	2	165323454 - 165323455	1069977	1059009		NC_000002.12:165323454::GTGCAATGTGTGAGGG
NM_001040142.2(SCN2A):c.1395_1406dup (p.Ala466_Ala469dup)	SCN2A		Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001045606	2	166171987 - 166171988	2	165315477 - 165315478	1045606	1023822		NC_000002.12:165315477:CTGCAGCCGCATCTGC:CTGCAGCCGCATCTGCAGCCGCATCTGC
NC_000002.11:g.(?_166210692)_(166226819_?)dup	SCN2A		Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV001008193	2	166210692 - 166226819			1008193	986185		
NM_001040142.2(SCN2A):c.3913dup (p.Leu1305fs)	SCN2A	L1305fs	Seizures, benign familial infantile, 3	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000976355	2	166229795 - 166229796	2	165373285 - 165373286	976355	964173		NC_000002.12:165373285:CCC:CCCC
NM_001040142.2(SCN2A):c.4389dup (p.Thr1464fs)	SCN2A	T1464fs	Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000857716	2	166237179 - 166237180	2	165380669 - 165380670	857716	825085		NC_000002.12:165380669:TTT:TTTT
NM_001040142.2(SCN2A):c.1019dup (p.Asn340fs)	SCN2A	N340fs	Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000848371	2	166168581 - 166168582	2	165312071 - 165312072	848371	825055		NC_000002.12:165312071:AA:AAA
NM_001040142.2(SCN2A):c.1396_1401dup (p.Ala466_Ala467dup)	SCN2A		Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Uncertain significance(Last reviewed: Apr 28, 2019)	criteria provided, single submitter	VCV000836884	2	166171989 - 166171990	2	165315479 - 165315480	836884	825057		NC_000002.12:165315479:GCAGCCGCA:GCAGCCGCAGCCGCA
NC_000002.12:g.(?_165295804)_(165389844_?)dup	SCN2A		Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Uncertain significance(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000831936	2	166152314 - 166246354			831936	819061		
NM_001040142.2(SCN2A):c.4343_4346dup (p.Met1449fs)	SCN2A	M1449fs	Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Apr 19, 2016)	criteria provided, single submitter	VCV000813736	2	166237134 - 166237135	2	165380624 - 165380625	813736	801977		NC_000002.12:165380624:TACAT:TACATACAT
NC_000002.11:g.(?_165946660)_(166246334_?)dup	SCN2A|SCN3A|LOC120977013		Early infantile epileptic encephalopathy 11|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000584355	2	165946660 - 166246334	2	165090150 - 165389824	584355	558070		
NM_001040142.2(SCN2A):c.709_711delinsTTG (p.Ile237Leu)	SCN2A	I237L	Early infantile epileptic encephalopathy 11|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000562197	2	166166844 - 166166846	2	165310334 - 165310336	562197	553374	rs1559353139	NC_000002.12:165310333:ATT:TTG
NC_000002.11:g.(?_165946640)_(166246354_?)dup	SCN2A|SCN3A|LOC120977013		Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Uncertain significance(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000533507	2	165946640 - 166246354	2	165090130 - 165389844	533507	516206		
NM_001040142.2(SCN2A):c.4270dup (p.Trp1424fs)	SCN2A	W1424fs	Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000533497	2	166234121 - 166234122	2	165377611 - 165377612	533497	516513	rs1553461662	NC_000002.12:165377611:T:TT
NC_000002.11:g.(?_166152283)_(166246384_?)dup	SCN2A		Seizures, benign familial infantile, 3	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495276	2	166152283 - 166246384	2	165295773 - 165389874	495276	486732		
NM_001040142.2(SCN2A):c.1198dup (p.Thr400fs)	SCN2A	T400fs	Early infantile epileptic encephalopathy 11|Seizures, benign familial infantile, 3	Pathogenic(Last reviewed: Oct 20, 2019)	criteria provided, single submitter	VCV000410976	2	166170429 - 166170430	2	165313919 - 165313920	410976	391571	rs1553568927	NC_000002.12:165313919:AAAA:AAAAA
NM_001040142.2(SCN2A):c.-51-1721_-51-1720dup	SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331724	2	166150550 - 166150551	2	165294040 - 165294041	331724	285069	rs1553563950	NC_000002.12:165294040:TTTTTTTTTTTTT:TTTTTTTTTTTTTTT
NM_001040142.2(SCN2A):c.-51-1720dup	SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331723	2	166150550 - 166150551	2	165294040 - 165294041	331723	284630	rs1553563950	NC_000002.12:165294040:TTTTTTTTTTTTT:TTTTTTTTTTTTTT
NM_001040142.2(SCN2A):c.-51-1733_-51-1732insGATT	SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331722	2	166150550 - 166150551	2	165294040 - 165294041	331722	283043	rs780674346	NC_000002.12:165294040::GATT
NM_001040142.2(SCN2A):c.-51-1733_-51-1732insGAT	SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331721	2	166150550 - 166150551	2	165294040 - 165294041	331721	282360	rs780674346	NC_000002.12:165294040::GAT
NM_001040142.2(SCN2A):c.-51-1733_-51-1732insAGATT	SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331720	2	166150550 - 166150551	2	165294040 - 165294041	331720	285062	rs780674346	NC_000002.12:165294040::AGATT
NM_001040142.2(SCN2A):c.-51-1733_-51-1732insAATTT	SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331719	2	166150550 - 166150551	2	165294040 - 165294041	331719	285055	rs780674346	NC_000002.12:165294040::AATTT
NM_001040142.2(SCN2A):c.-51-1733_-51-1732insAATT	SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331718	2	166150550 - 166150551	2	165294040 - 165294041	331718	282359	rs780674346	NC_000002.12:165294040::AATT
NM_001040142.2(SCN2A):c.-51-1733_-51-1732insAAT	SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331717	2	166150550 - 166150551	2	165294040 - 165294041	331717	282355	rs780674346	NC_000002.12:165294040::AAT
NM_001040142.2(SCN2A):c.-51-1733_-51-1732insAAAT	SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331716	2	166150550 - 166150551	2	165294040 - 165294041	331716	282354	rs780674346	NC_000002.12:165294040::AAAT
NM_001040142.2(SCN2A):c.-51-1733_-51-1732insAA	SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331715	2	166150549 - 166150550	2	165294039 - 165294040	331715	283042	rs1553563951	NC_000002.12:165294039:A:AAA
NM_001040142.2(SCN2A):c.-51-1733_-51-1732dup	SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331714	2	166150549 - 166150550	2	165294039 - 165294040	331714	284613	rs886054996	NC_000002.12:165294039:AT:ATAT
NM_004588.5(SCN2B):c.625_626delinsCC (p.Asn209Pro)	SCN2B	N209P	not specified|Atrial fibrillation, familial, 14	Uncertain significance(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000422854	11	118037624 - 118037625	11	118166909 - 118166910	422854	408276	rs1064796044	NC_000011.10:118166908:TT:GG
NC_000002.11:g.(?_165984121)_(166246354_?)dup	SCN3A|SCN2A		Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11|not provided	Uncertain significance(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV001015627	2	165984121 - 166246354			1015627	1001395		
NC_000002.11:g.165492423_165973543dup	SCN3A|COBLL1|SLC38A11		Epilepsy	Uncertain significance(Last reviewed: Apr 9, 2019)	no assertion criteria provided	VCV000635918	2	165492423 - 165973543			635918	623731		
NM_001330260.2(SCN8A):c.4443_4444delinsTG (p.Met1481_Thr1482delinsIleAla)	SCN8A		Early infantile epileptic encephalopathy 13	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000870200	12	52184205 - 52184206	12	51790421 - 51790422	870200	858352		NC_000012.12:51790420:GA:TG
NM_001330260.2(SCN8A):c.4146_4147dup (p.Asn1383fs)	SCN8A	N1383fs, N1342fs	Early infantile epileptic encephalopathy 13|not provided	Uncertain significance(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000448893	12	52180528 - 52180529	12	51786744 - 51786745	448893	442469	rs1555228380	NC_000012.12:51786744:GA:GAGA
NM_001365536.1(SCN9A):c.2667dup (p.Lys890Ter)	SCN9A|SCN1A-AS1	K879*, K890*	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV001075796	2	167133699 - 167133700	2	166277189 - 166277190	1075796	1059080		NC_000002.12:166277189:A:AA
NM_001365536.1(SCN9A):c.4740_4743dup (p.Asp1582delinsPheTer)	SCN9A|SCN1A-AS1		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV001070796	2	167060495 - 167060496	2	166203985 - 166203986	1070796	1059077		NC_000002.12:166203985:AAAAA:AAAAAAAAA
NM_001365536.1(SCN9A):c.1026_1027delinsTT (p.Ser343Cys)	SCN9A|SCN1A-AS1	S343C	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001018572	2	167149821 - 167149822	2	166293311 - 166293312	1018572	1003430		NC_000002.12:166293310:TC:AA
NM_001365536.1(SCN9A):c.5568_5569delinsTT (p.Met1856_Asp1857delinsIleTyr)	SCN9A|SCN1A-AS1		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000968581	2	167055580 - 167055581	2	166199070 - 166199071	968581	952765		NC_000002.12:166199069:CC:AA
NM_001365536.1(SCN9A):c.5840_5842dup (p.Asp1947dup)	SCN9A|SCN1A-AS1		Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA	Uncertain significance(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000846419	2	167055306 - 167055307	2	166198796 - 166198797	846419	825104		NC_000002.12:166198796:CATC:CATCATC
NM_001365536.1(SCN9A):c.5836dup (p.Thr1946fs)	SCN9A|SCN1A-AS1	T1946fs, T1935fs	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000839063	2	167055312 - 167055313	2	166198802 - 166198803	839063	825105		NC_000002.12:166198802:TTTTTT:TTTTTTT
NC_000002.11:g.(?_167055131)_(167168316_?)dup	SCN9A|SCN1A-AS1		Severe myoclonic epilepsy in infancy	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495275	2	167055131 - 167168316	2	166198621 - 166311806	495275	486734		
NM_001365536.1(SCN9A):c.690_691delinsAT (p.Gly230_Leu231=)	SCN9A		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Likely benign(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000471162	2	167159810 - 167159811	2	166303300 - 166303301	471162	449211	rs1553495271	NC_000002.12:166303299:GG:AT
NM_001365536.1(SCN9A):c.5746_5749delinsAACT (p.Tyr1916_Ile1917delinsAsnLeu)	SCN9A|SCN1A-AS1		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000471150	2	167055400 - 167055403	2	166198890 - 166198893	471150	449149	rs1553472800	NC_000002.12:166198889:TGTA:AGTT
NM_001365536.1(SCN9A):c.2305_2323dup (p.Val775delinsAspTer)	SCN9A|SCN1A-AS1		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000471095	2	167136886 - 167136887	2	166280376 - 166280377	471095	448889	rs1553488759	NC_000002.12:166280376:CATTTTTGAATTCCTCAGTCATT:CATTTTTGAATTCCTCAGTCATTTTTGAATTCCTCAGTCATT
NM_001365536.1(SCN9A):c.1975-12_1975-5dup	SCN9A|SCN1A-AS1		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Likely benign(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000471091	2	167138320 - 167138321	2	166281810 - 166281811	471091	449231	rs35888674	NC_000002.12:166281810:AAAAAAAAAA:AAAAAAAAAAAAAAAAAA
NM_032108.4(SEMA6B):c.1950_1969dup (p.Arg657fs)	SEMA6B	R657fs	Epilepsy, progressive myoclonic, 11	Pathogenic(Last reviewed: May 12, 2020)	no assertion criteria provided	VCV000872932					872932	861067		
NM_015559.3(SETBP1):c.1677_1686dup (p.Pro563fs)	SETBP1	P563fs	Mental retardation, autosomal dominant 29	Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000982630	18	42530981 - 42530982	18	44951016 - 44951017	982630	971102		NC_000018.10:44951016:GTCTGCATAT:GTCTGCATATGTCTGCATAT
NM_015559.3(SETBP1):c.1082_1083dup (p.Phe362fs)	SETBP1	F362fs	Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000976037	18	42530386 - 42530387	18	44950421 - 44950422	976037	964499		NC_000018.10:44950421:CA:CACA
NM_015559.3(SETBP1):c.2016_2017insT (p.Lys673Ter)	SETBP1	K673*	Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	VCV000375633	18	42531321 - 42531322	18	44951356 - 44951357	375633	362448	rs1057519594	NC_000018.10:44951356::T
NM_014712.3(SETD1A):c.1287dup (p.Ser430fs)	SETD1A	S430fs	Epilepsy, early-onset, with or without developmental delay	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000976774	16	30976348 - 30976349	16	30965027 - 30965028	976774	964874		NC_000016.10:30965027:CC:CCC
NM_020708.5(SLC12A5):c.1492dup (p.Ala498fs)	SLC12A5	A498fs, A521fs	Early infantile epileptic encephalopathy 34	Pathogenic(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001071231	20	44673698 - 44673699	20	46045059 - 46045060	1071231	1064839		NC_000020.11:46045059:GGGG:GGGGG
NM_020708.5(SLC12A5):c.531_532insT (p.Gly178fs)	SLC12A5	G178fs, G201fs	Early infantile epileptic encephalopathy 34	Pathogenic(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV001070214	20	44665943 - 44665944	20	46037304 - 46037305	1070214	1064838		NC_000020.11:46037304::T
NM_020708.5(SLC12A5):c.42dup (p.Ala15fs)	SLC12A5	A15fs	Early infantile epileptic encephalopathy 34	Pathogenic(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000938667	20	44658024 - 44658025	20	46029385 - 46029386	938667	938989		NC_000020.11:46029385:A:AA
NM_020708.5(SLC12A5):c.2250dup (p.Arg751fs)	SLC12A5	R751fs, R774fs	Early infantile epileptic encephalopathy 34	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000848475	20	44680381 - 44680382	20	46051742 - 46051743	848475	848447		NC_000020.11:46051742:G:GG
NM_020708.5(SLC12A5):c.2548-5_2548-4delinsCT	SLC12A5		Early infantile epileptic encephalopathy 34	Likely benign(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV000747421	20	44682212 - 44682213	20	46053573 - 46053574	747421	760960	rs1600604943	NC_000020.11:46053572:TG:CT
NM_020708.5(SLC12A5):c.3126-3dup	SLC12A5		not provided|Early infantile epileptic encephalopathy 34	Likely benign(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV000542328	20	44685805 - 44685806	20	46057166 - 46057167	542328	533559	rs767708918	NC_000020.11:46057166:C:CC
NM_020708.5(SLC12A5):c.980dup (p.Asn328fs)	SLC12A5	N328fs, N351fs	Early infantile epileptic encephalopathy 34	Pathogenic(Last reviewed: Sep 17, 2017)	criteria provided, single submitter	VCV000475662	20	44670092 - 44670093	20	46041453 - 46041454	475662	469375	rs1555863593	NC_000020.11:46041453:T:TT
SLC19A3, 1-BP DUP, 74T	SLC19A3		Biotin-responsive basal ganglia disease	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000004567					4567	19606		
NM_001191061.2(SLC25A22):c.20+18dup	SLC25A22		not specified|Early infantile epileptic encephalopathy with suppression bursts	Benign(Last reviewed: Nov 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207147	11	794968 - 794969	11	794968 - 794969	207147	202647	rs796053236	NC_000011.10:794968:CC:CCC
NM_006516.4(SLC2A1):c.1028dup (p.Met344fs)	SLC2A1	M344fs	Dystonia 9|GLUT1 deficiency syndrome 2|GLUT1 deficiency syndrome 1|Stomatin-deficient cryohydrocytosis with neurologic defects	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000973266	1	43394648 - 43394649	1	42928977 - 42928978	973266	961587		NC_000001.11:42928977:CC:CCC
NM_006516.4(SLC2A1):c.1199_1200insGAG (p.Pro401_Ala402insSer)	SLC2A1		GLUT1 deficiency syndrome 1	Likely pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000807495	1	43393354 - 43393355	1	42927683 - 42927684	807495	798474	rs1570590905	NC_000001.11:42927683:C:CTCC
NM_006516.4(SLC2A1):c.46_47insCTCCTCA (p.Val16fs)	SLC2A1	V16fs	GLUT1 deficiency syndrome 1	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801471	1	43408964 - 43408965	1	42943293 - 42943294	801471	789969	rs1570601060	NC_000001.11:42943293::TGAGGAG
NM_006516.4(SLC2A1):c.161dup (p.Ser55fs)	SLC2A1	S55fs	Dystonia 9|Stomatin-deficient cryohydrocytosis with neurologic defects|Epilepsy, idiopathic generalized, susceptibility to, 12|GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 2	Pathogenic	criteria provided, single submitter	VCV000619980	1	43396830 - 43396831	1	42931159 - 42931160	619980	611376		NC_000001.11:42931159:T:TT
NM_006516.4(SLC2A1):c.299dup (p.Asn100fs)	SLC2A1	N100fs	GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000598771	1	43396513 - 43396514	1	42930842 - 42930843	598771	589826	rs1557646673	NC_000001.11:42930842:TT:TTT
SLC2A1, 3-BP INS, TAT	SLC2A1		GLUT1 deficiency syndrome 2	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000029723					29723	38678		
NM_006516.4(SLC2A1):c.283_284delinsAT (p.Ser95Ile)	SLC2A1	S95I	GLUT1 deficiency syndrome 2	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000016116	1	43396529 - 43396530	1	42930858 - 42930859	16116	31155	rs267607060	NC_000001.11:42930857:GA:AT
NM_003042.4(SLC6A1):c.1191+16_1191+17dup	SLC6A1		Myoclonic-atonic epilepsy|not provided	Benign/Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV001167573	3	11070542 - 11070543	3	11028856 - 11028857	1167573	1154274		NC_000003.12:11028856:CCCCCCCC:CCCCCCCCCC
NC_000003.11:g.(?_11067125)_(11078652_?)dup	SLC6A1		Myoclonic-atonic epilepsy	Likely benign(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001105892	3	11067125 - 11078652			1105892	1087673		
NM_003042.4(SLC6A1):c.643_661dup (p.Ala221fs)	SLC6A1	A101fs, A221fs, A43fs	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001073686	3	11064081 - 11064082	3	11022395 - 11022396	1073686	1059567		NC_000003.12:11022395:GGCCATCACGCTGGCCATCG:GGCCATCACGCTGGCCATCGGCCATCACGCTGGCCATCG
NM_003042.4(SLC6A1):c.1311dup (p.Asn438Ter)	SLC6A1	N260*, N318*, N438*	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV001070240	3	11071025 - 11071026	3	11029339 - 11029340	1070240	1059569		NC_000003.12:11029339:T:TT
NM_003042.4(SLC6A1):c.1004dup (p.Phe336fs)	SLC6A1	F158fs, F216fs, F336fs	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001069245	3	11067969 - 11067970	3	11026283 - 11026284	1069245	1059568		NC_000003.12:11026283:GG:GGG
NM_003042.4(SLC6A1):c.109_110delinsGC (p.Lys37Ala)	SLC6A1|SLC6A1-AS1	K37A	Myoclonic-atonic epilepsy	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001043596	3	11059006 - 11059007	3	11017320 - 11017321	1043596	1024906		NC_000003.12:11017319:AA:GC
NM_003042.4(SLC6A1):c.990_991delinsAG (p.Ser331Gly)	SLC6A1	S153G, S211G, S331G	Myoclonic-atonic epilepsy	Uncertain significance(Last reviewed: Jun 9, 2020)	criteria provided, single submitter	VCV001025339	3	11067957 - 11067958	3	11026271 - 11026272	1025339	1004411		NC_000003.12:11026270:CA:AG
NM_003042.4(SLC6A1):c.336dup (p.Leu113fs)	SLC6A1|SLC6A1-AS1	L113fs	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000845762	3	11059620 - 11059621	3	11017934 - 11017935	845762	827305		NC_000003.12:11017934:GGGGGG:GGGGGGG
NC_000003.12:g.(?_11025429)_(11036986_?)dup	SLC6A1		Myoclonic-atonic epilepsy	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000831392	3	11067115 - 11078672			831392	819311		
NM_003042.4(SLC6A1):c.1335dup (p.Val446fs)	SLC6A1	V268fs, V446fs, V326fs	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Jul 15, 2018)	criteria provided, single submitter	VCV000663338	3	11072873 - 11072874	3	11031187 - 11031188	663338	630746	rs1574917501	NC_000003.12:11031187:T:TT
NM_003042.4(SLC6A1):c.523_524insA (p.Ser175fs)	SLC6A1	S175fs, S55fs	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000661842	3	11061950 - 11061951	3	11020264 - 11020265	661842	630737	rs1574897036	NC_000003.12:11020264::A
NM_003042.4(SLC6A1):c.1461_1462insCAG (p.Val488_Gly489insGln)	SLC6A1		Myoclonic-atonic epilepsy	Uncertain significance(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000651285	3	11075358 - 11075359	3	11033672 - 11033673	651285	630747	rs1574922559	NC_000003.12:11033672:G:GCAG
NM_003042.4(SLC6A1):c.1191+17dup	SLC6A1		Myoclonic-atonic epilepsy|not provided	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000475468	3	11070542 - 11070543	3	11028856 - 11028857	475468	451967	rs3841958	NC_000003.12:11028856:CCCCCCCC:CCCCCCCCC
NM_004211.5(SLC6A5):c.1260+20_1260+23dup	SLC6A5		not provided|Hyperekplexia 3	Benign(Last reviewed: Jun 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV001168294	11	20639449 - 20639450	11	20617903 - 20617904	1168294	1156671		NC_000011.10:20617903:TAAG:TAAGTAAG
NC_000011.9:g.(?_20621199)_(20676434_?)dup	SLC6A5		Hyperekplexia 3	Uncertain significance(Last reviewed: Sep 16, 2020)	criteria provided, single submitter	VCV001054321	11	20621199 - 20676434			1054321	1039153		
NM_004211.5(SLC6A5):c.1294delinsTT (p.Val432fs)	SLC6A5	V198fs, V432fs	Hyperekplexia 3	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000005762	11	20648287	11	20626741	5762	20801	rs281864924	NC_000011.10:20626740:G:TT
NM_001379110.1(SLC9A6):c.448-9_448-8insC	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV001146037	X	135080632 - 135080633	X	135998473 - 135998474	1146037	1150434		NC_000023.11:135998473::C
NM_001379110.1(SLC9A6):c.448-8_448-7insG	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001102761	X	135080633 - 135080634	X	135998474 - 135998475	1102761	1108022		NC_000023.11:135998474::G
NC_000023.11:g.(?_135985483)_(136024503_?)dup	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000831697	X	135067642 - 135106662			831697	821559		
NM_001379110.1(SLC9A6):c.1080+80dup	SLC9A6		not provided|Christianson syndrome	Benign/Likely benign(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000804088	X	135095664 - 135095665	X	136013505 - 136013506	804088	792125	rs35492327	NC_000023.11:136013505:AAAAAAAAAAAA:AAAAAAAAAAAAA
NM_001379110.1(SLC9A6):c.447+3_447+4delinsCC	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000011478	X	135080347 - 135080348	X	135998188 - 135998189	11478	26517	rs730882187	NC_000023.11:135998187:AA:CC
NM_001330723.2(SNX27):c.1240-5_1240-4insCT	SNX27		Severe myoclonic epilepsy in infancy	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV001147301	1	151664905 - 151664906	1	151692429 - 151692430	1147301	1130407		NC_000001.11:151692429:T:TCT
NM_001330723.2(SNX27):c.1240-4_1240-3insCTT	SNX27		Severe myoclonic epilepsy in infancy	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV001089453	1	151664905 - 151664906	1	151692429 - 151692430	1089453	1066254		NC_000001.11:151692429:TT:TTCTT
NM_001330723.2(SNX27):c.543+6_543+7insA	SNX27		Severe myoclonic epilepsy in infancy	Likely benign(Last reviewed: May 18, 2019)	criteria provided, single submitter	VCV000724536	1	151611601 - 151611602	1	151639125 - 151639126	724536	743638	rs778540185	NC_000001.11:151639125::A
NM_001330723.2(SNX27):c.265dup (p.Ala89fs)	SNX27	A89fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000644220	1	151584935 - 151584936	1	151612459 - 151612460	644220	626820	rs781657502	NC_000001.11:151612459:GGGGGGG:GGGGGGGG
NM_001330723.2(SNX27):c.1356dup (p.Leu453fs)	SNX27	L453fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000462810	1	151665024 - 151665025	1	151692548 - 151692549	462810	447223	rs1553266166	NC_000001.11:151692548:AAA:AAAA
NM_145207.3(SPATA5):c.1870-4dup	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Benign(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV001166813	4	123949332 - 123949333	4	123028177 - 123028178	1166813	1154641		NC_000004.12:123028177:TTTTT:TTTTTT
NC_000004.11:g.(?_123868378)_(123900551_?)dup	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Uncertain significance(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV001000676	4	123868378 - 123900551			1000676	986257		
NC_000004.12:g.(?_122923123)_(123256200_?)dup	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Uncertain significance(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000833456	4	123844278 - 124177355			833456	819441		
NC_000004.12:g.(?_122947213)_(122979406_?)dup	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Uncertain significance(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000830470	4	123868368 - 123900561			830470	819442		
NM_145207.3(SPATA5):c.289-8_289-7insAACATTTATTTC	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome|not provided	Likely benign(Last reviewed: Mar 20, 2020)	criteria provided, single submitter	VCV000760443	4	123850187 - 123850188	4	122929032 - 122929033	760443	774917	rs1463673475	NC_000004.12:122929032::AACATTTATTTC
NM_145207.3(SPATA5):c.1039_1040dup (p.Gln347fs)	SPATA5	Q346fs, Q347fs	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000652524	4	123855784 - 123855785	4	122934629 - 122934630	652524	631927	rs1578528119	NC_000004.12:122934629:CA:CACA
NM_145207.3(SPATA5):c.164-1053_446+1328dup	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Likely pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000584441	4	123847734 - 123847735	4	122926579 - 122926580	584441	575512		
NM_145207.3(SPATA5):c.2079+1dup	SPATA5	V693fs	Epilepsy, hearing loss, and mental retardation syndrome	Likely pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000569060	4	123949549 - 123949550	4	123028394 - 123028395	569060	561892	rs1560894236	NC_000004.12:123028394:GG:GGG
NM_001130438.3(SPTAN1):c.6273_6274delinsTT (p.Arg2092Cys)	SPTAN1	R2067C, R2087C, R2072C, R2092C	not specified	Uncertain significance(Last reviewed: Aug 17, 2014)	criteria provided, single submitter	VCV000207368	9	131388251 - 131388252	9	128625972 - 128625973	207368	202427	rs796053333	NC_000009.12:128625971:CC:TT
NC_000001.10:g.(?_206516175)_(206567055_?)dup	SRGAP2		Undetermined early-onset epileptic encephalopathy	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495283	1	206516175 - 206567055			495283	486728		
NC_000001.10:g.(?_206579711)_(206634815_?)dup	SRGAP2		Undetermined early-onset epileptic encephalopathy	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495282	1	206579711 - 206634815			495282	486729		
NM_014467.3(SRPX2):c.112_163+10dup	SRPX2		Rolandic epilepsy with mental retardation and speech dyspraxia, X-linked	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001035311	X	99905809 - 99905810	X	100650812 - 100650813	1035311	1035288		
NC_000023.11:g.(?_100646303)_(100671007_?)dup	SRPX2		Rolandic epilepsy with mental retardation and speech dyspraxia, X-linked	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000833080	X	99901300 - 99926004			833080	821539		
NC_000002.11:g.(?_86067247)_(86116048_?)dup	ST3GAL5		GM3 synthase deficiency	Uncertain significance(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000584076	2	86067247 - 86116048	2	85840124 - 85888925	584076	559164		
NM_001003787.4(STRADA):c.189_190delinsCT (p.Pro64Ser)	STRADA	P27S, P35S, P56S, P64S, P6S	Polyhydramnios, megalencephaly, and symptomatic epilepsy	Uncertain significance(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001060344	17	61791402 - 61791403	17	63714042 - 63714043	1060344	1050485		NC_000017.11:63714041:GC:AG
NC_000017.10:g.(?_61803978)_(61805749_?)dup	STRADA		Polyhydramnios, megalencephaly, and symptomatic epilepsy	Uncertain significance(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000536766	17	61803978 - 61805749	17	63726618 - 63728389	536766	530535		
NM_001003787.4(STRADA):c.842dup (p.Asp281fs)	STRADA	D237fs, D252fs, D223fs, D273fs, D244fs, D281fs	Polyhydramnios, megalencephaly, and symptomatic epilepsy	Pathogenic(Last reviewed: Sep 17, 2021)	no assertion criteria provided	VCV000254243	17	61784010 - 61784011	17	63706650 - 63706651	254243	248751	rs886037929	NC_000017.11:63706650:T:TT
NM_052874.5(STX1B):c.252_257delinsAT (p.Ala85fs)	STX1B	A85fs	Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Mar 10, 2019)	criteria provided, single submitter	VCV000968105	16	31012272 - 31012277	16	31000951 - 31000956	968105	957735		NC_000016.10:31000950:TTGGCC:AT
NM_052874.5(STX1B):c.852dup (p.Thr285fs)	STX1B	T285fs	Generalized epilepsy with febrile seizures plus, type 9	Likely pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000961584	16	31004156 - 31004157	16	30992835 - 30992836	961584	949372		NC_000016.10:30992835:CCCCCC:CCCCCCC
NM_052874.5(STX1B):c.165dup (p.Gln56fs)	STX1B	Q56fs	Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000807504	16	31012454 - 31012455	16	31001133 - 31001134	807504	798699	rs1596719437	NC_000016.10:31001133:TTTTTT:TTTTTTT
NM_052874.5(STX1B):c.35_36dup (p.Asp13fs)	STX1B	D13fs	Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000567167	16	31012918 - 31012919	16	31001597 - 31001598	567167	570129	rs1567379671	NC_000016.10:31001597:TTT:TTTTT
NM_052874.5(STX1B):c.133_134insGGATGTGCATTG (p.Lys45delinsArgMetCysIleGlu)	STX1B		Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000162396	16	31012486 - 31012487	16	31001165 - 31001166	162396	172099	rs1114167275	NC_000016.10:31001165::CAATGCACATCC
NM_001032221.6(STXBP1):c.25delinsCT (p.Val9fs)	STXBP1	V9fs	Early infantile epileptic encephalopathy 4	Pathogenic	no assertion criteria provided	VCV001202628	9	130374707	9	127612428	1202628	1192637		NC_000009.12:127612427:G:CT
NM_001032221.6(STXBP1):c.989dup (p.Met330fs)	STXBP1	M294fs, M316fs, M327fs, M330fs	Infantile epilepsy syndrome	Pathogenic(Last reviewed: Mar 25, 2019)	no assertion criteria provided	VCV000984905	9	130434354 - 130434355	9	127672075 - 127672076	984905	972949		NC_000009.12:127672075:T:TT
NM_001032221.6(STXBP1):c.690_692dup (p.Leu231dup)	STXBP1		Infantile epilepsy syndrome	Likely pathogenic(Last reviewed: Mar 3, 2017)	no assertion criteria provided	VCV000984824	9	130428468 - 130428469	9	127666189 - 127666190	984824	972946		NC_000009.12:127666189:CTCCT:CTCCTCCT
NM_001032221.6(STXBP1):c.1381_1390dup (p.Arg464fs)	STXBP1	R464fs, R428fs, R450fs, R461fs	Early infantile epileptic encephalopathy 4|Infantile epilepsy syndrome	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000973268	9	130440722 - 130440723	9	127678443 - 127678444	973268	961612		NC_000009.12:127678443:GCCGGAGCAAGCCGGAGC:GCCGGAGCAAGCCGGAGCAAGCCGGAGC
NM_001032221.6(STXBP1):c.37+2dup	STXBP1		Early infantile epileptic encephalopathy 4	Pathogenic/Likely pathogenic(Last reviewed: Aug 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000870412	9	130374720 - 130374721	9	127612441 - 127612442	870412	858591		NC_000009.12:127612441:T:TT
NM_001032221.6(STXBP1):c.1492dup (p.His498fs)	STXBP1	H498fs, H462fs, H495fs, H484fs	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000620007	9	130442465 - 130442466	9	127680186 - 127680187	620007	611399	rs1564356269	NC_000009.12:127680186:C:CC
NM_001032221.6(STXBP1):c.692dup (p.Ile232fs)	STXBP1	I232fs, I218fs, I229fs	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000560298	9	130428472 - 130428473	9	127666193 - 127666194	560298	551300	rs1564351388	NC_000009.12:127666193:T:TT
SUCLA2, 43-BP DEL AND 5-BP INS	SUCLA2		Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	Pathogenic(Last reviewed: Jun 1, 2005)	no assertion criteria provided	VCV000005975					5975	21014		
NM_003849.4(SUCLG1):c.532_533delinsAA (p.Pro178Asn)	SUCLG1	P178N	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Uncertain significance(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV001030715	2	84668227 - 84668228	2	84441103 - 84441104	1030715	1016110		NC_000002.12:84441102:GG:TT
NM_003849.4(SUCLG1):c.[460C>T;987dup]	SUCLG1	A330fs, R154*	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: May 31, 2019)	no assertion criteria provided	VCV000998016	2|2	84652565 - 84652566	2|2	84425441 - 84425442	998016	985717|985718		NC_000002.12:84425441:A:AA|NC_000002.12:84441317:G:A
NM_003849.4(SUCLG1):c.457_458delinsTA (p.Val153Ter)	SUCLG1	V153*	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: Feb 16, 2020)	criteria provided, single submitter	VCV000818207	2	84668444 - 84668445	2	84441320 - 84441321	818207	806417	rs1573369929	NC_000002.12:84441319:AC:TA
NM_003849.4(SUCLG1):c.98-15_98-14insAACC	SUCLG1		Mitochondrial DNA depletion syndrome|Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000337163	2	84676890 - 84676891	2	84449766 - 84449767	337163	290736	rs886056352	NC_000002.12:84449766::GGTT
NM_006950.3(SYN1):c.1166dup (p.Ser390fs)	SYN1	S390fs	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001301801	X	47434665 - 47434666	X	47575266 - 47575267	1301801	1292084		NC_000023.11:47575266:CCC:CCCC
NM_006950.3(SYN1):c.1269_1270delinsTT (p.Gln423_Arg424delinsHisTrp)	SYN1		Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Uncertain significance(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV000998962	X	47434562 - 47434563	X	47575163 - 47575164	998962	999799		NC_000023.11:47575162:GC:AA
NM_006950.3(SYN1):c.1648_1649delinsTT (p.Ala550Phe)	SYN1	A550F	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Uncertain significance(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000944089	X	47433734 - 47433735	X	47574335 - 47574336	944089	929741		NC_000023.11:47574334:GC:AA
NC_000023.10:g.(?_47464357)_(47479147_?)dup	SYN1		Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Uncertain significance(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000533668	X	47464357 - 47479147	X	47604958 - 47619748	533668	534938		
NM_006950.3(SYN1):c.1439dup (p.Leu481fs)	SYN1	L481fs	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Likely pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000496675	X	47433943 - 47433944	X	47574544 - 47574545	496675	488164	rs1556857481	NC_000023.11:47574544:GGGGG:GGGGGG
NM_182961.4(SYNE1):c.226-2dup	SYNE1		Spinocerebellar ataxia, autosomal recessive 8|Arthrogryposis multiplex congenita 3, myogenic type|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|not provided|Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jul 9, 2019)	criteria provided, conflicting interpretations	VCV000279936	6	152841678 - 152841679	6	152520543 - 152520544	279936	264275	rs774388631	NC_000006.12:152520543:T:TT
NM_006772.3(SYNGAP1):c.3269dup (p.Asn1090fs)	SYNGAP1	N1076fs, N1090fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 28, 2021)	criteria provided, single submitter	VCV001285474	6	33411596 - 33411597	6	33443819 - 33443820	1285474	1275317		NC_000006.12:33443819:AA:AAA
NM_006772.3(SYNGAP1):c.190-9_190-8insCCCA	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001076726	6	33393566 - 33393567	6	33425789 - 33425790	1076726	1060656		NC_000006.12:33425789::CCCA
NM_006772.3(SYNGAP1):c.828dup (p.Lys277fs)	SYNGAP1	K277fs	Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001075097	6	33405504 - 33405505	6	33437727 - 33437728	1075097	1060658		NC_000006.12:33437727:CCCCCC:CCCCCCC
NM_006772.3(SYNGAP1):c.2387dup (p.Pro797fs)	SYNGAP1	P783fs, P797fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 14, 2020)	criteria provided, single submitter	VCV001071936	6	33410711 - 33410712	6	33442934 - 33442935	1071936	1060664		NC_000006.12:33442934:CCCCC:CCCCCC
NM_006772.3(SYNGAP1):c.3903dup (p.Pro1304fs)	SYNGAP1	P1304fs, W1286fs	Mental retardation, autosomal dominant 5	Uncertain significance(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001020775	6	33419548 - 33419549	6	33451771 - 33451772	1020775	1006597		NC_000006.12:33451771:CCCCCC:CCCCCCC
NM_006772.3(SYNGAP1):c.2250dup (p.Pro751fs)	SYNGAP1	P751fs	Intellectual disability|Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV000976428	6	33409487 - 33409488	6	33441710 - 33441711	976428	964278		NC_000006.12:33441710:GGGGG:GGGGGG
NM_006772.3(SYNGAP1):c.2621_2625dup (p.Ser876fs)	SYNGAP1	S876fs, S862fs	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000974573	6	33410946 - 33410947	6	33443169 - 33443170	974573	962861		NC_000006.12:33443169:GCCAGGCC:GCCAGGCCAGGCC
NM_006772.3(SYNGAP1):c.3587dup (p.Glu1197fs)	SYNGAP1	E1197fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000934236	6	33414354 - 33414355	6	33446577 - 33446578	934236	933304		NC_000006.12:33446577:AA:AAA
NM_006772.3(SYNGAP1):c.761dup (p.Asp255fs)	SYNGAP1	D255fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000813755	6	33403387 - 33403388	6	33435610 - 33435611	813755	801991		NC_000006.12:33435610:AA:AAA
NM_006772.3(SYNGAP1):c.3384dup (p.Leu1129fs)	SYNGAP1	L1129fs, L1115fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000813751	6	33411707 - 33411708	6	33443930 - 33443931	813751	801993		NC_000006.12:33443930:GGGGGG:GGGGGGG
NM_006772.3(SYNGAP1):c.3599dup (p.Glu1201fs)	SYNGAP1	E1185fs, E1201fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802205	6	33414367 - 33414368	6	33446590 - 33446591	802205	790620	rs1582001015	NC_000006.12:33446590:A:AA
NM_006772.3(SYNGAP1):c.1677-3dup	SYNGAP1		Mental retardation, autosomal dominant 5|not provided	Benign(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000765431	6	33408497 - 33408498	6	33440720 - 33440721	765431	775229	rs1381203371	NC_000006.12:33440720:CCCCCC:CCCCCCC
NM_006772.3(SYNGAP1):c.3167_3188dup (p.Pro1065fs)	SYNGAP1	P1065fs, P1051fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000646638	6	33411491 - 33411492	6	33443714 - 33443715	646638	634861	rs1581996778	NC_000006.12:33443714:GGGGGCAGCGGTGGGGGTGGCGGGGG:GGGGGCAGCGGTGGGGGTGGCGGGGGGCAGCGGTGGGGGTGGCGGGGG
NM_006772.3(SYNGAP1):c.2391_2392dup (p.Pro798fs)	SYNGAP1	P798fs, P784fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000645497	6	33410718 - 33410719	6	33442941 - 33442942	645497	634853	rs1581995453	NC_000006.12:33442941:CAC:CACAC
NM_006772.3(SYNGAP1):c.539dup (p.His181fs)	SYNGAP1	H181fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000620049	6	33402957 - 33402958	6	33435180 - 33435181	620049	611393	rs1561783309	NC_000006.12:33435180:C:CC
NM_006772.3(SYNGAP1):c.2635_2636delinsAA (p.Ala879Lys)	SYNGAP1	A865K, A879K	not provided|Mental retardation, autosomal dominant 5	Likely benign(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV000575856	6	33410964 - 33410965	6	33443187 - 33443188	575856	565618	rs1561789088	NC_000006.12:33443186:GC:AA
NM_006772.3(SYNGAP1):c.1235dup (p.Leu412fs)	SYNGAP1	L412fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000569874	6	33405915 - 33405916	6	33438138 - 33438139	569874	563522	rs1561785003	NC_000006.12:33438138:TT:TTT
NM_006772.3(SYNGAP1):c.2272dup (p.Tyr758fs)	SYNGAP1	Y758fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000567471	6	33409513 - 33409514	6	33441736 - 33441737	567471	563527	rs1561787845	NC_000006.12:33441736:T:TT
NM_006772.3(SYNGAP1):c.3416dup (p.Thr1140fs)	SYNGAP1	T1140fs, T1126fs	Inborn genetic diseases|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000522008	6	33412227 - 33412228	6	33444450 - 33444451	522008	511673	rs1554122458	NC_000006.12:33444450:A:AA
NM_006772.3(SYNGAP1):c.857_864dup (p.Met289fs)	SYNGAP1	M289fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000469164	6	33405537 - 33405538	6	33437760 - 33437761	469164	456125	rs1554121189	NC_000006.12:33437760:CTGGATGAC:CTGGATGACTGGATGAC
NM_006772.3(SYNGAP1):c.384dup (p.Ser129fs)	SYNGAP1	S129fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000469158	6	33400023 - 33400024	6	33432246 - 33432247	469158	456122	rs1554120498	NC_000006.12:33432246:CCC:CCCC
NM_006772.3(SYNGAP1):c.2066_2071delinsC (p.Leu689fs)	SYNGAP1	L689fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	VCV000212349	6	33409102 - 33409107	6	33441325 - 33441330	212349	207407	rs797046029	NC_000006.12:33441324:TCTCCA:C
NM_001199107.2(TBC1D24):c.76_77delinsTT (p.Glu26Leu)	TBC1D24	E26L	Epileptic encephalopathy, early infantile, 1|Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65	Uncertain significance(Last reviewed: May 26, 2020)	criteria provided, single submitter	VCV001026209	16	2546225 - 2546226	16	2496224 - 2496225	1026209	1012056		NC_000016.10:2496223:GA:TT
NC_000016.9:g.(?_2546130)_(2550979_?)dup	TBC1D24		Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24	Uncertain significance(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000655213	16	2546130 - 2550979	16	2496129 - 2500978	655213	653128		
NM_001199107.2(TBC1D24):c.*3478dup	TBC1D24		Myoclonic epilepsy, familial infantile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318685	16	2554415 - 2554416	16	2504414 - 2504415	318685	342590	rs901354911	NC_000016.10:2504414:TTTTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTTT
NM_001199107.2(TBC1D24):c.*2875dup	TBC1D24		Myoclonic epilepsy, familial infantile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318676	16	2553832 - 2553833	16	2503831 - 2503832	318676	341046	rs886051864	NC_000016.10:2503831:TT:TTT
NM_001199107.2(TBC1D24):c.*2851dup	TBC1D24		Myoclonic epilepsy, familial infantile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318671	16	2553802 - 2553803	16	2503801 - 2503802	318671	342575	rs376511845	NC_000016.10:2503801:CCCCCCCC:CCCCCCCCC
NM_001199107.2(TBC1D24):c.*2834_*2835insA	TBC1D24		Myoclonic epilepsy, familial infantile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318670	16	2553793 - 2553794	16	2503792 - 2503793	318670	334470	rs548778667	NC_000016.10:2503792::A
NM_001199107.2(TBC1D24):c.*2624_*2625dup	TBC1D24		Myoclonic epilepsy, familial infantile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318666	16	2553570 - 2553571	16	2503569 - 2503570	318666	324858	rs35944492	NC_000016.10:2503569:TTTTTTTTTTTTTT:TTTTTTTTTTTTTTTT
NM_001199107.2(TBC1D24):c.*2625dup	TBC1D24		Myoclonic epilepsy, familial infantile	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318665	16	2553570 - 2553571	16	2503569 - 2503570	318665	324860	rs35944492	NC_000016.10:2503569:TTTTTTTTTTTTTT:TTTTTTTTTTTTTTT
NM_001199107.2(TBC1D24):c.1460dup (p.His487fs)	TBC1D24	H481fs, H487fs	DOORS syndrome	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000183156	16	2550425 - 2550426	16	2500424 - 2500425	183156	181293	rs797044549	NC_000016.10:2500424:A:AA
NM_005149.3(TBX19):c.*1109dup	TBX19		Adrenocorticotropic hormone deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000293498	1	168283347 - 168283348	1	168314109 - 168314110	293498	277090	rs550552066	NC_000001.11:168314109:CC:CCC
NM_005149.3(TBX19):c.1053-11dup	TBX19		Adrenocorticotropic hormone deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000293479	1	168281934 - 168281935	1	168312696 - 168312697	293479	277322	rs138050448	NC_000001.11:168312696:T:TT
NM_005149.3(TBX19):c.603+10_603+11insTT	TBX19		Adrenocorticotropic hormone deficiency	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000293471	1	168262525 - 168262526	1	168293287 - 168293288	293471	277077	rs373712384	NC_000001.11:168293287:T:TTT
NM_005149.3(TBX19):c.603+10_603+11insTTGT	TBX19		Adrenocorticotropic hormone deficiency	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000293470	1	168262523 - 168262524	1	168293285 - 168293286	293470	277078	rs72294615	NC_000001.11:168293285:TGT:TGTTTGT
NM_005149.3(TBX19):c.603+10_603+11insTTGTGT	TBX19		not provided|Adrenocorticotropic hormone deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000293466	1	168262522 - 168262523	1	168293284 - 168293285	293466	278097	rs746785887	NC_000001.11:168293284:GTGT:GTGTTTGTGT
NM_005149.3(TBX19):c.603+6_603+7insCTGTGT	TBX19		Adrenocorticotropic hormone deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000293461	1	168262522 - 168262523	1	168293284 - 168293285	293461	278094	rs746838916	NC_000001.11:168293284::CTGTGT
NM_001083962.2(TCF4):c.1772_1776delinsCT (p.Leu591_Gly592delinsPro)	TCF4		Inborn genetic diseases	Likely pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000520970	18	52896181 - 52896185	18	55228950 - 55228954	520970	512362	rs1555710416	NC_000018.10:55228949:GCCGA:AG
NM_001083962.2(TCF4):c.680_682delinsT (p.Trp227fs)	TCF4	W156fs, W227fs, W202fs, W233fs, W329fs, W67fs, W11fs, W185fs, W203fs, W225fs, W226fs, W97fs	not provided	Pathogenic(Last reviewed: Jan 10, 2013)	criteria provided, single submitter	VCV000207541	18	52942957 - 52942959	18	55275726 - 55275728	207541	203510	rs796053425	NC_000018.10:55275725:TCC:A
NC_000011.9:g.(?_59596957)_(68707199_?)dup	TMEM216|TMEM223|TMEM258|TRMT112|TRPT1|TSGA10IP|ZFPL1|ZFTA|VWCE|WDR74|YIF1A|ZBTB3|ZDHHC24|TUT1|UBXN1|TTC9C|ACTN3|UNC93B1|UQCC3|VEGFB|VPS37C|VPS51|ACY3|AHNAK|AIP|ALDH3B1|ALDH3B2|ANKRD13D|AP5B1|ARL2|ASRGL1|ATG2A|ATL3|B3GAT3|B4GAT1|BAD|BANF1|BATF2|BBS1|BEST1|BRMS1|BSCL2|C11orf24|C11orf68|C11orf80|C11orf86|CABP2|CABP4|CAPN1|CARNS1|CATSPER1|CATSPERZ|CBLIF|CCDC85B|CCDC86|CCDC87|CCDC88B|CCS|CD248|CD5|CD6|CDC42BPG|CDC42EP2|CDCA5|CDK2AP2|CFL1|CHKA|CHRM1|CLCF1|CNIH2|CORO1B|COX8A|CPSF7|CPT1A|CSKMT|CST6|CTSF|CTSW|CYB561A3|DAGLA|DDB1|DNAJC4|DPF2|DPP3|DRAP1|EEF1G|EFEMP2|EHBP1L1|EHD1|EIF1AD|EML3|ESRRA|FADS1|FADS2|FADS3|FAM89B|FAU|FEN1|FERMT3|FIBP|FKBP2|FLRT1|FOSL1|FRMD8|FTH1|GAL|GAL3ST3|GANAB|GNG3|GPHA2|GPR137|GPR152|GRK2|GSTP1|HNRNPUL2|IGHMBP2|INCENP|INTS5|KAT5|KCNK4|KCNK7|KDM2A|KLC2|KMT5B|LBHD1|LGALS12|LRFN4|LRP5|LRRC10B|LRRN4CL|LTBP3|MACROD1|MAJIN|MALAT1|MAP3K11|MAP4K2|MARK2|MEN1|MIR192|MIR194-2|MRPL11|MRPL21|MRPL49|MS4A1|MS4A10|MS4A12|MS4A13|MS4A14|MS4A15|MS4A18|MS4A2|MS4A3|MS4A4A|MS4A4E|MS4A5|MS4A6A|MS4A6E|MS4A7|MS4A8|MTA2|MUS81|MYRF|NAA40|NAALADL1|NDUFS8|NDUFV1|NDUFV1-DT|NEAT1|NPAS4|NRXN2|NUDT22|NUDT8|NXF1|OOSP2|OTUB1|OVOL1|PACS1|PC|PCNX3|PELI3|PGA3|PGA4|PGA5|PITPNM1|PLAAT2|PLAAT3|PLAAT4|PLAAT5|PLCB3|POLA2|POLD4|POLR2G|PPP1CA|PPP1R14B|PPP1R32|PPP2R5B|PPP6R3|PRDX5|PRPF19|PTGDR2|PTPRCAP|PYGM|RAB1B|RAB3IL1|RAD9A|RASGRP2|RBM14|RBM14-RBM4|RBM4|RBM4B|RCE1|RCOR2|RELA|RHOD|RIN1|RNASEH2C|ROM1|RPS6KA4|RPS6KB2|RTN3|SAC3D1|SART1|SCGB1A1|SCGB1D1|SCGB1D2|SCGB1D4|SCGB2A1|SCGB2A2|SCYL1|SDHAF2|SF1|SF3B2|SIPA1|SLC15A3|SLC22A10|SLC22A11|SLC22A12|SLC22A24|SLC22A25|SLC22A6|SLC22A8|SLC22A9|SLC25A45|SLC29A2|SLC3A2|SNHG1|SNORD22|SNORD25|SNORD26|SNORD27|SNORD28|SNORD29|SNORD30|SNORD31|SNX15|SNX32|SPDYC|SPINDOC|SPTBN2|SSH3|STIP1|STX5|SYT12|SYT7|SYVN1|TAF6L|TBC1D10C|TBX10|TCIRG1|TCN1|TESMIN|TIGD3|TKFC|TM7SF2|TMEM109|TMEM132A|TMEM134|TMEM138|TMEM151A|TMEM179B|ZNHIT2|ZNRD2|ZP1		Epilepsy, familial temporal lobe, 8	Uncertain significance(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001062699	11	59596957 - 68707199			1062699	1039156		
TNRC6A, 5-BP INS, TTTCA(n)	TNRC6A		Epilepsy, familial adult myoclonic, 6	Pathogenic(Last reviewed: Aug 3, 2018)	no assertion criteria provided	VCV000559390					559390	550118		
NM_000391.4(TPP1):c.1087delinsTT (p.Ala363fs)	TPP1	A363fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000969357	11	6637294	11	6616063	969357	956594		NC_000011.10:6616062:C:AA
NM_000391.4(TPP1):c.1397_1408delinsGACACCGA (p.Val466fs)	TPP1	V466fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000967557	11	6636419 - 6636430	11	6615188 - 6615199	967557	956592		NC_000011.10:6615187:ATGGAATGGGCA:TCGGTGTC
NM_182916.3(TRNT1):c.1252dup (p.Ser418fs)	TRNT1	S418fs, S398fs	not provided|Retinitis pigmentosa and erythrocytic microcytosis|Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000234934	3	3189778 - 3189779	3	3148094 - 3148095	234934	236731	rs876661298	NC_000003.12:3148094:AAAAAAA:AAAAAAAA
NM_000368.5(TSC1):c.86_90dup (p.Glu31fs)	TSC1	E31fs	Tuberous sclerosis 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000569229	9	135804169 - 135804170	9	132928782 - 132928783	569229	565705	rs1564504869	NC_000009.12:132928782:TTTAA:TTTAATTTAA
NM_000368.5(TSC1):c.737_737+1dup	TSC1		not provided	Pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	VCV000207646	9	135796748 - 135796749	9	132921361 - 132921362	207646	202498	rs118203435	NC_000009.12:132921361:CC:CCCC
NM_000548.5(TSC2):c.4005+4_4005+7dup	TSC2		not specified|Tuberous sclerosis 2	Conflicting interpretations of pathogenicity(Last reviewed: Feb 20, 2020)	criteria provided, conflicting interpretations	VCV000207793	16	2133817 - 2133818	16	2083816 - 2083817	207793	203180	rs796053519	NC_000016.10:2083816:GTGAGTG:GTGAGTGAGTG
NM_000548.5(TSC2):c.3738dup (p.Thr1247fs)	TSC2	T1155fs, T1204fs, T1167fs, T1203fs, T1214fs, T1247fs, T1003fs	not provided	Pathogenic(Last reviewed: Jan 2, 2015)	criteria provided, single submitter	VCV000207776	16	2131722 - 2131723	16	2081721 - 2081722	207776	203174	rs796053506	NC_000016.10:2081721:C:CC
NM_000548.5(TSC2):c.2859dup (p.Lys954fs)	TSC2	K954fs	Tuberous sclerosis 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 27, 2020)	criteria provided, conflicting interpretations	VCV000207774	16	2127614 - 2127615	16	2077613 - 2077614	207774	203156	rs796053504	NC_000016.10:2077613:CCCCCC:CCCCCCC
NM_025265.4(TSEN2):c.770_776delinsCA (p.Tyr257fs)	TSEN2	Y257fs, Y198fs	Pontocerebellar hypoplasia type 2B	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV001031439	3	12545222 - 12545228	3	12503723 - 12503729	1031439	1019736		NC_000003.12:12503722:ACGTGCT:CA
NM_001077446.4(TSEN34):c.862_865dup (p.Leu289fs)	TSEN34	L289fs	Pontocerebellar hypoplasia type 2C	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804160	19	54697144 - 54697145	19	54193289 - 54193290	804160	791960	rs1246937494	NC_000019.10:54193289:CCTGC:CCTGCCTGC
NM_207346.3(TSEN54):c.1216dup (p.Thr406fs)	TSEN54	T406fs	Pontocerebellar hypoplasia type 5	Likely pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000930694	17	73518377 - 73518378	17	75522296 - 75522297	930694	919770		NC_000017.11:75522296:A:AA
NM_207346.3(TSEN54):c.1397dup (p.Gly467fs)	TSEN54	G467fs	Pontocerebellar hypoplasia type 2A	Pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	VCV000212452	17	73519824 - 73519825	17	75523743 - 75523744	212452	208420	rs797046055	NC_000017.11:75523743:CCC:CCCC
NM_207346.3(TSEN54):c.1386_1387insTA (p.Lys463Ter)	TSEN54	K463*	Pontocerebellar hypoplasia type 2A	Pathogenic(Last reviewed: Apr 10, 2015)	criteria provided, single submitter	VCV000212451	17	73519815 - 73519816	17	75523734 - 75523735	212451	208419	rs797046054	NC_000017.11:75523734:A:ATA
NC_000023.10:g.(?_99551255)_(99926004_?)dup	TSPAN6|SRPX2|PCDH19|TNMD		Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000831118	X	99551255 - 99926004			831118	821535		
NC_000002.12:g.(?_165090130)_(166311776_?)dup	TTC21B|SCN9A|SCN3A|SCN1A|CSRNP3|GALNT3|SCN2A		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|Early infantile epileptic encephalopathy 11|Seizures, benign familial infantile, 3|not provided|Early infantile epileptic encephalopathy with suppression bursts	Uncertain significance(Last reviewed: Jun 29, 2020)	criteria provided, single submitter	VCV000831785	2	165946640 - 167168286			831785	819059		
NM_006009.4(TUBA1A):c.196_206delinsACGTGTGTCGC (p.Val66_Asp69delinsThrCysValAla)	TUBA1A		Lissencephaly 3	Likely pathogenic	no assertion criteria provided	VCV000977831	12	49580414 - 49580424	12	49186631 - 49186641	977831	965987		NC_000012.12:49186630:TCTACAAACAC:GCGACACACGT
NM_175748.4(UBR7):c.35_54dup (p.Ser19fs)	UBR7	S19fs	Intellectual disability, mild	Pathogenic(Last reviewed: Aug 11, 2020)	no assertion criteria provided	VCV001294425	14	93673670 - 93673671	14	93207325 - 93207326	1294425	1284215		NC_000014.9:93207325:CGGAGCTGGAGCCCGTGGTA:CGGAGCTGGAGCCCGTGGTACGGAGCTGGAGCCCGTGGTA
NM_001083961.2(WDR62):c.1821dup (p.Arg608fs)	WDR62	R608fs	not provided|Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000817049	19	36579989 - 36579990	19	36089087 - 36089088	817049	806043	rs1213710245	NC_000019.10:36089087:TTT:TTTT
NM_016373.4(WWOX):c.516+6_516+7delinsCT	WWOX		Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12	Likely benign(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV001157774	16	78198192 - 78198193	16	78164295 - 78164296	1157774	1146548		NC_000016.10:78164294:TG:CT
NC_000016.9:g.(?_78198060)_(78198206_?)dup	WWOX		Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12	Likely pathogenic(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001067418	16	78198060 - 78198206			1067418	1054598		
NC_000016.9:g.(?_78133656)_(78458972_?)dup	WWOX		Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12	Uncertain significance(Last reviewed: Apr 24, 2020)	criteria provided, single submitter	VCV001054449	16	78133656 - 78458972			1054449	1039206		
NC_000016.9:g.(?_78133671)_(78466659_?)dup	WWOX		Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12	Uncertain significance(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV001008077	16	78133671 - 78466659			1008077	986584		
NM_016373.4(WWOX):c.854dup (p.Asn285fs)	WWOX	N172fs, N285fs	Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000941526	16	78466441 - 78466442	16	78432544 - 78432545	941526	937626		NC_000016.10:78432544:AAAAAA:AAAAAAA
NC_000016.10:g.(?_78386840)_(78624496_?)dup	WWOX		Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12	Uncertain significance(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000832944	16	78420737 - 78658393			832944	820883		
NC_000016.10:g.(?_78386840)_(78432772_?)dup	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Uncertain significance(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV000831308	16	78420737 - 78466669			831308	820882		
NM_016373.4(WWOX):c.108-13dup	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1|not provided	Benign(Last reviewed: Nov 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000676824	16	78142301 - 78142302	16	78108404 - 78108405	676824	668595	rs146697931	NC_000016.10:78108404:TTTTTT:TTTTTTT
NC_000016.9:g.(?_78312480)_(78658393_?)dup	WWOX|LOC110120570|LOC112486209		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Uncertain significance(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000662278	16	78312480 - 78658393	16	78278583 - 78624496	662278	652662		
NC_000016.9:g.(?_78133656)_(78149071_?)dup	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Uncertain significance(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV000661187	16	78133656 - 78149071	16	78099759 - 78115174	661187	652481		
NC_000016.9:g.(?_78133656)_(78658393_?)dup	WWOX|WWOX-AS1|LOC110120570|LOC112486209		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Uncertain significance(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000583748	16	78133656 - 78658393	16	78099759 - 78624496	583748	569815		
NC_000016.9:g.(?_78133656)_(78133806_?)dup	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Uncertain significance(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000583609	16	78133656 - 78133806	16	78099759 - 78099909	583609	567542		
NC_000016.9:g.(?_78458747)_(78466669_?)dup	WWOX|LOC112486209		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Likely pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000583590	16	78458747 - 78466669	16	78424850 - 78432772	583590	569399		
NC_000016.9:g.(?_78312480)_(78466669_?)dup	WWOX|LOC112486209		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Uncertain significance(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000583479	16	78312480 - 78466669	16	78278583 - 78432772	583479	569397		
NC_000016.9:g.(?_78133656)_(78198206_?)dup	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Uncertain significance(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000540248	16	78133656 - 78198206	16	78099759 - 78164309	540248	529274		
Single allele	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000473015			16	78318746 - 78386940	473015	464847		
NC_000016.9:g.(?_78133656)_(78466669_?)dup	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Uncertain significance(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000473014	16	78133656 - 78466669			473014	465441		
NM_014795.4(ZEB2):c.760_761dup (p.Gln255fs)	ZEB2	Q231fs, Q255fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000004758	2	145161528 - 145161529	2	144403961 - 144403962	4758	19797	rs587776605	NC_000002.12:144403961:GTG:GTGTG
NM_022095.4(ZNF335):c.757dup (p.Arg253fs)	ZNF335	R253fs	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000521497	20	44596429 - 44596430	20	45967790 - 45967791	521497	512455	rs1555851216	NC_000020.11:45967790:GG:GGG
